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ABSTRACT OF DISSERTATION

A MASS SPECTROMETRY-BASED STUDY OF SERUM
BUTYRYLCHOLINESTERASE INHIBITION FROM PESTICIDE EXPOSURE
AND ORGANOPHOSPHATE PESTICIDE-INDUCED PROTEOME ALTERATION
Pesticides including organophosphates (OPs) and carbamates (CBs) are widely
used to control undesirable pests.

These compounds are neurotoxic and inhibit

hydrolysis of the neurotransmitter acetylcholine by acetylcholinesterase. Public health
concerns have increased with the escalating usage of pesticides. Reliable monitoring
programs are required to detect and quantify pesticide exposure, as well as to promote
an understanding of their neurotoxic properties.

In this dissertation, both the

anticholinergic (Part I) toxicity and neurotoxicity in neuroblastoma cells (Part II) of
pesticides were explored using mass spectrometry (MS). The high sensitivity and
high-throughput of this technique renders it well-suited for proteomics analysis.
Part I describes the study of butyrylcholinesterase (BChE) inhibition resulting
from OP and CB exposure.

The main hypothesis of Part I is that the special

modification of BChE can provide the origin and extent of pesticide exposure. A novel
method for detection and quantification of pesticide exposure was designed using a
proteomics approach and equine BChE (eBChE) as a model system. The methodology
featured detection and analysis of phosphorylated or carbamylated peptides at the
active site serine residue. The developed technique was successfully applied towards
the study of human BChE (hBChE) inhibition in vitro and in serum samples. A
specially designed affinity column enabled an isolation of BChE from serum. Enriched
BChE was subjected to enzymatic digestion by a novel on-bead double digestion
protocol. LC/MS/MS was employed to produce a calibration system for the analysis of
hBChE inhibition, which was then applied towards quantification of the enzyme.

Part II describes a proteomic study of the neurotoxicity in neuroblastoma cells
caused from chlorpyrifos (CPF), an organophosphate pesticide. The concerns of CPF
exposure to pregnant women, infants and children are increasing due to
developmentally neurotoxic effects of this chemical. The main hypothesis of Part II is
that CPF can cause protein alterations and these altered proteins can be detected using
proteomics. Systematic studies at subcellular levels evaluated proteome changes in
SH-SY5Y cells exposed to CPF. Two-dimensional gel electrophoresis (2DE) was
applied with MALDI-TOF-MS to analyze differential protein expression. Thirty seven
common unique altered proteins were identified, which play important roles in
metabolic pathway.
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GENERAL INTRODUCTION
PESTICIDE BACKGROUND
Pesticides are biologically active by design and intentionally dispersed into the
environment. They are extensively used in the world to destroy or control undesired pests,
including insects, weeds, bacteria or other organisms. A prominent group of cholinesterase
inhibitors includes two different kinds of pesticides, organophosphate (OP) and carbamate
(CB), which were investigated in this dissertation. The following describes their properties,
metabolism, and mode of action.
Properties
Forty one different kinds of OPs are registered for use in the United States. They
are normally esters, amides, or thiol derivatives of phosphoric, phosphonic,
phosphorothioic, or phosphonothioic acids. Although there are various structures of OPs,
they share a common basic structure (R1)(R2)(X)P=(S or O). All OPs contain a central
phosphorus atom with a double bond to either sulfur or oxygen. R1 and R2 groups are
usually simple alkyl or aryl groups, both of which may be either bonded directly to the
phosphorus, or linked via –O–, or –S–. A leaving group X is specific to the individual OP,
which can be any one of a wide variety of substituted and branched aliphatic, aromatic, or
heterocyclic groups linked to phosphorus via a bond (usually –O– or –S–). In order to be
useful, these OP compounds must be reasonably stable at a neutral pH. Many OPs are
formulated as high concentration in oil, or in a water-miscible solvent, and they are slightly
soluble in water and have a high oil-water partition coefficient and low vapor pressure. As
such, OPs are applied either directly or after dispersion in water to reach target organisms.
All the OPs can be degraded by hydrolysis, yielding water-soluble products that are
believed to be non-toxic at all practical concentrations.
More than 50 cabamates are known as N-substituted esters of carbamic acid. Their
general structure is R1NHC(O)OR2, in which R2 is an aromatic and/or aliphatic moieties.
Three main classes of CBs are known: (i) carbamate insecticides (R1 is a methyl group); (ii)
carbamate herbicides (R1 is an aromatic moiety); and (iii) carbamate fungicides (R1 is a
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benzimidazole moiety). Carbamate ester derivatives are crystalline solids of low vapor
pressure with variable, but usually low, water solubility. They are moderately soluble in
solvents such as benzene, toluene, xylene, and chloroform. In general, they are poorly
soluble in nonpolar organic solvents such as petroleum but highly soluble in polar organic
solvents like ethanol. CBs can be hydrolyzed by alkali. The instability in alkali is of use for
decontamination and clean-up.
Metabolism
The metabolic fate of OPs and CBs is basically the same in insects, and animals.
Animals take in OPs and CBs through the skin, inhalation, or gastrointestinal tract.
Metabolism of OPs occurs primarily by oxidation, hydrolysis by esterases, and by transfer
of portions of the molecule to glutathione. Oxidation of OPs may result in more or less
toxic products. Phosphorothioates generally require oxidative metabolism to produce the
proximal toxin, which exerts their acute effects. The rates of hydrolysis of OPs by esterases
mostly are faster in mammals than insects. Therefore, mammals are often more efficient in
their detoxification processes. In most cases, the products from the glutathione transferase
reactions are of low toxicity. Hydrolytic and transferase reaction affect both the thioates
and their oxons. Numerous conjugation reactions follow primary metabolic processes, and
elimination of the phosphorus-containing residue may be via the urine and feces.
CBs are metabolically transformed by a variety of chemical reactions, including
oxidation and enzymatic hydrolysis by enzyme, into more water soluble molecules with
increased polar properties. Oxidative products are more or less toxic and are cholinesterase
inhibitors. CBs are hydrolyzed either spontaneously or by esterases, yielding as final
products, an amine, carbon dioxide, and an alcohol or phenol. Most mammals have more
efficiency in hydrolytic enzymes than insects and, therefore, are often more efficient their
detoxification processes. The conversion to conjugated compounds of the hydroxyl
products produced from the primary metabolic processes is an important reaction that leads
to the water-soluble compounds, which can be eliminated via urine and feces.
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Mode of action
OPs and CBs exert their acute effects in both insects and mammals by inhibiting
acetylcholinesterase (AChE) in the nervous system with subsequent accumulation of toxic
levels of acetylcholine (ACh), which is a neurotransmitter. In many cases, the
organophosphorylated enzyme is fairly stable, so that recovery from intoxication may be
very slow. However, the carbamylated enzyme is unstable, and the regeneration of AChE
is relatively rapid compared with that of a phosphorylated enzyme. Thus, carbamate
pesticides are less dangerous with regard to human exposure than OPs. The ratio between
the dose required to cause death and the dose required to produce minimum symptoms of
poisoning is substantially larger for CBs than for OPs.
With the introduction of the organophosphate pesticides (OPs) and carbamates
(CBs) into American agriculture, interest in their chemistry, mode of action, and toxicity
has increased. Many articles and books have been published concerning the inhibitory
action of pesticides on AChE. The inhibitory action of OPs and CBs on AChE appears to
be largely responsible for their toxicity toward invertebrates and vertebrates. The action of
pesticides may be purely anticholinergic; however, several researchers discovered that
some of the OPs chlorpyrifos (CPF) for example are more than cholinergic agonist.
In this dissertation, both the anticholinergic properties (Part I) and neurotoxicity in
neuroblastoma cells (Part II) of CPF were studied using proteomics approaches and mass
spectrometry (MS). In the last decade, the sensitivity of MS has improved by several orders
of magnitude (1). Because of the high sensitivity, selectivity and its high-throughput
operations, MS has become an increasingly reliable technique for protein identification.
Two new mass spectrometric techniques, electrospray ionization (ESI) and matrix-assisted
laser desorption/ionization (MALDI), have dramatically extended protein analysis. These
two types of mass spectrometry work in different ways and produce different, but
complementary, information. Both MALDI and LC/MS were applied in this dissertation
and will be discussed later.
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PROTEOMICS BACKGROUND
Marc Wilkins and colleagues first mentioned “proteomics” and “proteome” to
mirror “genomics” and “genome” in the early 1990s. Proteomics is the protein complement
of the organism’s genome (2). Three developments changed the biological landscape and
formed the foundation of the new biology. The first was the growth of the gene database,
expressed sequence tag (EST), and protein sequence databases during the 1990s. The
genome-sequencing projects yielded complete genomic sequences of bacteria, yeast,
nematodes, and drosophila, and culminated recently in the complete sequence of the
human genome in the late 1990s. The second key development was the introduction of
browser-based bioinformatics tools to extract information from the gene databases.
Searching an entire genome for specific nucleic acid or protein sequences in seconds is
possible. The third key development is the oligonucleotide microarray. The array contains
a series of gene-specific oligonucleotides or cDNA sequences on a slide or a chip.
Although gene microarrays offer a global view of the expression of many or all
genes in a cell, it can not predict the levels of the corresponding proteins in a cell. In
addition, mRNA levels tell us nothing about the functions of the corresponding proteins,
whose activities and functions are subject to many posttranslational modifications.
Consequently, many proteins are present in many forms. The detection and differentiation
between multiple protein isoforms add an analytical challenge of proteomics.
To address these concerns, scientific researchers recently started to focus on
elucidating genomic sequence to total protein analysis, giving rise to a new scientific
discipline called “proteomics” (3, 4). Proteomics requires analytical tools to detect and
quantify proteins in their different isoforms. Currently two methods, “top-down” and
“bottom-up”, are performed for proteomics analysis. Both techniques rely on mass
spectrometry (MS) for the protein analysis. However, only “bottom-up” proteomics is
described and used in this dissertation.
Bottom-up Proteomics
A proteomics approach currently drawing the most attention is that of bottom-up
proteomics. The approach collects protein information from the analysis of peptides
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generated from proteolytic digests and can be carried out via two basic strategies. The first
strategy of proteomics approaches (Figure 0-1 A) is known as the peptide mass
finger-printing scheme by combination of two dimensional gel electrophoresis (2D gel)
with mass spectrometry. The protein mixture can be resolved by 2D gel in high resolution,
and proteins can be identified using MS in high sensitivity. A typical protocol of this
approach begins with 2D gel electrophoresis, where protein mixtures are separated by
charge (pI) in the first dimension and then separated orthogonally by size (MW) in the
second dimension. Resolved proteins are visualized by staining proteins with Coomassie
Blue, SYPRO Ruby, or Silver staining. After analysis of the 2D gel image with software
e.g. PDQuest (Bio-Rad), proteins of interest are excised and subjected to in-gel digestion.
The digests are further analyzed to generate mass spectra by MALDI-TOF-MS. The
experimental peptide masses are then compared to the theoretical ones from the insilico
digestion of the protein database to identify the protein of interest.
A second proteomic approach is by peptide fragmentation (Figure 0-1B). The
approach starts to convert a protein or protein mixture into peptides by protease digestion
(Figure 0-1 B). Generated peptides are then resolved by different types of chromatography
columns, and each peptide is subjected to MS/MS analysis to produce unique peptide
fragmentations. Through electrospray ionization (ESI), peptides in the HPLC effluent are
directly introduced into the mass analyzer, such as ion trap or triple quadrupole, allowing
on-line MS/MS analysis. The experimental MS/MS spectrum of each peptide is compared
with the theoretical MS/MS spectra to elucidate its amino acid sequence using modern
protein database search algorithms. Thus, the parent protein of interest is identified.
Bottom-up Proteomics Tools
As described in the previous section, the growth of proteomics is dependent on the
development of mass spectrometry and the ability to rapidly obtain accurate masses of
proteins and peptides. A typical proteomics experiment is divided into three main classes:
protein preparation and analysis, mass spectrometry, and bioinformatics. A variety of
instrumentation is required to resolve protein/peptide mixtures and introduce them to the
analyzer for analysis. After an analysis using mass spectrometry, bioinformatics tools are
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A

Protein mixture

Digest Protein mixture to
peptides

Two dimensional gel
electrophoresis (2D gel)

Digest pure protein to peptides

B

Mass spectrometer

Multi-dimensional
peptide separation

Database search to identify
proteins

Figure 0-1. Strategies for the analysis of protein mixture using mass spectrometry. (A)
Protein mixtures can be resolved by 2D gel electrophoresis. The protein of interest is
picked, digested, and analyzed by mass spectrometry. (B) The entire protein mixture is
digested, separated by multi-dimensional chromatography, analyzed by tandem MS, and
identified by database search.
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then applied to identify proteins of interest by searching protein databases. This section
will describe some important tools used in this dissertation. These tools include HPLC, two
dimensional gel electrophoresis (2DE), MALDI-TOF-MS, ESI, and quadrupole ion trap
mass analyzer.
High-pressure Liquid Chromatography
High-pressure liquid chromatography (HPLC) separation/ electrospray ionization
(ESI) mass spectrometric detection has been an important tool in proteomics since the last
ten years (5, 6). HPLC performs separation by pumping the mobile phase through a column
at high pressure to increase the separation performance. Furthermore, the diversity of
stationary phases and separation modes increases HPLC resolving power. The major
HPLC separation modes used in peptide separation and the characteristics that dictate
separation are listed as follows.
•

Reversed phase (RP): hydrophobicity

•

Strong cation exchange: net positive charge

•

Strong anion exchange: net negative charge

•

Affinity: interaction with specific functional groups

However, RP-HPLC is usually chosen for resolving a mixture of peptides. The stationary
phase of RP-HPLC is non-polar, and the mobile phase is a polar solvent. A typical
stationary phase of the reversed phase (RP) chromatography consists of silica based
packings or the other supports covalently bound with n-alkyl chains. For example, C-8
signifies an octyl chain and C-18 an octadecyl ligand in the matrix. A typical mobile phase
is a mixture of water or buffer with polar solvents such as methanol, acetonitrile, or
tetrahydrofuran.
The more hydrophobic the matrix, the greater is the tendency of the column to
retain hydrophobic moieties. There are three competing explanations for retention in
reverse phase chromatography: the hydrophobic theory, partitioning, and adsorption.
However, a complete theory of retention mechanism of reversed-phase chromatography
must include both partitioning and adsorption(7). The theory of Jaroniec (8) treats the
retention mechanism as a mixture of partitioning and displacement. The partitioning model
can explain how peptide mixtures can be resolved in RP-HPLC. Based on this theory, an
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equilibrium exists when peptides partition between the stationary phase and the liquid
mobile phase. Peptides migrate in and out of the stationary phase along with the mobile
phase. However, the equilibrium can be shifted toward the mobile phase by increasing the
organic component of the solvent. Peptides in a mixture are separated based on their
hydrophobicity using a gradient mobile phase of increasing organic component.
The separation of a peptide mixture into its individual components takes place in
the chromatography column. In order to understand the mechanism of retention and
selectivity and thus be in a position to exercise some control over the chromatography
system, it is necessary to know the theory of chromatography. Next, the theory of
chromatography, especially of the hydrodynamics of chromatography will be covered.
The quality of a separation is measured by the plate count N, which is related to the
height equivalent to a theoretical plate (HETP). HETP is described by the equation:
h=

dσ 2
dL

(0.1)

Where L is the column length, σ is the standard deviation of a Gaussian distributed
chromatographic peak. Generally, if HETP is plotted against a linear velocity, a curved
relationship with a minimum of the HETP will be obtained (Figure 0-2). Among all the
equations describing the dependence of the HETP on linear velocity, the van Deemter
equation (9) is conceptually the simplest. It is assumed that the overall spreading of a peak
is the result of a number of individual, non-interacting, random processes that, taken
together, account for the total peak dispersion. Since these contributions are independent of
each other, HETP is simply described by adding them up:

H = A+

B
+ Cu
u

(0.2)

Where u is the velocity; A, velocity-independent, is a function of the size and
distribution of the inter-particle channels and other non-uniformities in the packed bed; B,
describing the molecular diffusion in the axial direction, is inversely proportional to the
linear velocity; C, containing all terms related to mass transfer, is directly proportional to
the linear velocity.
The A term of the van Deemter equation is expressed as

A = λi d p
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(0.3)

Resistance to
Mass Transfer
Mobile phase

Resistance to
Mass Transfer
Stationary Phase

HEPT

Longitudinal
Diffusion

Multi-path Term
Optimum
Velocity

Mobile Phase Velocity

Figure 0-2. Relationship between HETP and linear velocity. The curve has a minimum
and the right-hand branch increases usually practically linearly with the linear velocity.
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Where λi stands for the factor of the packed bed, which is between 1.5 and 2, dp is the
particle diameter. The A term is proportional to the particle size and can be influenced by
the column packing technique.
The B term of the van Deemter equation is described as
B = 2γ

DM
u

(0.4)

The coefficient γ is the obstruction factor, which depends on the amount and the
nature of the “obstruction” that is in the way of free movement of the molecule. The factor

γ is usually between 0.5 and 1. DM is the diffusion coefficient in the mobile phase,
assuming that the diffusion coefficient in the pores is the same as that in the interstitial
mobile phase.
Now, let us look at the term of the van Deemter equation that describes all the
phenomena resulting in an increase in HETP with increasing linear velocity. This term
includes the mass transfer from the center of the moving mobile phase to the surface of the
particle (mobile-phase mass transfer), through the stagnant mobile phase in the pores to the
stationary phase on the internal surface of the packing (mobile-phase mass transfer
resistance to the stagnant mobile phase), and the interaction kinetics with the stationary
phase (stationary-phase mass transfer). Although these contribute to the resistance to mass
transfer, a rough estimation is made for the coefficient on the mass-transfer term in a
packed bed with porous particles in the practical range as
C=c

dp

2

DM

(0.5)

u

Where the coefficient c is between 0.1 and 0.3 in most practical cases; dp is the
particle diameter; DM is the diffusion coefficient in the mobile phase.
The whole van Deemter equation is described as follows, including all the
coefficients used to estimate the HETP for a normal packed bed of porous particles:
2

D
1 dp
H = 1 .5 d p + M +
u
u
6 DM

(0.6)

The plate count of a column can be estimated using this equation assuming that the
diffusion coefficient is known. Figure 0-2 shows a curve with a minimum, which means
that there is an optimum mobile phase velocity at which the column will give the minimum
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HETP, and consequently, a maximum efficiency. In practice, this usually means that
reducing the flow rate of a column will increase the efficiency, and thus, the resolution. In
doing so, however, it also will increase the analysis time. In addition, there is a limit to
velocity procedure, as reducing the column flow rate so that the mobile phase velocity falls
below the optimum will result in an increase in the HETP, and thus, a decrease in column
efficiency.
It is seen that equation (0.6) is explicit and would permit the design of a column to
have the particular efficiency required for a specified analysis. Based on this theory,
designed columns, packed in laboratory, were applied in this dissertation. ESI requires low
liquid flow rate and, thus, very small diameter HPLC columns. Currently, microflow
(μl/min) and nanoflow (nl/min) HPLC have already been developed (10). Packed capillary
columns range in inner diameter (I.D.) from 50-500 μm with 15 to 30 cm in length. The
required flow range (e.g.100 nl/min to 5 μl/min) for a packed capillary column with
conventional HPLC pump can be obtained by using a flow splitter prior to the injector. In
addition to the compatibility with direct mass spectrometry, microflow and nanoflow
HPLC also provide an advantage of smaller sample volumes and increased sensitivity.
Two-dimensional Gel Electrophoresis
Two-dimensional gel electrophoresis (2D gel) is still the best method for
simultaneously resolving highly complex protein mixtures. In brief, 2D gels resolve
proteins in the first dimension by charge (pI) and in the second dimension by molecular
weight (MW) (Figure 0-3).
The introduction of immobilized pH gradients (IPG) for the isoelectric forcusing
step (IEF), has greatly improved the reproducibility of 2D gel electrophoresis (11). IPGs
are based on the principle that the pH gradient is generated by a limited number of
well-defined chemicals, which are co-polymerized with the acrylamide matrix. IPGs allow
the generation of pH gradients of any desired range between pH 3 and 12. The first
dimension of 2D gel electrophoresis, isoelectric focusing (IEF), is performed in individual
IPG gel strips 5 mm wide. Prior to IEF, the IPG strip is hydrated with protein mixture in
sample hydration buffer (containing chaotic reagent and ampholytes), and proteins are
slowly loaded into the strip under voltage prior to isoelectric focusing. After 12 hours of
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Figure 0-3. Schematic representation of 2D gel electrophoresis.
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loading time, the voltage is then increased to achieve focusing. With the presence of a pH
gradient in the IEF technique, a protein will migrate to the position in the gradient where its
charge is zero. Proteins with a positive net charge will migrate toward the cathode until it
meets its pI. Similarly, proteins with a negative net charge will migrate toward the anode
until it meets its pI. IEF is performed under high voltages (> 1000 V) until the proteins have
reached their final position in the pH gradient.
After the focusing step, the strip is then treated with equilibration buffers
containing a thiol reductant and denaturing reagent (i.e. SDS) followed by loading it on the
second dimensional gel, polyacrylamide gel electrophoresis (PAGE). In this situation, the
IPG strip with the focused proteins is like a ‘stacking gel’ in a 1D SDS gel electrophoresis.
The proteins are then separated on the SDS-PAGE on the basis of their size in the same
manner as the 1D gel electrophoresis. Gels are run at constant current until the blue dye
front line reaches the bottom of the gel. After termination of the second dimension run
(PAGE), it is necessary to immobilize the resolved proteins in the gel with a fixing solution.
TCA (20%) or methanolic or ethanolic acetic acid are widely used as fixatives. Proteins
can be visualized by several staining methods – silver staining, fluorescent staining,
colloidal Coommassie Blue G-250 staining, and Coommassie R-250 staining. The protein
of interest can be digested with proteolytic enzymes, such as trypsin. The digest is then
subjected to MALDI-TOF-MS or ESI-MS analysis.
MALDI-TOF-MS
MALDI Source
For purposes of proteomics, data on peptide masses is obtained by matrix-assisted
laser desorption ionization-time of flight (MALDI-TOF), whereas MALDI refers to a
method of ionization, and TOF refers to the mass analyzer. The question of how to obtain
good data requires us to understand how a MALDI-TOF instrument works. It is easiest to
start with the MALDI source for understanding the principle of MALDI-TOF instruments.
The production of ions depends on the selection of laser and matrix.
Lasers and Matrix
There are different kinds of lasers, including ultraviolet (UV) and infrared (IR)
lasers. Because of their ease of use and low price, UV lasers are the most common.
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Nitrogen lasers (λ = 337 nm) and Nd : YAG (λ = 266 or 355 nm) are used, among which
nitrogen lasers are considered standard. IR lasers include Er : YAG lasers (λ = 2.94 μm)
and CO2 lasers (λ = 10.6 μm). The production of ion current depends on the total energy in
the laser pulse at a given wavelength. The pulse widths of lasers vary from a few tens of
nanoseconds to a few hundred microseconds. Big molecular ions are generally observed at
slightly higher laser power. However, high energy causes extensive fragmentation and
lower mass resolution. It is important to set up a suitable laser pulse power, which starts
desorption of the matrix, to obtain a high quality mass spectrum.
High quality mass spectra also depend on the matrix selection. A good matrix must
have the following properties: strong absorbance at the laser wavelength, low molecular
weight, stability in high vacuum condition, and low chemical reactivity. After
investigating numerous matrix candidates, only a few have been proven as good matrices
(Table 0-1). Table 0-1 lists some common matrices and their applications in the
compounds analysis.
Principle of MALDI
Matrix-assisted laser desorption/ionization is achieved in two steps. In the first step,
the analyte is mixed with a chemical matrix solution containing small organic molecules,
which absorb light at a certain wavelength. The most popular matrix compounds are
α-cyano-4-hydroxycinnamic acid (CHCA), 2,5-dihydroxybenzoic acid (DHB), and
3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid). A dried-droplet method is the
most frequently used on-target preparation. The protocol for producing a dried droplet
sample has several simple steps. First, make a saturated solution of the matrix chemical
ands mix with sufficient peptide for a final concentration of 1-10 mM. Second, place a
droplet (0.5-2 µl) of the former solution on the sample target of the mass spectrometer. Dry
the droplet at room temperature or through blowing room-temperature air over the droplet
to dry the spot. The result is a “solid solution” deposit of analyte-mixed matrix crystals,
where the analyte molecules are distributed in the matrix and separated from each other.
The second step involves irradiation of the solid solution by an intense pulse of
laser light. The laser energy can be adjusted to ionize different samples. The matrix
chemicals absorb photons from a laser beam, which induces rapid heating of the crystals.
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Table 0-1. Some common UV-MALDI matrices.
Matrix

Applications

α-Cyano-4-hydroxycinnamic acid

Peptides, proteins, organic compounds

3,5-Dimethoxy-4-hydroxycinnamic acid

Higher mass biopolymers

2,5-Dihyoxybenzoic acid

Peptides, proteins, carbohydrates

3-Hydroxypicolinic acid

Oligonucleotides

Trihydroxyacetophenone

Oligonucleotides, peptides

5-chlorosalicylic acid

Water-insoluble polymers
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Such rapid heating causes localized sublimation of matrix crystals and dispersion of the
matrix into the gas phase. During this process, the matrix serves to reduce sample damage
from the laser pulse by absorbing most of the incident energy. At the same time, the matrix
also plays important roles in the energy transfer from the laser to analyte. Ionization
reactions can occur at any time during this process. However, it is still not fully understood
how the ions are originally produced in MALDI. Chemical and physical ionization
pathways for MALDI include gas-phase photonization, excited-state proton transfer,
ion-molecule reactions, desorption of preformed ions, etc. It is most widely accepted that
the ion formation mechanism involves gas-phase proton transfer in the expanding cloud
with photonized matrix molecules. Both positive and negative ions can be formed during
ionization process based on the nature of the sample. Usually, each peptide molecule
accepts one proton from the matrix as it enters into the gas phase to form a single-charged
ion. Because of the pulse property of laser desorption, a time-of-flight analyzer is chosen as
a detector. The ions formed in the MALDI source are then extracted and directed into the
TOF mass analyzer.
TOF Analyzer
The first linear time-of-flight (TOF) was developed in 1946 by Stephens (12). After
ions are expelled from the source in bundles produced by laser desorption, they are
accelerated by a high potential field. Ions with different mass-to-charge ratios have the
same kinetic energy, but with different velocities resulting in different flight time through a
field free drift tube. Mass-to-charge ratios are determined by the flight time in the drift tube
between the source and the detector. When an ion leaves the ion source, its kinetic energy
is described as:

mv 2
= zeVs
2

(0.7)

Where m and z are the mass and charge of the ion, v is the velocity of the ion, Vs is
the acceleration voltage.
The time needed to pass through the drift-tube (distance is d):

t=

d
v

(0.8)

16

Replacing v with the former equation (0.7), it gives a new equation as following:

t2 =

m d2
(
)
z 2Vs e

(0.9)

This equation shows that the lower the m/z ratio, the faster it will reach the detector.
The typical length of flight tube is 1-2 m, and acceleration voltage of at least 20 kV for
keeping the sensitivity high.
Due to variations in the velocities of ions of the same m/z, the resolution of linear
mode is poor. Mass resolution is affected by the following factors: the length of the ion
formation pulse (time distribution), where the ions are formed (space distribution), and
initial kinetic energy of the ions (kinetic energy distribution). A technique called “pulse ion
extraction” was first developed by Wiley and McLaren in the 1950s (13). A time delay
between ion formation and extraction is used to reduce the kinetic energy distribution of
ions with the same m/z ratio. The process of delayed pulses extraction has two simple steps.
First, ions produced in the source are allowed to expand into a field-free region. Second, a
voltage pulse is applied to extract the ions outside the source after a certain delay (hundreds
of nanoseconds to several microseconds).
In the delayed pulse extraction mode, ions initially separate according to their
kinetic energy in the field-free region. For ions with the same m/z ratio, those with more
kinetic energy move further toward the detector than those with less energy. Then the
extraction pulse is applied after a certain delay time, which transmits more energy to the
ions that remained for a longer time in the source. Thus, the ions with initially less energy
receive more kinetic energy. Thus, ions with the same m/z ratios are energy focused.
Reflectron mode of TOF analyzer was used in this dissertation (Figure 0-4). The
reflectron field is composed of a series of grids and ring electrodes, which was first
proposed by Mamyrin (14). It acts as an ion mirror by reflecting the ions and sending them
back through the flight tube. The higher resolution in the reflectron mode is obtained by a
reflecting field at the end of the flight tube equipped with higher potential and the same
polarity as the accelerating voltage. Ions with the same m/z value but different velocities
are time-focused with the reflector. Indeed, ions with more kinetic energy will penetrate
the reflectron more deeply and will spend more time in reflectron. Thus, they reach the
detector as the same time as those with slower velocity.
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Figure 0-4. Schematic representation of reflectron mode of MALDI-TOF-MS.
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If two ions with the same m/z ratio but with different energies: one with kinetic
energy Ek and another one with kinetic energy Ek’, we define the ratio of two kinetic
energies as
Ek '
= a2
Ek

(0.10)

So, the ratio of the velocity of two ions can be obtained
Vis '
=a
Vis

(0.11)

Thus, the ratio of the time of these two ions in the field-free flight is

t' = t / a

(0.12)

And the ratio of the time of these two ions in the reflectron is
'

tr
=a
tr

(0.13)

The total flight time (including flight time in field-free tube and reflectron field) for
these two ions are
'

tTOT = t + t r , and tTOT ' = t ' + t r = t / a + at r

(0.14) (0.15)

When a > 1, ions with high kinetic energy take less time to pass through the
field-free tube, but will spend longer time inside the reflectron field. Thus, the variations of
the flight times compensate each other. A good compensation will yield the same total
flight time for all ions with the same m/z ratios but with different kinetic energy, which
requires the proper values for reflectron field strength, acceleration voltage, and the length
of the field-free flight tube.
Post Source Decay (PSD)

The term post-source decay refers to the fragmentation of molecular ions, which
occurs after ion acceleration field and prior to detection region. PSD analysis is an
extension of MALDI-TOF-MS, which allows one to observe and identify structural
information of precursor ions. The precursor ion can be selected by applying electrodes
after the source on the ion path before entering into the field free tube. Ions can be deflected
by applying potential. Turning off this potential for a short time allows the selected ions to
pass through. After leaving the ion source, all ions have the same nominal kinetic energy,
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most of them are unfragmented precursor ions and they already acquired internal energy by
various mechanisms. During their flight through the field-free drift region they have a long
time available for post source decay into product ions. These product ions still have
basically the same velocity as their precursor ions, but have a much lower kinetic energy
because of their lower mass. The kinetic energy of the product ions is a measure of their
mass. The kinetic energy of fragment products is described as:

E kf = E kp

mf
mp

(0.16)

Where Ekf and Ekp are kinetic energy of fragment and precursor ions respectively,

mf and mp are the mass of the fragment and precursor ions.
Thus, the penetration depth of fragments in the reflectron is:

x f = xp

mf
mp

(0.17)

Where xf and xp are the penetration depth of fragment and precursor in the
reflectron.
Hence, the flight time of the fragment in the reflectron is:

t rf = t rp

mf
mp

(0.18)

This equation shows that the fragment ions take shorter time in the reflectron than
the precursor. Measurement of the flight times of fragment ions corresponding to a
particular precursor ion makes it possible to get the sequence information of this ion.
Although PSD is not the best MS technique to obtain peptide sequencing, it was
successfully used to identify the phosphorylated peptide in this dissertation.
LC/MS Instrument
Electrospay Ionization

The success of electrospray ionization (ESI) started when Fenn and coworkers
showed that multiply charged ions were obtained from proteins (15). Proteins in multiple
charged forms are detected with the instruments whose mass range is limited to as low as
2000 Da. Later on, the use of ESI extended not only to analyze polymers or biopolymers,
but also to analyze small polar molecules. ESI is widely used throughout the biochemical
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field, since it is easily coupled with high performance liquid chromatography (HPLC),
micro-HPLC and capillary electrophoresis. A lot of researchers discussed electrospray
principles and its biological applications(16-18). Based on the understanding of their
theories, the following describes the principle of electrospray.
An electrospray is produced by applying a strong electric field(19-22), which is
obtained by the use of a potential difference of 3-6 kV between a capillary and its
counter-electrode located at the entrance to the mass spectrometer 0.3-2 cm away. When a
flow in stream containing sample is pumped through this narrow-bore capillary with high
potential, the resulting high field induces a charge accumulation at the liquid surface
located at the end of the capillary, which will break into droplets with multiple charges
(Figure 0-5). Gas at a low flow rate is applied coaxially to disperse the spray into a mist of
very fine, charged droplets. The ‘onset voltage’ to form a spray depends on the solvent, the
surface tension of which is different for different solvents. As this voltage is applied, the
shape of the drop changes (Figure 0-6), and the surface tension is broken. During this time,
charge separation of ions occurs in solution as negative ions migrate to the needle surface
and positive ions move toward to the counter electrode. As the solvent contained in the
droplets evaporates, the droplets shrink to the point where the repelling coulombic forces
reach the Rayleigh instability limit, thereby causing their division. These droplets continue
to be divided, and they become smaller and smaller. This process of droplet desolvation
and fissions continues until all solvent is completely removed and only ions in gas phase
remain.
A unique characteristic of ESI is the production of multiply charged ions for big
molecules such as proteins and peptides. These multiply charged ions are either in
positive-ion mode, or negative-ion mode, and also cover a range of charge states. On
average, one charge is added per 1000 Da in mass. Many peptides have multiple proton
accepting sites, resulting in singly charged or multiply charged ions in solution. Because
tryptic peptides have lysine or arginine residues at their C-termini as well as N-terminal
amino groups, and both of them can be protonated in acidic solutions, they normally have
double charges. Obtaining multiply charged ions is an especially convenient feature, since
ESI can analyze high-molecular-weight molecules using an analyzer with a weak nominal
mass limit, such as a quadrupole mass filter.
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Figure 0-5. Schematic representation of a typical ESI source.
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Figure 0-6. Schematic representation of electrochemical process in ESI.
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The Quadrupole Ion Trap

In 1960, Paul and Steinwedel (23) (24) invented the ion trap, which was further
developed to a useful mass spectrometer by Stafford et al. (25). An ion trap is comprised of
three hyperbolic electrodes: the ring electrode, the entrance endcap electrode and the exit
endcap electrode. Both endcap electrodes have small holes in the center through which the
ions can enter/exit. The ring electrode is located halfway between the two endcap
electrodes. Paul and Steinwedel proposed that this ion trap could be used as a mass
spectrometer by applying a resonant frequency on the endcap to expel the ions along z.
Stable trajectory of ions at a given masse can be located by the mathematic analysis
through the Mathieu equation. In the trap, the motion of ions is in three dimensions, x, y,
and z, which is under the influence of the applied potentials on the ring electrode. However,
because the ion trap is cylindrical symmetry x 2 + y 2 = r 2

, two coordinates, z and r, are

used to describe the motion of the trapped ions (Figure 0-7).
The equations of the movement of ions inside the trap are described as followed:

d 2z
4Ze
−
(U − V cos ωt ) z = 0
2
2
2
dt
m(r0 + 2 z 0 )

(0.19)

d 2r
2 Ze
−
(U − V cos ωt )r = 0
2
2
2
dt
m(r0 + 2 z 0 )

(0.20)

Where ω is the angular frequency (in rad s-1) = 2πν, ν is the frequency of the radio
frequency (RF) on the ring electrode, U is the direct potential and V is the amplitude of the
RF voltage, r0 is the distance between the center of the ion trap and the ring electrode, Z is
used for the number of charges, r and z are the distance between the ring and endcap
electrodes, respectively.
The following equation was established in 1866 by Mathieu in order to describe the
propagation of waves in membranes:
d 2u
+ (au − 2qu cos 2ξ )u = 0
dξ 2

(0.21)

Where u stands for either z or r. Comparing the preceding equations with this Mathieu

24

Endcap Electrode

Ring
Electrode

Ions In
Fundamental rf

V

Auxiliary ac

V

Ring Electrode
Endcap Electrodes

Ions Out

Figure 0-7. Quadrupole ion trap. (A) Photograph of dissembled ion trap. (B) Schematic

representation of an ion trap MS instrument.
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equation, the following changes of variables allow the equation of motion to be depicted in
the form of Mathieu equation:

ξ=

ωt
2

, au = a z = −a r =
qu = q z = −q r =

− 16 ZeU
2

2

m(r0 + 2 z 0 )ω 2
8ZeV
2

2

m(r0 + 2 z 0 )ω 2

(0.22)
(0.23)

As long as r and z both are less than r0 and z0, ions are trapped in the ion trap with a
stable trajectory. A function e (α +iβ ) is needed to integrate the Mathieu equation by the
Floquet and Fourier method. The stable trajectories of ions requires both α = 0 and
0 < β u < 1 . The parameter βu can be obtained from qu and au parameters of the Mathieu
equation. A simpler approximate equation of βu is as following for qu is less than 0.4.

β u = [au + (q u 2 / 2)]1 / 2

(0.24)

Because βu can be calculated from qu and au, and also based on the limitation of β u
for a stable trajectory, a, q values inside the limited values of βu for a stable trajectory are
displayed in Figure 0-8. Based on the expression of equation (0.23), qz will increase if V
increases and will decrease if m increases assuming the other parameters (including r0 ,z0
and ω) are constant. If V is increased, the qz value of all the ions will become bigger. When

qz= 0.908, β is equal to 1, the ion has reached its stability limit. This ion will have an
unstable trajectory if the V is slightly increased, and will be ejected from the trap in the z
direction, which allows the ions present in the trap to be analyzed. Thus, a mass spectrum is
generated by sequentially ejecting fragment ions from low mass to high mass by scanning
amplitudes of the fundamental rf potential that sequentially makes the ion trajectories
unstable; 50% of the ejected ions will reach the detector.
Ions can also be ejected from the trap by applying a supplementary potential on the
endcap electrodes. This technique is called as “resonance ejection”, which allows ejection
to occur at voltage lower than those required for ejection at qz = 0.908. Resonance is caused
by matching the frequency of the supplementary potential to the secular frequency (fz ) of
the ion, which is determined by the values of βz and the frequency of the fundamental rf.
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Figure 0-8. Stability diagram for a quadrupole ion trap. The value at βu=1 along the qz axis

is qz =0.908(26).
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f z = β zν / 2

(0.25)

where fz is secular frequency, ν is the frequency of the fundamental rf.
If the frequency of the supplementary potential is at fz, the ion will come in
resonance and the amplitude of its oscillations will increase along the z-axis. If the applied
amplitude is sufficient, the oscillations of the ion will be large enough to be ejected from
the trap in z direction. When resonance ejection is used and the amplitude of the voltage is
ramped from low to high amplitudes, all the ions are sequentially ejected from the trap and
detected. It is also used to isolate ions in the trap by combination of forward and reverse
resonance ejection ramps.
After the production of ions, they are focused through a skimmer and two RF-only
octapoles. A gating lens is used to manipulate the number of the injected ions to an
acceptable limit with a reasonable resolution and sensitivity. A positive potential is used
for positive ions. However, during injection of ions, a negative potential is used to draw
ions into ion trap. A gating time can be calculated in order to inject the selected number of
ions, which will not overfill the trap and produce a space-charge effect. After the injection
of ions in the trap, they encounter helium to remove excess energy by collision. The
pressure of helium in the ion trap is around 1x10-3 torr. Ions can be further analyzed
according to their masses by scanning the fundamental rf voltage on the ring or
combination with additional rf voltage to the endcaps as described before.
In some circumstance, it may be desirable to obtain structure information of a
particular ionized molecule subjecting it to MS/MS fragmentation. The special isolation of
an ion with a particular m/z in the ion trap prior to the ion dissociation event is required for
tandem mass analysis. There are several ways to perform tandem mass spectrometry in an
ion trap. The general sequence of operation is described as follows.
First, ions with a particular mass-to-charge ratio were isolated through expelling all
other ions from ion trap. This approach can be obtained in several ways. One approach for
isolation of a precursor ion is by selecting the precursor ion at the apex of the stability
diagram. This is accomplished through the use of a dc potential to the ring electrode in
addition to the preexisting fundamental rf. The ion of interest is brought to the apex of the
stability diagram (Figure 0-9) by a combination of dc and rf potentials. All other ions will
be ejected from ion trap at qz less than 0.908. Another approach to isolate a precursor ion is
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by the use of a supplemental potential to the endcaps through resonance ejection of all ions
except for the selected one.
Secondly, a precursor ion isolated in an ion trap is then subjected to fragmentation
into product ions. This fragmentation is improved by excitation of the selected ions
through the application of a low-amplitude ac resonance signal across the endcap
electrodes, which causes the ion kinetic energies to increase. These excited ions are then
subjected to dissociate due to many collisions with the helium damping gas.
Finally, tandem mass spectrum is obtained by one of the scanning methods:
stability limit or with the assistance of resonance ejection as described before.
Perhaps the biggest strength of the ion trap technique lies in the multiple stages of
mass spectrometry. Up to 12 stages of tandem mass (MS12) have been performed using an
ion trap, which greatly increase the structural information for a given molecule. Product
ions can also be further isolated and dissociated to provide MSn mass spectra using this
technique. MSn is obtained by retaining the fragment ions from MS/MS and further
acquiring another round of fragmentation. MSn analysis is useful to yield highly detailed
information in certain cases. For example, a dominant doubly charged fragment ion
corresponds to the loss of the modification group from the interesting alkyl-phosphorylated
peptide, which makes it impossible to localize the modification site. So, MS3 is further
applied to determine the amino acid sequence, and localize the phosphorylation site.
STATEMENT OF RESEARCH

As mentioned before, the actions of pesticides on the organisms include
anticholinergic mode and neurotoxic mode. Both of the properties of pesticides are
investigated in this dissertation. The remainder of this dissertation is divided into two parts:
anticholinergic study of pesticides (Part I), and toxic study of CPF in neuroblastoma cells
(Part II).
Anticholinergic Study of Pesticides

The first part of this dissertation studied the butyrylcholinesterase (BChE)
inhibition resulting from OPs and CBs. Three steps were included in this project. First of
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all, a new methodology was developed for the detection and quantification of pesticide
exposure using MALDI-TOF and eBChE as a model system (Chapter 2 of Part I). The
methodology was based on the analysis of pesticide-inhibited BChE, particularly based on
the detection of modified active site peptide produced from trypsin digests of the enzyme.
Although MALDI method was proven to be useful for the analysis of single pesticide
exposure, the lower response of phosphorylated peptide in MALDI and the suppression of
the modified peptides in a peptide mixture make this method limited for the analysis of
multiple pesticide exposure. In the second stage, an in vitro investigation was designed to
examine the relative quantification of each pesticide exposure, and to identify the types of
pesticide using LC/MS/MS and eBChE as a model system (Part I, Chapter 3). This
LC/MS/MS technique was successfully applied to analyze a mixture of the phosphorylated
peptides in vitro, and the precursor ions were monitored by a common fragment ion.
Finally, the developed technique was applied to investigate hBChE inhibition in vitro and
in serum samples (Part I, Chapter 4 and 5). Chapter 4 of Part I focused on the method
development for synthesizing the affinity column, which enabled the isolation of BChE
from the serum. The performance characteristics of the synthesized affinity beads were
evaluated. Chapter 5 described the application of the developed method (LC/MS/MS
method) towards the analysis of hBChE inhibition in the serum sample. A calibration
system was constructed for the analysis of hBChE inhibition, which was then applied
towards the quantification of the enzyme present in the serum. A novel on-bead double
digestion protocol was investigated. The reliability of this double digestion was also
evaluated.
Neurotoxic study of CPF

The second part of this dissertation studied the neurotoxic properties of CPF, an
organophosphate. Systematic studies at subcellular levels were designed to evaluate
proteome changes in SH-SY5Y cells exposed to CPF. Two-dimensional gel
electrophoresis (2DE) was applied with MALDI-TOF-MS to analyze differential protein
expression. Results proved our hypothesis as described in Part II, Chapter 2.
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PART I. STUDY OF SERUM BUTYRYLCHOLINESTERASE INHIBITION FROM
PESTICIDE EXPOSURE
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CHAPTER ONE
INTRODUCTION OF PART I
BUTYRYLCHOLINESTERASE BACKGROUND

Dale predicted the existence of cholinesterase in 1914 (27). However, until 1932,
the term ‘cholinesterase’ (CHE) was used to name an enzyme from a horse serum (28) by
Stedman et al. The identification of CHE was based on the ability to hydrolyze
acetylcholine (Ach) in horse serum, which was distinct from the other esterases known at
the time. Stedman et al. were the first to use conventional rate studies to measure Ach
hydrolysis catalyzed by the enzyme. They also observed that horse serum BChE
hydrolyzes butyrylcholine more rapidly than Ach, which is one of the criteria to distinguish
BChE

from

AChE.

In

1950,

Sturge

and

Whittaker

proposed

the

terms

“aceto-cholinesterase” for AChE and “butyro-cholinesterase” for plasma CHE. These
terms were later changed to acetylcholinesterase (AChE) and butyrylcholinesterase
(BChE). BChE is restricted as the class of CHE present in plasma, which is distinguished
from AChE present in nerve system or red blood cells.
Properties of hBChE

Ninety-five percent of hBChE is a water soluble globular tetrameric G-4 form, the
subunits of which are connected by two disulfide bonds (29). The G-4 form of hBChE has
four identical subunits. The molecular weight of each subunit is 340,000, and it contains
574 amino acids and 9 carbohydrate chains (about 23.9% of the subunit) (30). The
remaining 5% of hBChE occurs as monomers and dimers. The concentration of BChE in
human serum is 5 mg/l. Human serum only contains BChE, no AChE. However, human
red blood cells contain AChE, but no BChE. The resulting concentration of BChE in whole
blood is 36 nM taking into account that the packed red cells take up 40% of the volume of
blood. BChE is a non-specific enzyme, which can hydrolyze a variety of esters, including
butylthiocholine,

butyrylcholine,

propionylthiocholine,

propionylcholine,

acetylthiocholine, acetylcholine, heroin, and aspirin, among others. Another characteristic
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of plasma BChE is its relative high stability. BChE can be stored at -70ºC and have little
effect on the activity after being frozen and thawed several times. Furthermore, plasma
BChE can be stored for several years at -20ºC without loss of activity (31). Therefore,
outdated blood from blood banks is recommended for large studies, for example, BChE
purification from serum.
BChE in Diagnosis of Pesticide Poisoning

Organophosphorous compounds (OPs) and carbamates (CBs) are extensively used
as insecticides, fungicides and herbicides. The chemicals exert their toxic action by their
ability to inhibit AChE, which plays an important role in the catalyzing the release and
removal of acetylcholine at the neuromuscular junction. Diagnosis of poisoning by OPs
and CBs is made on the basis of clinical symptoms and laboratory measurement of
cholinesterase, including AChE and BChE, activity. However, serum BChE is the most
sensitive enzyme for poisoning measurement. Plasma BChE activity decreases are
separated into several inhibition levels. These levels are 20-50%, 80-90% and over 90%,
which correspond to mild, moderate and severe poisoning, respectively. It has to be
emphasized that the percentage decreases in enzyme activity are only guidelines and are
not absolute indicators of the degree of poisoning. The severity of the symptoms can not be
judged through the BChE activity decreases (32). As such, the assessment of clinical
severity must be based on clinical symptoms, and the measurement of serum cholinesterase
activity.
Protective Role of BChE

Although no physiological function has been assigned to BChE, it plays an
important role in the protection against pesticides (33, 34). BChE reacts with a variety of
anticholinesterase poisons stoichiometrically. Poisons hydrolyzed by BChE are unable to
inhibit AChE, and in this way BChE guards against toxicity. The protective role of BChE
is demonstrated by the finding that pesticide applicators can have reduced BChE activity
with no clinical signs of poisoning. When the dose of pesticide is low so that only BChE
activity but not AChE activity is reduced, there is no threat to health. For instance, if only
BChE activity is reduced, even up to 70% decrease of a preexposure value, there is no
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health threat (35). The protective role of BChE against pesticides can also be demonstrated
by injecting purified BChE into the animals before they were treated with nerve agents.
Pretreatment with BChE increased survival and alleviated post-exposure symptoms, which
was proven by an in vivo animal study of mice and rats treated with the nerve agents. In
further experiments (36), monkeys were injected with 503 nmols BChE, and then exposed
to 2 times the LD50 of soman. Results showed that BChE was far more effective than the
conventional treatment with pralidoxime (2-PAM).
Inhibition of BChE by Pesticides

In 1973, Hart and O’Brien (37) proposed an original description of the
cholinesterase (including AChE and BChE) inhibition process. The inhibition process
includes two steps: equilibrium of the OP compound with the active site of CHE and a
phosphorylation reaction by forming a covalent bond between the phosphorus of the OP
compound and the oxygen of the hydroxyl group of serine at the active site. In general,
CHE (EH) combines with pesticides (PX) resulting in an enzyme-pesticide complex
(EHPX) that is converted to an inhibited enzyme (EP) and a leaving group (HX) (Figure
1-1-1). If the inhibited enzyme is caused by OPs, an aging reaction could happen by further
removing an alkyl group from the covalently bound OP, leaving a very stable OP-enzyme
derivative. BChE inhibited by OPs can be regenerated by some nucleophilic agents, such
as pralidoxime (2-PAM), if the agent is used within a few hours of poisoning, before the
OP-enzyme complex has had time to age. The esterase inhibited by CBs spontaneously
reactivates by hydrolytic de-carbamylation, a process similar to that which happens with
their natural substrates, such as acetylcholine (38, 39), but much slower.
Purification of Plasma Cholinesterase

Although BChE was discovered by Stedman et al. in 1932 (28), it was not
sequenced until 1986 due to the difficulty of purification from plasma (40). Svensmark
mentioned in 1965 that the molecular properties of BChE had not been studied extensively
at that time mainly because of the lack of the pure enzyme (41).
Many efforts have been made to purify BChE and AChE from a few sources such
as pig parotid glands (42), dog pancreas (43), and human liver (44). However, most efforts
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Kaging
EH + PX

EHPX

[Aged Enzyme]

EP + HX
Kreactivation
[Active Enzyme]

Figure 1-1-1. The scheme of CHE inhibition. Where EH is CHE (including AChE and

BChE), PX is pesticide, EHPX is a reversible enzyme-pesticide complex and EP is the
modified enzyme. Aged enzyme is the phosphorylated enzyme with the loss of the alkyl
group from EP.
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have been put on the purification of the BChE and AChE from horse and human plasma.
The purification of BChE has proven to be difficult due to several factors: i) the large size
and the complex structure of BChE make it difficult to purify, ii) the low concentration of
BChE in plasma (about 3 to 5 mg/l) and the complex protein composition of plasma make
the purification of plasma BChE more difficult. The following describes a history of the
BChE purification development.
In the early history of BChE purification, the first step in most of the horse plasma
BChE purification was 33% saturation with (NH4)2SO4, giving a two-fold purification.
Later, the key step in the most successful procedures for purifying horse serum CHE was
the acidification of (NH4)2SO4 serum fractions proposed by Strelitz, which gave a
seven-fold purification (45). The Strelitz method was not widely used to purify hBChE
from plasma because of the less stable property of hBChE than eBChE in solution at low
pH value (46).
Another significant purification development was the introduction of DEAE
cellulose column chromatography in the purification procedure by Connel and Shaw (47).
BChE is bound to the DEAE cellulose at pH 4.2, while most of the serum proteins are
washed off. The BChE is then eluted with 0.2 M NaCl resulting in a 45-fold purification
and 53% yield.
The most significant improvement of the purification methods with the high
efficiency and capacity is the use of affinity gels to supply the amount of pure enzyme
needed for structural study. Affinity gels were originally made for the purification of
AChE, particular for electric eel AChE. P-phenyl-trimethylammonium (PTA) gel was one
of the first gels developed by Kalderon et al (48). However, PTA-gels were proven to be
ineffective for purifying serum BChE. In 1972, a highly effective methylacridinium (MAC)
affinity gels were introduced by Dudai et al (49). The potential of MAC gels for purifying
serum BChE was reported by Blanchet et al (50). A 26 ml bed volume column of MAC
gels was used to purify BChE from 20 ml horse serum, resulting in 2176-fold purification
and 115% yield after a second passage. Although purification of BChE was improved
using MAC, the wide usage of this affinity gel was hindered because of its difficult
synthesis.
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Finally, procainamide affinity gel was used to simplify the purification procedure
into a two-step process introduced by Lockridge and La Du (51). Procainamide gel was
relatively easy to synthesize compared with MAC gel. The synthesis procedure of the
procainamide gel is briefly described as follows, the same procedure is also used in this
dissertation. Sepharose 4B was activated with cyanogen-bromide and then coupled with
6-aminohexanoic acid to make CH-Sepharose 4B, which was further coupled to the
procainamide through a carbodiimide reaction at room temperature for 24 h (52).
Procainamide gel was effectively used in the first step of a large-scale purification
procedure.
These affinity gels are far more effective than commonly used ion exchange gels,
such as DEAE. The selectivity of these affinity gels is based on the interaction of the
ligands with the active sites of BChE. The specificity of the affinity gels makes them
widely applicable for the enzyme purification. Although the affinity gels are very effective,
it is worth noting that they must still be supplemented by earlier techniques to obtain pure
enzyme.
RESEARCH STATEMENT

This chapter provided a general background of BChE, including properties,
physical function, pesticide inhibition mechanism, and the purification history of plasma
BChE. Chapter 2 includes a method development for detection and quantification of BChE
inhibition using MALDI-TOF-MS. Chapter 3 describes how to analyze a mixture of the
phosphorylated peptides in vitro using LC/MS/MS. Chapter 4 focuses on the method
development for BChE isolation from human serum. The specific character of the affinity
column was evaluated. Finally, Chapter 5 presents the application of the developed method
towards the human serum by combination affinity chromatography with MS.
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CHAPTER TWO

IDENTIFICATION AND QUANTIFICATION OF INHIBITED
BUTYRYLCHOLINESTERASE AFTER EXPOSURE TO
ORGANOPHOSPHATES AND CARBAMATES USING MALDI-TOF-MS
INTRODUCTION

The potential for civilian exposure to cholinesterase inhibitors is greater today than
anytime in history. In addition to exposure to cholinesterase inhibiting pesticides, today the
threat of chemical warfare (CW) terrorism raises the stakes. Several recent events such as
the 1988 slaughter of Kurds in Iraq (53) and the 1995 Tokyo Subway Attack (54) point to a
need for accurate and sensitive methods to monitor exposure to CW agents and pesticides.
Identification of the type of cholinesterase inhibitor (CW or pesticides) is critical for
deciding an appropriate treatment. We developed a new method for detection,
quantification, and categorization of cholinesterase inhibitors using two types of pesticides,
a proteomics approach and MALDI-TOF-MS. Our technique is based on the analysis of
the inhibited active-site peptide produced from trypsin digestion of BChE. Our in vitro
studies indicate that the type of pesticides can be determined by the mass difference
between the inhibited and intact active-site peptide. In this chapter, we evaluated all
phosphyl and carbamyl adducts on the active site serine of BChE from commercial
organophosphates (OPs) and carbamates (CBs). Although we did not investigate CW
agents in this study, information about their presence can be deduced from mass
differences using the same approach.
BChE present in serum is of toxicological and pharmacological importance.
Although no physiological function has been assigned to BChE, it plays a key role in ester
detoxification. Pesticides such as OPs and CBs inhibit AChE, which plays an important
role in removing the neurotransmitter acetylcholine at the synapses. Because BChE is
highly reactive with pesticides, it sacrificially protects AChE against pesticides. Therefore,
serum BChE activity measurement is the most sensitive way to detect pesticide exposure.
To determine pesticide exposure, U.S. Environmental Protection Agency (USEPA)
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scientists proposed a blood esterase monitoring program for pesticide exposure (55) based
on the measurement of red blood cell AChE and plasma BChE activity. The most
conventional method for detection of pesticide exposure is based on the measurement of
BChE activity by the Ellman method (56). However, the Ellman method has several
drawbacks. First, the percentage decreases in BChE activity is only a guideline and it is not
accurate to determine the degree of poisoning (32). Second, the source of cholinesterase
inhibition can not be determined by detection of the decline of BChE activity using the
Ellman method. This is because the decline of the enzyme activity can be caused from a
number of ailments such as liver disease, anemia, acute infections, cardiac failure, and
renal disease. Furthermore, since BChE is a nonspecific enzyme, many chemicals can
influence activity measurement such as asprin, which will influence the accuracy of
activity measurement.
In addition to the Ellman method, Polhuijs et al. (57) developed a technique to
monitor exposure to pesticides based on the analysis of pesticide inhibited BChE. In brief,
the method is based on the reactivation of the inhibited enzyme with fluoride ions
producing a phosphofluoridate. Identification and quantification of phosphofluoridate by
GC/MS can be related to the BChE inhibition. This Polhuijs method requires a
sophisticated chemical technique, and it is time consuming. The major limitation of the
Polhuijs method from in vivo analysis is that the aged enzyme cannot be analyzed, because
the aged enzyme blocks the reactivation reaction with fluoride ions. Doorn et al. (58, 59)
used MALDI-TOF-MS to detect the inhibited peptide from a tryptic digest of AChE in
order to study the mechanism of AChE inhibition with OPs. In addition, Fidder et al. (60)
developed a procedure for detection of nerve agent exposure using LC/MS. This analysis is
based on the detection of phosphorylated nonapeptides obtained after pepsin digestion of
hBChE. Since pepsin is a nonspecific protease, reproducible pepsin digestion was difficult
to achieve, thus limiting the universal application of this approach.
We developed a new method for detection and quantification of the inhibited BChE
after in vitro pesticide exposure using MALDI-TOF-MS. In this initial study, eBChE was
selected because this enzyme is commercially available. Three OPs, methyl paraoxon,
ethyl paraoxon and EPN oxon, represented all possible types of phosphoryl group found in
commercial OPs. Carbaryl was selected to represent the N-methyl carbamates in common

39

commerce. Oxons were used in this in vitro study to represent OPs. OPs require Phase I
metabolic biotransformation to become active inhibitors. By selecting oxons, no further
metabolism was required to facilitate the in vitro study. OPs and CB inhibit BChE by
forming a covalent bond with the active site serine by attaching a phosphoryl or carbamyl
group resulting in inhibited enzyme. The modified peptide was generated by trypsin
digestion of this inhibited eBChE. Using our new improved method, the category of
pesticides was identified. The degree of poisoning was also determined based on the
intensity of the modified peak and that of the intact active site peak from mass
spectrometric analysis. Furthermore, these results demonstrate that our newly developed
method is more sensitive than the Ellman method.
EXPERIMENTAL
Chemicals

All the OPs (EPN, methyl paraoxon, and ethyl paraoxon) and carbaryl (Figure
1-2-1) were purchased from Chem Service, Inc (West Chester, PA). Chemical purity of
these inhibitors were >99% as assessed by the supplier. eBChE (610 units/mg solid, 50%
protein of solid), butyrylthiocholine iodide (BTCh), 5, 5’-dithiobis-(2-nitrobenzoic acid)
(DTNB) were purchased from Sigma Chemical Co. (ST. Louis, MO). Sequencing grade
modified porcine trypsin was purchased from Promega Corporation (Madison, WI). EPN
oxon (Figure 1-2-1) was oxidized from EPN (61). In brief, a 2 mM EPN solution in
acetonitrile was mixed with the same volume of 40 mM bromine solution in acetonitrile.
The resulting solution was mixed for one minute. After the reaction, the solution was dried
by Speed Vacuum concentrator to remove the excess bromine and the residue dissolved in
500 μl methanol prior to analysis. The chemical purity of EPN oxon was >99% as assessed
by GC/MS.
eBChE Inhibition

eBChE (265 units) was dissolved in 400 µl 50 mM ammonium bicarbonate buffer,
and incubated with OPs (dissolved in methanol) for 1 h, and with carbaryl for
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Figure 1-2-1. Structure of pesticides.
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30 min at 37ºC. The final concentration of methanol was less than 0.05% (v/v) and did not
significantly affect enzyme activity.
eBChE Activity

A modified Ellman assay (56) was used to measure the eBChE activity. BTCh (4 μl
of 0.25 M) and DTNB (16 μl of 0.02 M) were added to 1 ml phosphate buffer (50 mM,
pH=8), and the resulting solution was used as a baseline for the later measurements. Then,
an aliquot of inhibited eBChE or control was added in the same cuvet. The absorbance of
the solution was measured at 412 nm for the first 10 min of the reaction. Plotting
absorbance vs time, a straight line was obtained (R=0.99). The slope of the line was
calculated from three parallel measurements, and the mean value of the slopes from
triplicate analysis was used in all calculations. Raw data were converted to the relative
activity (percent) of the control.
Trypsin Digestion

Acetonitrile was added as a mild protein denaturant (62) to each sample in order to
increase trypsin activity, at a final concentration of 40% (v/v). The digestion was
performed in a 60 mM NH4HCO3 buffer with a ratio of 20:1 eBChE to trypsin and
incubated at 40 ºC overnight. Formic acid was used to terminate the reaction.
MALDI-TOF-MS Analysis

The matrix solution was 10 mg/ml α-cyano-4-hydroxycinnamic acid in 50% (v/v)
acetonitrile / 50% (v/v) aqueous 0.1% (v/v) trifluoroacetic acid. Sample preparation for the
MALDI experiment involved addition of 1 μl of 1 mM diammonium citrate solution to 1 μl
analyte and 1 μl matrix solutions. The mixture (1 μl) was then applied to the MALDI
Massive target (Bruker, Billerrica, MA). Samples were allowed to air dry and crystallize
before the target was loaded into the mass spectrometer. An Autoflex MALDI-TOF
(Bruker, Billerrica, MA) mass spectrometer was used for all analysis. Standard instrument
parameters for peptide analysis were used. All spectra resulted from an average of 300
laser shots. A standard peptide mixture consisting of angiotensin II and vasopressin was
used to provide an external mass calibration. The trypsin autolysis product m/z 842.51 was
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used for an internal mass calibration. The identity of an OP or CB adduct was confirmed by
analyzing the post source decay (PSD) MALDI-TOF mass spectra of modified active site
peptides. The time ion selector was set for the modified peptide and the ion selector
window was ±1 % of the m/z value of the precursor ions. Mirror voltage acceleration
voltage of 20 kV, 16 kV, 13.11 kV and 10.61 kV were used to obtain the PSD spectrum.
Determination of IC50 and IC100

The relative activity (the percentage activity of eBChE inhibited by the pesticides
relative to the control), and the intensity ratios (the intensity of the modified or intact active
site peptide to the native reference peptide at m/z 2222.5) were reported based on the
triplicate analysis. Normalized intensity ratios (NIRs) were obtained through dividing the
intensity ratios of intact peptide or modified peptide by the total intensity of all peptide
signals that contains the active site serine, and these NIRs were further used for data
analysis. All data were analyzed using Microsoft Office Excel 2003 (Redmond, WA).
Determination of IC50s

Two linear regression lines were obtained by plotting the NIR of the intact peptide
vs concentration of OPs and the NIR of the modified peptide vs concentration of OPs. IC50
from MALDI method was calculated from the intercept of these two regression lines.
Determination of IC50 for methyl paraoxon is different from the other OPs, because the
aged peptide (further removal of the alky group from phosphate group) contribution
required an additional regression line. The IC50 for methyl paraoxon was determined when
the NIR of the intact active site peptide equals to the sum of NIR of the inhibited and the
aged peptide.
IC50s were also obtained for the Ellman method by plotting relative activity vs
concentration of OP. IC50 values were determined from the regression line equations
assuming a relative activity of 50 %.
IC50s for carbaryl from MALDI and the Ellman method were calculated using the
same approach as OPs. A linear relationship of NIR or relative activity with logarithmic
concentration of carbaryl (plot not shown) was used for the calculation.
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Determination of IC100s

IC100s for OPs from MALDI and Ellman method were determined by extrapolating
lines of NIR of intact peptide and relative activity to the x-axis. IC100s were determined
from this x-intercept. IC100 for carbaryl was determined using the same approach and linear
regression lines of NIR or relative activity with logarithmic concentration of carbaryl.
RESULTS
MALDI-TOF-MS Analysis

Mass spectra were collected for the control and pesticide-treated samples. Figure
1-2-2 shows MALDI-TOF-MS spectra for the control and eBChE treated with OPs and
carbaryl. The modified peptides were determined by comparing the mass spectra before
and after treatment. For example, the modified peptide by ethyl paraoxon at an average
mass 2336.1 was determined by comparing the mass spectra before (Figure 1-2-2 A) and
after treatment (Figure 1-2-2 B). This modified active site peptide peak appeared in the
mass spectrum for the pesticide-treated sample but not for the control sample. However,
peaks with an average mass corresponding to the intact active site peptide (average mass
2200.1) appeared in both control and treated sample with 1 μM ethyl paraoxon. A peak at

m/z 2222.1 was also observed in both control and treated sample, which was used as native
reference peptide in this study.
The same method was also performed to determine modified peptides from methyl
paraoxon, EPN oxon and carbaryl. Peaks with average masses corresponding to the
modified and intact active peptides were observed in mass spectra of tryptic digests of OP
and CB inhibited eBChE (Figure 1-2-2). Table 1-2-1 summarizes the observed MH+ peaks
at average mass corresponding to the intact and modified active site peptide of eBChE
treated with 1 μM of individual pesticide. MH+ (Table 1-2-1) were the average masses of
the modified or the intact peptide containing the catalytic serine by the tryptic digestion.
Modified groups were determined based on the mass differences (Table 1-2-1)
between the modified peptide and the intact active site peptide. For example, the mass
difference (Table 1-2-1) between the modified peptide at m/z 2336.5 and the intact active
peptide at m/z 2200.5 was 136 Da for ethyl paraoxon. This mass difference takes into
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of eBChE from (A) control

and (B) treated sample by ethyl paraoxon. Peaks with average masses at m/z 2200.1
demonstrate the presence of unmodified active site peptide. Peak at m/z 2336.1 (B)
corresponds to the modified active site peptide with O,O-diethyl phosphorylated group.
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of methyl paraoxon (C) and

EPN oxon (D) treated eBChE, respectively. Peaks at m/z 2294.1 and 2308.2 (C) represent
the modified peptide with O-methyl phosphorylated group, and O,O-dimethyl phosphate
respectively. Peak at m/z 2368.3 (D) is the modified peptide with O-ethyl phenyl phosphate.
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Figure 1-2-2. MALDI-TOF-MS spectra of the tryptic digest of eBChE (E) treated sample

by carbaryl. Peak at m/z 2257.3 (E) is the modified peptide with carbamylate group.
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Table 1-2-1. Masses of observed MH+ (average mass)b for the intact and modified active

site peptide of eBChE treated with 1 μM inhibitor

Pesticide

Intact

Inhibited ∆ma

(m/z)

(m/z)

(Da)

Modified with
group
CH3O

Methyl
paraoxon

2200.5

2308.5

108

CH3O

Ethyl
paraoxon

2200.5

2336.5

136

CH3CH2O

EPN
oxon

2200.5

2368.5

168

Carbaryl

2200.5

2257.5

57

P O

CH3CH2O

P O

∆ma
aged

(Da)

Modified
with group
CH3O

2293.5 93

O

-----

----

-------

CH3CH2O
C 6H5 P O

------

----

-------

O C NHCH3

------

----

------

P O

a

Difference in mass between the modified and the intact active site peak. All these mass
differences are taking account of the proton loss on the catalytic serine during the
phosphorylation reaction.

b

The average mass of the modified or the intact peptide containing the catalytic serine by
the tryptic digestion.
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account the proton loss on the catalytic serine during the phosphorylation reaction. Based
on this mass difference, the modified group was deduced as O,O-diethyl phosphate. Using
the same approach, two modified groups were determined for methyl paraoxon as
O-methyl phosphate and O,O-dimethyl phosphate , which correspond to the modified
peptides at m/z 2293.5 and 2308.5, respectively. Similarly, the modified group for EPN
oxon was O-ethyl phenyl phosphate. The corresponding modified peptide was observed at

m/z 2368.5. The modified group for carbaryl was the carbamylate group that was observed
at m/z 2257.5.
Post Source Decay (PSD) Analysis

To further confirm the phosphorylated and carbamylated peptide, PSD analysis in
MALDI-TOF-MS was used. All of PSD analyses of modified peptide ions are shown in
Figure 1-2-3, which correspond to the modified active site peptides with phosphate or
carbamate generated from tryptic digests of eBChE treated with OPs or CB. The timed ion
selector of MALDI was set for a series of precursors with average masses. These
precursors were at m/z 2293.5 and 2308 (aged and inhibited peptide by methyl paraoxon)
(Figure 1-2-3 A and B), at m/z 2336 (inhibited peptide by ethyl paraoxon) (Figure 1-2-3 C),
at m/z 2368 (inhibited peptide by EPN oxon) (Figure 1-2-3 D), and at m/z 2257 (inhibited
peptide by carbaryl) (Figure 1-2-3 E). ). In PSD analysis, a common fragment ion at m/z
2182.1 was observed for all of the precursor ions (Figure 1-2-3). The fragment ion at
2182.1 was formed by elimination on serine to form the homoalanine residue. However,
precursor ion at m/z 2293.5 had an additional fragment ion at m/z 2199.5 (Figure 1-2-3 A),
which was formed by removal of the phosphate group from the catalytic serine.
Lost neutral fragments were deduced from the mass differences between the
precursor ions and fragment ions (Table 1-2-2). The fragment ions at m/z 2199 and m/z
2182.1 were generated by the loss of CH3OPO2 (94 Da) and CH3OP(O)(OH)2 (112 Da),
respectively, from the precursor ion at m/z 2294 corresponding to O-methyl
phosphorylated peptide. Similarly, the fragment ions at m/z 2182.1 of precursor ions at m/z
2308, 2336, 2368, and 2257, were generated by the neutral loss of (CH3O)2P(O)OH (126
Da), (CH3CH2O)2P(O)OH (154 Da), (CH3CH2O)P(O)(OH)(C6H5) (186 Da) and
CH3NHC(O)OH (75 Da) from their precursor ions, respectively.
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Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2294.3 represents

the aged peptide with O-methyl phosphate by methyl paraoxon (A), at m/z 2308.6 is
inhibited peptide with O,O-dimethyl phosphate group (B).
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Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2336.8 corresponds

to the modified active site peptide with O,O-diethyl phosphorylated group generated from
the tryptic digest of eBChE treated with ethyl paraoxon (C), peptide at m/z 2368.3 is with
O-ethyl phenyl phosphate from EPN oxon (D).
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Figure 1-2-3. PSD analysis of precursor ion with average mass at m/z 2257.2 corresponds

to the modified active site peptide with carbamylated group (E).
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Table 1-2-2. Masses of observed MH+ (average mass)a for the precursor ions and fragment

ions from PSD analysis.

Fragment
Pesticide Precursor

Ion 1

2293.5
Methyl
paraoxon

2182.1

2308.5

2182.1

Ethyl
paraoxon 2336.5
EPN
oxon

2368.5

Carbaryl

2257.1

2182.1

2182.1
2182.1

∆m

112

126
154

186
75

Loss of the
Adduct
CH3O
HO P O
HO
CH3O
CH3O P O
HO
CH3CH2O
CH3CH2O P O
HO
CH3CH2O
C6H5
P O
HO

NHCH3
O C OH

a

Fragment
Ion 2

∆m

Loss of the
Adduct
CH3O
O

P

2199.2

94

--------b

---b ----------b

--------b

---b ---------b

--------b

---b --------b

--------b

---b --------b

O

The average mass of the modified or the intact peptide containing the catalytic
serine obtained from the tryptic digestion.
b

No fragment 2 was found.
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IC50 and IC100 Values

The relative activities and the normalized intensity ratios (NIR) were reported
(Table 1-2-3, 1-2-4, 1-2-5, and 1-2-6) based on the triplicate parallel analysis after the
inhibition of eBChE by pesticides. Graphs of NIR vs concentration of pesticides were
plotted according to these reported data. Plots of NIR vs concentration of OPs and carbaryl
are shown in Figure 1-2-4. A linear relationship between the NIR of the modified peptide
and intact peptide with the concentration of [OP] was observed for all three OPs. For the
Ellman method, linear relationships between the relative activity and the concentration of
OP were observed for all three OPs (Figure 1-2-5). While for CB, both methods produced a
non-linear relationship between the NIR or relative activity and the concentration of
carbaryl (Figure 1-2-4 D and Figure 1-2-5 B). To obtain IC50 (the concentration required
for producing 50% BChE inhibition) and IC100 (the concentration required for producing
100% BChE inhibition) data, the NIR or relative activity was plotted against the logarithm
of concentration of carbaryl (plot not shown).
IC50s and IC100s of EPN oxon for both methods were determined from Figure
1-2-4 and Figure 1-2-5 (see Experimental section). The same approach was also applied to
determine IC50s and IC100s of the other pesticides. IC50s from this study were 1.30 ± 0.08,
0.90 ± 0.05, 1.19 ± 0.01, 3.57 ± 0.03 µM, and corresponding IC100s were 2.72 ± 0.09, 1.75
± 0.06, 2.48 ± 0.01, and 17.3 ± 0.03 µM for methyl paraoxon, ethyl paraoxon, EPN oxon
and carbaryl, respectively. To compare results from our new method, IC50s and IC100s from
the Ellman method were also obtained. The IC50s from the Ellman method were 1.10 ±
0.97, 0.79 ± 0.69, 0.97 ± 0.27, 4.9 ± 0.1 µM, and IC100s were 2.41 ± 0.80, 1.54 ± 0.86, 2.20
± 0.31, and 23.6 ± 0.11 µM for methyl paraoxon, ethyl paraoxon, EPN oxon, and carbaryl,
respectively. IC50 and IC100 for carbaryl from both methods were determined from the
linear regression between NIR or relative activity and logarithm of concentration of
carbaryl (plots not shown).
The IC50 value of carbaryl was larger than those of OPs, which means eBChE is
the least sensitive to carbaryl compared to OPs. These data were consistent with the facts
provided by the supplier that carbaryl is a significant less potent inhibitor of eBChE (LD50
of carbaryl 500 mg/kg; methyl paraoxon 3 mg/kg; and ethyl paraoxon 2 mg/kg).
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Table 1-2-3. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and

relative activities of eBChE treated with methyl paraoxon at different concentrations

Concentration
(μM)

NIRs of Intact
Peptide
(m/z 2200.1)

NIRs of Aged
Peptide
(m/z 2294.1)

NIRs of
Inhibited
Peptide
(m/z 2308.1)

0.00

1.00 ± 0

N/A

N/A

100 ± 0

0.10

0.97 ± 0.02

0 + 0.01

0.03 ± 0.01

96.6 ± 2.5

0.20

0.87 ± 0.03

0.04 ± 0.01

0.08 ± 0.01

95.3 ± 3.1

0.50

0.73 ± 0.05

0.10 ± 0.01

0.16 ± 0.02

54.2 ± 7.5

1.00

0.52 ± 0.08

0.11 ± 0.03

0.37 ± 0.02

49.6 ± 1.0

1.80

0.38 ± 0.07

0.13 ± 0.01

0.48 ± 0.05

23.0 ± 1.5
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Relative
Activity (%)

Table 1-2-4. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and

relative activities of eBChE treated with ethyl paraoxon at different concentrations

Concentration
(μM)

NIRs of Intact
Peptide
(m/z 2200.2)

NIRs of Inhibited
Peptide
(m/z 2336.1)

Relative
Activity (%)

0

1.00 ± 0

N/A

100 ± 0

0.1

0.97 ± 0.01

0.03 ± 0.01

100 ± 3.5

0.2

0.78 ± 0.05

0.22 ± 0.05

82.3 ± 2.5

0.5

0.83 ± 0.06

0.17 ± 0.02

71.6 ± 3.0

0.8

0.67 ± 0.05

0.33 ± 0.05

53.7 ± 1.5

1

0.56 ± 0

0.44 ± 0.02

35.9 ± 2.5

1.5

N/A

1.00 ± 0.05

0.65 ± 0.5
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Table 1-2-5. Normalized intensity ratios (NIRs) of intact peptide, modified peptide, and

relative activities of eBChE treated with EPN oxon at different concentrations

Concentration
(μM)

NIRs of Intact
Peptide
(m/z 2200.1)

NIRs of Inhibited
Peptide
(m/z 2368.1)

Relative
Activity (%)

0

1.00 ± 0

N/A

100 ± 0

0.2

0.93 ± 0.02

0.07 ± 0.01

100 ± 3.5

0.5

0.76 ± 0.01

0.24 ± 0.02

71.2 ± 2.5

0.7

0.64 ± 0.03

0.36 ± 0.03

50.3 ± 2.0

1

0.49 ± 0.05

0.51 ± 0.04

32.5 ± 5.0

2

0.23 ± 0.01

0.77 ± 0.02

1.76 ± 1.5

2.5

N/A

1.00 ± 0.02

0.649 ± 0.5
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Table 1-2-6. Normalized intensity ratios of intact peptide, modified peptide, and relative

activities of eBChE treated with carbaryl at different concentrations

Concentration
(μM)

NIRs of Intact
Peptide
(m/z 2200.1)

NIRs of Inhibited
Peptide
(m/z 2257.1)

Relative
Activity (%)

1

0.84 ± 0.02

0.16 ± 0.02

95 ± 1.5

1.5

0.75 ± 0.03

0.25 ± 0.03

90 ± 1.0

2.5

0.68 ± 0.05

0.32 ± 0

81 ± 1.5

3

0.58 ± 0.06

0.42 ± 0.04

73 ± 2.0

4

0.50 ± 0.05

0.50 ± 0.03

50 ± 3.2

5

0.42 ± 0.06

0.58 ± 0.05

40 ± 4.0

8

0.23 ± 0.03

0.77 ± 0.02

33 ± 1.0

10

0.13 ± 0.01

0.87 ± 0.05

27 ± 1.2

15

0.03 ± 0.01

0.97 ± 0.03

18 ± 1.4
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Figure 1-2-4. Plots of the normalized intensity ratio to the [methyl paraoxon] (A), [ethyl

paraxon] (B).
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Figure 1-2-4. Plots of the normalized intensity ratio to [EPN oxon] (C), and [carbaryl] (D).

The intensity ratio is the intensity of the modified or the intact active site peptide relative to
that of the native reference peptide (average m/z=2222.5). The intensity ratios of all
peptides containing catalytic serine were added to obtain a sum value. The normalized
intensity ratios (NIRs) were obtained by dividing the intensity ratios of intact peptide and
modified peptide with the sum value. The IC100s were determined from the points by
extrapolation of linear-regression to x-axis. Results are expressed as mean ± SD (n=3).
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Figure 1-2-5. Plots of relative activity vs [OPs] (A) and [carbaryl] (B). Results are

expressed as mean ± SD (n=3).
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DISCUSSION

The goal of this work was to develop an improved method for the detection of OP
and CB exposure using a proteomic approaches and MALDI-TOF-MS. The advantage of
this approach is that both the origin and the extent of the exposure to pesticide can be
determined. This method is based on the analysis of the inhibited BChE, particularly based
on the detection of active site peptide of BChE from tryptic digests. The amino acid
sequence of the tryptic peptide containing active site serine from eBChE is
SVTLFGESAGAASVSLHLLSPR (calculated MH+ at m/z 2200.5), where the catalytic
serine is underlined.
eBChE was separately incubated with each of the four pesticides studied in this
chapter. The resulting inhibited eBChE was digested with trypsin and peptide containing
active site serine was identified by MALDI-TOF-MS. Modified peptides were identified
by comparing the MALDI mass spectra before and after treatment, and further confirmed
by PSD analysis. During the modified peptide identification processes, we observed that
the aged peptide was detected only from methyl paraoxon treated eBChE (Table 1-2-1).
Usually, the rate of an aging reaction of a cholinesterase (ChE) inhibitor has an inverse
relationship with the rate of spontaneous reactivation (63). Since the esterase inhibited by
CBs undergoes fast reactivation by hydrolytic decarbamylation compared with OPs, it is
understandable that no aged peptide was detected for carbaryl. In addition to this, the aging
reaction also depends on the nature of the substitutents on the phosphorus atom attached to
the active site residue of the enzyme. Mason et al (64) reported that the order of the aging
reaction rate for the alkyl phosphate substitutents is dimethoxy > methoxy-phenyl =
diethoxy , which is consistent with our observation. O’Brien also reported that the rate of
aging of dialkylphosphorylated AChE is dimethoxy > diisoProxy > diethyoxy (65). Our
findings that aged peptide was detected only for methyl paraoxon agree with the previous
observations (64) that dimethoxy phosphorylated BChE by methyl paraoxon aged faster
than BChE modified by both EPN oxon and ethyl paraoxon.
When eBChE was treated with methyl paraoxon at concentrations lower than 0.1
µM, only modified peptide at m/z 2308.1 was observed and no aged peptide showed in the
MALDI spectrum. This is because that the aged peptide with (CH3O)OP(O) moiety had a
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negative charge and a peptide in anionic form exhibited low ionization efficiency in
MALDI experiment (66). As such, the detection of the aged peptide was limited using
MALDI-MS, although ammonium citrate greatly improved the detection signal of the
phosphorylated peptides. Another possible explanation is that the peptide inhibited by
phosphorylation is very stable, thus the further aging reaction is unlikely to occur. We
suggest that the former explanation is correct.
In the PSD analysis, one common fragment ion at m/z 2182.1 was observed as a
dominant fragment ion for each inhibited peptide (Table 1-2-2). A likely explanation is that
the phosphate elimination occurs at a higher rate than skeletal bond cleavage. The available
internal energy content of the ions is used to eliminate phosphate groups instead of
producing a series of the sequence related fragment ions. The observations were consistent
with those from the previous studies of a triphosphorylated peptide by MALDI (67) and a
pentaphosphorylated peptide using LC/MS (68). Another interesting phenomenon was that
it was more preferable to lose the alkyl phosphoric acid than the phosphate group from the
precursor ions during fragmentation pathway. When internal energy of the precursor ion
was high, the process was prone to lose the alkyl phosphoric acid, which produced a
fragment ion with lower energy. As such, the fragment ion at 2182.1 was exclusively
observed as the dominant product ion. This observation was consistent with Annan and
Carr’s results (67), which have shown that singly phosphorylated peptides mainly lose
H3PO4 with a relative minor loss of HPO3. Although the subjects of our study were alkyl
phosphorylated peptides, the same results were observed.
After the modified peptides were detected, the extent of the inhibition was
determined based on the normalized intensity ratios of modified peptides to the reference
peptide and intact peptide to the reference peptide. A peptide (average MH+ m/z 2222.5)
generated

from

a

tryptic

digest

of

eBChE

(amino

acid

sequence:

AILQSGSSNAPWAVTSLYEAR) was used as the native reference peptide. It is known
that the quantification of analyte using MALDI can be disturbed by some external
influences, such as the crystal forms of matrix on target, the laser power used for collecting
the mass spectra, and the different response of analytes for MALDI. Therefore, the native
reference peptide at m/z 2222.5 was used to minimize or control for these influences. This
tryptic peptide has no missed cleavage, no modified amino acid and the similar response to
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MALDI as the intact active site peptide (average MH+ m/z 2200.5). All these properties for
this peptide satisfied the criteria for an ideal native reference peptide as proposed by Ruse
et al.(69). The relative intensity ratios between the peptide of the intact active site or the
modified peptide and the native reference peptide reflect the extent of the pesticide
exposure.
Comparison of IC50s and IC100s from MALDI Method and from Ellman Method

The normalized relative intensity ratios were reported and plotted as a function of
the concentrations of pesticides based on the mass spectra collected from the tryptic digests
of inhibited eBChE. Figure 1-2-4 shows plots of the NIR vs EPN oxon concentration and
NIR vs carbaryl concentration. IC50s from MALDI method were obtained from the plots
based on the recorded data (Table 1-2-2, 1-2-3, 1-2-4, and 1-2-5) for each OP (see details in
Experimental section). The IC50s were 1.30 ± 0.08 μM for methyl paroxon, 0.90 ± 0.05 μM
for ethyl paraoxon, and 1.19 ± 0.01 μM for EPN oxon. These results were compared with
the IC50s obtained from the Ellman method, which were 1.10 ± 0.97, 0.79 ± 0.69, and 0.97
± 0.27 µM for methyl paraoxon, ethyl paraoxon, and EPN oxon, respectively. IC100s of the
OPs were determined graphically from linear regressions by extrapolation of
linear-regression fits to the points on the x-axis (see details in Experimental section). The
IC100s from our method were 2.72 ± 0.09 μM for methyl paraoxon, 1.75 ± 0.06 μM for
ethyl paraoxon, and 2.48 ± 0.01 μM for EPN oxon. In order to compare the results from the
MALDI method with the Ellman method, the plot of linear regression of the relative
activity and the concentration of OPs were shown in Figure 1-2-5A. The IC100s from the
relative activity were also determined graphically from Figure 1-2-5A using the same
method as those from NIR. From the Ellman method, IC100s were 2.41 ± 0.80 μM for
methyl paraoxon, 1.54 ± 0.86 μM ethyl paraoxon and 2.20 ± 0.31 μM for EPN oxon,
respectively, which were very close to the values obtained by our method.
An interesting phenomenon was observed that all the IC50s and IC100s of OPs were
higher from the MALDI method than those from the Ellman method. The possible
explanation is that the response of the modified peptides was lower than that of the intact
active site peptide and resulting in the higher measured IC50s and IC100s. This observation
is consistent with the study of Liao et al. (70), who have reported that the
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desorption/ionization efficiencies for phosphorypeptides in MALDI-MS are about one
order of magnitude lower than for their non-phosphorylated form. This lower response of
the phosphorylated peptides in MALDI possibly results from the high negative electron
density of oxygen attached on phosphorus atom, which will cause a partial negative charge
on the phosphate group.
Similarly, the IC50 and IC100 of carbaryl from our method were determined from
the linear-regression relationship of NIR vs logarithm of carbaryl concentration, which
were 3.57 ± 0.03 and 17.3 ± 0.03 µM, respectively. In order to compare the results from the
MALDI method with those from the Ellman method, the relative activities were reported
and plotted as a function of the carbaryl concentration (Figure 1-2-5B). IC50 and IC100 of
carbaryl from the Ellman method were determined as 4.9 ± 0.10 and 23.6 ± 0.11 µM from
this linear relationship between the relative activity and logarithm of concentration of
carbaryl.
In contrast, the results from carbaryl were different from that of OPs. For both
methods, NIR or relative activity had nonlinear relationships with concentration of
carbaryl, while for OPs, a linear relationship was obtained for both NIR and relative
activity. This non-linearity was due to the different CB inhibition mechanism. ChE
inhibition occurs via the formation of enzyme-inhibitor complex followed by
carbamylation or phosphorylation of the active site and release of the leaving group. The
aging reaction, resulting in the non-reversible enzyme, may occur after the inhibition
reaction for OPs. No reactivation will happen for the phosphorylated enzyme. However, a
spontaneous reactivation of carbamylated enzyme will happen very quickly for CBs. The
different carbaryl inhibition mechanism resulted in the linear regression of NIR or relative
activity versus logarithm of concentration of carbaryl. This result was in agreement with
the study of Rao et al. (71), except that they plotted the linear regression of relative
inhibition versus log [carbaryl].
In contrast to OPs, IC50 and IC100 of carbaryl from the Ellman method based on the
measurement of eBChE activity were greater than those from the MALDI method. The
response to MALDI for the carbamylated active-site peptide was higher than that of the
phosphorylated peptide. Although ammonium citrate greatly increased the response of
phosphorylated peptides as reported by Rao et al. (71), the ionization efficiency of
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phosphorylated peptides were still not competitive with that of the intact peptide. Since
carbaryl inhibits eBChE in a noncompetitive pattern, the natural substrate can
competitively displace the carbamylate group from the enzyme-inhibitor complex and
result in a greater measured activity. In addition, free thiols produced from DTNB in the
Ellman reagents may help decarbamylation of inhibited enzyme and eventually helps to
reactivate the cabamylated enzyme during the measurement of eBChE activity. Therefore,
the measured enzyme activity was greater than the actual value. Competition with the
phosphate group will not happen for the phosphorylated enzyme, because the
phosphorylated eBChE is so stable that natural substrate cannot reactivate this inhibited
enzyme.
From all the above mentioned results, we can conclude that our newly developed
method can detect and quantify pesticide exposure and IC50s and IC100s from the MALDI
method are comparable with those from the Ellman method. This method is not only useful
for the detection and quantification of eBChE exposure to OPs, but also useful for exposure
to CBs, despite their spontaneous reactivation.

CONCLUSION

In conclusion, a new method was developed to provide unambiguous identification
of the modified active-site peptide produced from tryptic digest of eBChE using
MALDI-TOF-MS. Furthermore, this method can be applicable to quantify pesticide
exposure using the linear relationship between the modified peptide intensity with OP
concentration or logarithmic carbaryl concentration. The Ellman measurement of eBChE
activity is limited for pesticide exposures at inhibition levels less than 20%. However, the
reported method can provide information on eBChE inhibition levels as low as 5%. This
assay was also suitable for the analysis of carbaryl inhibited eBChE, although
carbamylated enzyme has higher spontaneous reactivation.
Although CW agents were not investigated in this chapter, the analysis of the
chemical exposures can be examined using the same methodology. For example, if eBChE
is exposed to soman, a CW agent, the eBChE will be inhibited. The digest will be subjected
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to the MALDI analysis after the inhibited eBChE is hydrolyzed by trypsin. The inhibited
active site peptide should be observed at m/z 2280.3 in MALDI mass spectrum. The mass
difference between the modified peptide at m/z 2280.3 and the intact peptide at m/z 2200.1
is unique to soman. The identification of the soman inhibited peptide could be confirmed
by PSD analysis. Furthermore, the extent of the soman exposure could be determined by
the relative intensity ratios of the modified and intact active-site peptides.
The broad use of pesticides in every day life and the increasing threat of terrorism
of chemical war agents have raised the chances of multiple pesticide exposure. Because of
the limitation of using MALDI to analyze complex peptide mixtures, a novel methodology
is required for the analysis of multiple pesticide exposure. Chapter 3 will cover an in vitro
study for the analysis of a mixture of phosphorylated peptides using LC/MS/MS
techniques.
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CHAPTER THREE

ANALYSIS OF MULTIPLE PESTICIDE EXPOSURE USING LC/MS/MS

INTRODUCTION

The potential for multiple-pesticide exposure, either sequentially or concurrently,
is greater today than anytime in history, due to the extensive use of pesticides. With the
onset of the Gulf War Syndrome (72), the issue of multiple chemical exposures poses an
ever increasing military and civilian threat. The rising public healthcare concerns over
multiple chemical exposures require more sensitive and reliable methods to monitor
multiple-chemical exposure. However, about 95% of all chemical studies were performed
on individual chemicals(73). In this study, a novel methodology was developed to analyze
multiple chemical exposures using LC/MS/MS techniques. An in vitro investigation was
designed to examine the relative quantification of each pesticide exposure, and to identify
the types of pesticide using eBChE as a model system. Although we did not examine
chemical warfare (CW) agents in this study, investigation of BChE inhibition resulting
from pesticides can provide insight into human exposure to these classes of compounds.
As described in Chapter 2, the analysis of inhibited BChE was used to monitor
pesticide exposure (57, 60). In our previous work (Chapter 2), we successfully identified
and quantified the modified (phosphorylated or carbamylated) active site peptide generated
from tryptic digests of inhibited eBChE using MALDI-MS. In this chapter, we continued
to investigate the analysis of a mixture of phosphorylated active site peptides after
multiple-pesticide exposure using LC/MS/MS.
In the last decade, mass spectrometry has emerged as an increasingly viable
technique for the analysis of protein modifications, such as phosphorylation. Although
both electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser
desorption ionization-mass spectrometry (MALDI-MS) have been used quite successfully
for phosphoprotein analysis (74), ESI-MS offers a better choice for investigations with
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more complex phosphoprotein mixtures because of online separation capabilities. Chapter
2 described the successful identification of phosphorylated peptides by MALDI-MS,
through comparisons of the peptide maps before and after treatment. However, a
noteworthy limitation of the MALDI approach is observed in the low desorption/ionization
efficiency of phosphorylated peptides. This lower response was established by comparing
MALDI data with results from LC/MS/MS investigations. In addition, a further worsening
of the detection signal for these analytes arises due to ion suppression in the presence of the
other peptides. Therefore, investigations of a mixture of OP-modified active site peptides
were much more challenging using MALDI methodology. A further limitation of the
MALDI technique stems from the difficulty in obtaining sequence information of the
phosphoprotein under study. Although the modified peptide was confirmed by
post-source-decay (PSD) MALDI-MS analysis, it was not possible to obtain sequence
information. Since loss of the phosphate moiety was the dominant fragmentation pathway
and the yield of the other fragments was low, the collection and interpretation of sequence
information from PSD mass spectra was difficult. It was evident that the MALDI
methodology described here was not suitable for multiple pesticide exposure analyses.
In this chapter, three OPs, methyl paraoxon, ethyl paraoxon, and EPN oxon, were
used to inhibit eBChE, separately. Subsequently, the inhibited enzyme was digested with
trypsin. The same amount of tryptic digests was mixed, and the resulting mixture was
further analyzed using LC/MS due to its online separation capability. However, the
phosphorylated peptide separation and the quality of their product spectra were still not
good enough for the analysis. This is because the other abundant peptides in the mixture
suppress the peptide ions of interest. Some situations make the phosphorylated peptide
analysis even worse, such as coelution of four phosphorylated peptides as well as the other
peptides and relatively long duty cycles (time for MS full scan and subsequent MS/MS).
Therefore, an LC/MS/MS technique for the analysis of the phosphorylated peptide ions
during on-line analysis, was applied for the investigation of the mixture. The ions of
interest can be isolated and fragmented in the ion trap even in the presence of the other
abundant peptides using LC/MS/MS techniques. The isolation ability of LC/MS/MS
technology was evaluated by comparing the ion chromatogram (IC) of one kind of
phosphorylated peptide enriched from the offline fractioned sample with that from the
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un-fractioned sample. Results demonstrated that this LC/MS/MS technique was a powerful
tool for the analysis of the phosphorylated peptide mixture. Results clearly showed that this
method was applicable for the measurement of the relative abundance of each individual
phosphorylated peptide in a complex peptide mixture. Furthermore, the phosphorylation
and carbamylation sites were localized from LC/MS3 and LC/MS/MS analysis,
respectively.
EXPERIMENTAL
Chemicals and Reagents

All the chemicals, and enzymes, including their purity and grade, are the same as
those described in Experimental Section of Part I, Chapter 2.
eBChE Inhibition

The same eBChE inhibition protocol was used as described in Experimental
Section of Part I, Chapter 2.

Trypsin FDigestion

The same trypsin digestion protocol was used as described in Experimental Section
of Part I, Chapter 2.

Offline Peptide Separation

A tryptic digest of eBChE (200 µl, 184 µg) was injected onto the C18 reversed
phase column (2.1 mm x 25 cm, 3 µm). Peptide separation was done by a linear gradient
elution that started with 95% (v/v) solvent A [water + 0.1% trifluoroacetic acid] and 5%
solvent B [acetonitrile + 0.1% trifluoroacetic acid] using a flow rate of 0.25 ml/min.
Phosphorylated peptides were enriched by HPLC separation. For the first separation, the
concentration of solvent B was increased to 95% (v/v) in 30 min, then kept at this
concentration for 5 min. Fractions containing modified active site peptide were collected
and concentrated using a Speed Vacuum concentrator. The residue was dissolved in 20 µl
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of solvent A and subjected to the second offline separation. For the second separation the
concentration of solvent B was increased to 85% over 50 min and then to 95% over 1 min,
and kept this concentration for 2 min. Peaks were detected at 214 nm. Each peak was
manually collected in 1 ml vials.
Instrument
MALDI-TOF-MS Analysis

The sample preparation, target spotting technique and parameters of the instrument
were the same as described in the Experimental Section of Part I, Chapter 2.
LC-MS Analysis

A tryptic digest of eBChE (9 µL, about 19 pmol) was injected into the capillary
column. Separations were performed with an HP 1100 HPLC modified with a custom
splitter to deliver mobile phase at 4 μl/min to a custom C18 capillary column (300 μm id x
15 cm, packed in-house with Macrosphere 300 Å 5 μm C18 (Alltech Associates, Deerfield,
IL)). A linear gradient was used to elute peptides from the capillary column that started
with 95% (v/v) solvent A [water + 0.1% formic acid] and 5% solvent B [acetonitrile +
0.1% formic acid] using a flow rate of 0.2 ml/min. The concentration of solvent B was
increased to 20% over 8 min and then to 90% over 25 min, and kept at this concentration
for 8 min. The heated capillary temperature of the mass spectrometer was 175 °C. The
number of microscans was 5 and the scan range was from 150 Da to 2000 Da. The
acquisition time was 45 min. For LC/MS/MS technique, the isolation width was 5 Da (m/z),
normalized collision energy was 35%, activation Q was 0.25 and the activation time was
30 ms.
RESULTS AND DISCUSSION
Sequence Information of Phosphorylated Peptides

In order to confirm the identity of the phosphorylated peptides, LC/MS/MS was
applied to obtain the amino acid sequence information. A representative LC/MS/MS of the
phosphorylated peptide (calculated MH2+ at m/z 11682+) by ethyl paraoxon is shown in
Figure 1-3-1. As shown in Figure 1-3-1, a dominant fragment ion at m/z 10912+ was
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observed corresponding to the loss of the alkyl phosphate group HOP(O)(OCH2CH3)2. The
low intensity of the other fragment ions made it impossible to obtain the fragmentation
information of the phosphorylated peptide ions. A similar phenomenon was observed in
the MS/MS spectra of the other three phosphorylated peptides (data not shown), where the
dominant product ion was at m/z 10912+. The common fragment ion corresponded to the
neutral fragment loss of the alkyl phosphoric acid from the phosphorylated ions. As such,
the alkyl-phosphorylated peptides were differentiated by the neutral fragment loss.
In order to acquire sequence information of the phosphorylated peptide ions,
MS/MS of the dominant product ion was obtained. Figure 1-3-2 shows the MS/MS of
10912+, which was the common daughter ion for all of the phosphorylated peptides. A high
quality tandem mass spectrum was obtained for the common product ions (Figure 1-3-2).
The sequence of the active site peptide of eBChE digested by trypsin is known to be
SVTLFGESAGAASVSLHLLSPR (calculated MH+ at m/z 2200.5, numbered 1 to 22 from
right to left), where the active site serine is underlined (75). The MS/MS spectrum of the
intact active site peptide is also reported (Figure 1-3-3). It is known that fragmentation of
peptides usually occurs at the peptide bonds to produce a series of fragment ions, where
ions containing an N-terminal are “b” ions and ions containing an C-terminal are “y” ions.
Most fragment ions were observed as y-ions in the tandem mass spectra of both intact
peptide and the common product ion of phosphorylated active site peptides (Figure 1-3-2
and Figure 1-3-3). By comparing the tandem mass spectra of Figure 1-3-2 and Figure 1-3-3,
an identical set of unphosphorylated fragment ions corresponding to y14 - y3 was observed.
Mass shifts with 18 Da were observed for y15Δ - y19Δ ions (Figure 1-3-2) compared with
those y ions from the intact peptide. This mass shift was due to the elimination of alkyl
phosphoric acid on the catalytic serine resulting in a homoalanine residue. All the
fragmentation information confirmed that the precursor ion at m/z 11682+ was the
phosphorylated peptide. Furthermore, the modified group can be deduced based on the
mass difference (77 Da) between the precursor ion and fragment ion. The lost fragment
should be 2 times that of the mass difference due to the doubly charged precursor and
product ions. As such, the modified group was identified as O,O-diethyl phosphate (154
Da). The other phosphorylated peptides can be determined using the same approach. In
addition, the phosphorylation site was also localized as serine at position 15.
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Figure 1-3-1. MS/MS of the alkyl-phosphorylated peptide by ethyl paraoxon. The doubly

charged precursor ion at m/z 11682+ was selected for collision-induced dissociation. The
dominant fragment ion was doubly charged ion at m/z 10912+ corresponding to the loss of
the O,O-ethyl phosphoric acid from the precursor ion.
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Identification of the Carbamylated Peptide

The MS/MS spectrum of the doubly charged precursor ion at m/z 11292+ was also
obtained (Figure 1-3-4). The pattern of tandem MS for the carbamylated peptide was
different from those of phosphorylated peptides. Although the doubly charged ion at m/z
10912+, due to the loss of the carbamylated group, was also observed, it was not the
dominant fragmentation ion. Enough fragmentation information was collected to identify
the doubly charged precursor ion at m/z 11292+ from the tandem mass spectrum.
Comparing the product mass spectra of the carbamylated peptide and the intact peptide, an
identical set of unmodified fragment ions corresponding to y14-y3 was observed. Mass
shifts with 57 Da, due to the attached carbamylated-group (57 Da) on the active site serine
residue, were observed for y15Δ-y19Δ ions (Figure 1-3-4). It was evident that the
precursor ion at m/z 11292+ was the carbamylated peptide, and the carbamylation site was
identified as serine at the position 15 from the LC/MS/MS analysis.
Comparison of Sensitivity of MALDI and LC/MS/MS

In Chapter 2, we successfully detected and quantified inhibited eBChE resulting
from OP and CB exposure using MALDI-TOF-MS methodology. In order to compare the
detection sensitivity of the MALDI-TOF-MS method and the LC/MS method, the tryptic
digests of eBChE treated by ethyl paraoxon at different concentrations were used. Table
1-3-1 lists the peak area ratios (peak area of phosphorylated peptide to that of intact peptide)
from LC/MS analysis and the intensity ratios (intensity of the phosphorylated peptide to
that of the intact peptide) from MALDI-MS at different concentrations of ethyl paraoxon
(0, 0.05, 0.5, 1.0, and 1.5 µM).
The peak area ratios from the LC/MS method were higher than the intensity ratio
from the MALDI-MS method for the same tryptic digest. This is because the low response
of phosphorylated peptides detected by MALDI. The poor detection signal of the
phosphorylated peptide by the MALDI method resulted from the electron withdrawing
property of the phosphate group on the modified peptide. The low response of
phosphorylated peptides was also due to the suppression effects in the presence of the other
peptides from the tryptic digest of eBChE. In contrast, the online separation of LC/MS/MS
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Table 1-3-1. The relative ratio of modified peptide peak area or intensity by ethyl

paraoxon to the intact peptide peak area or intensity from the RICa LC/MS/MS and that
from MALDI.

Concentration of ethyl

I2336.2/I2200.2b from

I2336.2/I2200.2c from RIC of

paraoxon (µM)

MALDI

LC/MS/MS

0.05

0

0.47

0.5

0.20

1.72

1

0.79

3.02

1.5

∞

35.06

a

: RIC stands for reconstructed ion chromatogram;

b

: the data from the previous work (Chapter 2);

c

: the relative ratio of the modified peak (at m/z 2336.2) area by ethyl paraoxon to

that of the intact peptide (at m/z 2200.2).
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method decreased the complexity of the peptide mixture, and increased the response for
each individual peptide accordingly. Furthermore, the CID of the selected ion for the
LC/MS analysis dramatically increased the interest-peptide response. The data (Table
1-3-1) clearly showed that the LC/MS/MS method was more sensitive than MALDI
method. For instance, no phosphorylated peptide was detected from the sample treated
with 0.05 µM ethyl paraoxon, and no intact peptide was identified when the concentration
of ethyl paraoxon was at 1.5 µM using the MALDI method. However, both the modified
peptide and the intact peptide were detected at 0.1 µM and 1.5 µM ethyl paraoxon using the
LC/MS/MS method.
MALDI and LC/MS/MS Analysis for Offline-fractionated Peptides

In order to reduce the complexity of the peptide mixture and enrich the
phosphorylated peptide, a tryptic digest of ethyl paraoxon inhibited eBChE was
fractionated by offline HPLC with UV detector (see Experimental section). Every peak
was manually collected as a different fraction using UV detector at 214 nm. After two
offline separations, the MALDI spectrum of every fraction was obtained to determine
which fractions contained the modified peptide. The modified peptide at m/z 2336.2 was
identified all the fractions from 13th to 18th. Only the 15th fraction was analyzed using
LC/MS/MS. Figure 1-3-5 shows the MALDI mass spectrum of the 15th fraction separated
from the tryptic digest of the eBChE inhibited by ethyl paraoxon (see Experimental
section). Although most of the small peptides were removed from the mixture, the
modified peptide at m/z 2336.2 was observed in the 15th fraction as well as the other
peptides. The modified peptide ion with a double charge at m/z 11682+ was selected,
specially isolated and fragmented using the LC/MS/MS technique. Figure 1-3-6 shows the
ion chromatogram (IC) of LC/MS/MS of the precursor ion at m/z 11682+. The
phosphorylated peptide was monitored by its dominant doubly charged fragment ion at m/z
10912+ (lower panel of Figure 1-3-6), which corresponded to the neutral loss of
(CH3CH2O)2P(O)(OH) from the precursor ion. A typical Gaussian-shaped peak at
retention time 26.50 min was observed. The peak area was related to the amount of the
phosphorylated peptide present in the mixture.
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Figure 1-3-5. Representative MALDI-TOF-MS spectrum of the 15th fraction separated by

HPLC containing the modified peptide with O,O- diethyl phosphate group from the tryptic
digest of eBChE treated with ethyl paraoxon. The modified peptide is labeled with an
arrow.

80

26.50

100

50

0
100

26.50

50

0

0

5

10

15

20

25

30

35

40

Time (min)

Figure 1-3-6. Reconstructed ion chromatogram (RIC) of the modified active site peptide

after two offline HPLC fractionations. RIC of the doubly charged precursor ions at m/z
11682+ is shown in the upper panel. RIC of the fragment ion at m/z 10912+, which
corresponds to the loss of the alkyl phosphoric acid HOP(O)(OCH2CH3)2 and is used to
monitor the phosphorylated peptide, is shown in the lower panel.
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LC/MS/MS Analysis for Unfractionated Phosphorylated-peptides

From the above discussion, LC/MS/MS was capable of analyzing the enriched
phosphorylated-peptide after two offline separations. At this stage, we were curious to
determine whether or not the assay could be used for the isolation of the phosphorylated
peptide from the un-fractionated peptide mixture. Figure 1-3-7 shows the RIC of 11682+
from the un-fractionated tryptic digest of inhibited eBChE resulting from ethyl paraoxon
exposure. LC/MS/MS techniques were performed to analyze particular ions of interest.
The fragment ion at m/z 10912+ was used to monitor the precursor ion. A sharp and narrow
peak, corresponding to the precursor ion m/z 11682+ at retention time 26.55 min, was
observed.
By comparing the results from the fractionated (Figure 1-3-6) and un-fractionated
(Figure 1-3-7) digests of the inhibited eBChE by ethyl paraoxon, the RIC of the modified
peptide from the fractionated sample was found to not be better than that of the
unfractionated one. A side shoulder peak of the RIC for the phosphorylated peptide from
the fractionated sample, which was a peptide with the same m/z as that of the
interest-peptide. The disadvantages of the fractionated methodology were its time
consuming nature and the low sample recovery. All the results clearly showed that the
LC/MS/MS technique was a powerful tool for the isolation of the phosphorylated peptide
ions without offline separation before analysis.
LC/MS/MS for Un-fractionated Carbamylated- peptides

The carbamylated peptide was baseline-isolated from un-fractioned tryptic digests
of the carbamylated eBChE (Figure 1-3-8) using LC/MS/MS analysis. The fragment ion at

m/z 10912+ was also used to monitor the carbamylated peptide ion. Because the fragment
ion was not the dominant ion in the product mass spectrum, the peak area of the fragment
ion at 10912+ was much less than that of the precursor ion (Figure 1-3-8). Although the
LC/MS/MS method was applicable for the isolation of carbamylated peptide, the amount
of the carbamylated ions can not be monitored by the fragment ion at m/z 10912+.
Relative Quantification of the Phosphorylated Peptides

One kind of phosphorylated peptide was successfully analyzed using LC/MS/MS
method without any offline fractionation prior analysis. We were curious to find out
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Figure 1-3-7. Ion chromatogram (IC) of the modified active site peptide without offline

fraction prior to LC/MS analysis. The modified peptide with O,O-diethyl phosphate adduct
(MH2+ at m/z 11682+) is shown in the upper panel and the fragment ion at m/z 10912+ with
the loss of the alkyl phosphoric acid HOP(O)(OCH2CH3)2 is shown in the lower panel.
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whether the same assay could be used for the analysis of a mixture of phosphorylated
peptides. eBChE was inhibited with 1.2 μM methyl paraoxon, 0.5 μM ethyl paraoxon, and
0.2 μM EPN oxon, separately. Each of these three treated samples was subsequently
digested with trypsin, respectively. The same amount of the tryptic digest (0.9 µg/μl) of the
inhibited BChE by methyl, ethyl and EPN oxon were mixed, and analyzed with LC/
MS/MS technique.
As described in Chapter 2, inhibited peptides resulting from methyl paraoxon
exposure were detected as phosphorylated peptides with O-methyl phosphate (calculated
MH+ at m/z 2294.5) and O, O-dimethyl phosphate (calculated MH+ at m/z 2308.5). The
inhibited peptide from ethyl paraoxon was identified with O,O-diethyl phosphate
(calculated MH+ at m/z 2336.5). Similarly, the inhibited peptide from EPN oxon was
detected with O-ethyl phenyl phosphate (calculated MH+ at m/z 2368.5). All the above
results were obtained using MALDI-TOF-MS technique (Chapter 2).
Phosphorylated peptides were further confirmed through the sequence information
using LC/MS/MS analysis (Figure 1-3-1 and Figure 1-3-2). Collision induced dissociation
(CID) of the phosphorylated peptides ions were specially selected to isolate and fragment
in the ion trap. If only data dependent acquisition for the CID of the four precursor ions was
used, the phosphorylated peptide by EPN oxon was always omitted (data not shown). Data
dependent acquisition is set up to analyze the most abundant ions each time. Because the
four phosphorylated peptides eluted from the capillary column during a short time interval
(2.23 minutes for elution of all the four selected ions, Figure 1-3-9) and the suppression
from the other abundant ions, not all of the ions of interest can be analyzed. A time segment
LC/MS/MS technique was used to solve the problem, which was referred that the mass
spectrometer was set up to analyze one kind of precursor ion during a certain time period
and ignore all the other peptides. Using the time-segmented LC/MS/MS technique, the
phosphorylated peptides from the mixture of the tryptic digests of eBChE were baseline
separated (Figure 1-3-9).
As described before, all phosphorylated peptides had a similar product mass
spectrum. Only one dominant fragment ion at m/z 10912+ was observed, which
corresponded to the loss of the alkyl phosphoric acid (neutral fragment) from the precursor
ions. As such, the phosphorylated peptides were deduced by the neutral fragment ion from
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Figure 1-3-9. Ion chromatograms (IC) of common fragment ion (m/z 1091 ). Precursor

ions were determined by the neutral loss fragments. Panel A is with neutral loss fragment
112 Da, corresponding to CH3OP(O)(OH)2 (112 Da), from the precursor ion MH2+ at m/z
11472+ modified by methyl paraoxon; panel B is with neutral loss fragment 126 Da,
corresponding to (CH3O)2P(O)OH (126 Da), from the precursor ion MH2+ at m/z 11552+
modified by methyl paraoxon; panel C is with neutral loss fragment 154 Da, corresponding
to (CH3CH2O)2P(O)(OH)2 (154 Da), from the precursor ion MH2+ at m/z 1168+2 modified
by ethyl paraoxon; panel D is with neutral loss fragment 186 Da, corresponding to
(CH3CH2O)(C6H5)P(O)(OH)2 (186 Da), from the precursor ion MH2+ at m/z 11842+
modified by EPN oxon.
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the precursor ions. For instance, the neutral loss-fragment in panel A (Figure 1-3-9) was 56,
which was the mass difference between the doubly charged precursor ion and the doubly
charged fragment ion at 10912+. The precursor ion was then deduced as 11472+
corresponding to the modified peptide with O-methyl phosphate (112 Da). Using the same
approach, all the precursor ions for panel B, C, and D (Figure 1-3-9) were deduced based
on the neutral loss of O,O- dimethyl phosphoric acid (126 Da), O,O-diethyl phosphoric
acid (154 Da), and O-ethyl phenyl phosphoric acid (186 Da), respectively.
The stoichiometries of the phosphorylated peptides were obtained by comparing
the integrated peak intensities. An assumption was made that all the alkyl phosphorylated
peptides ionized at the same efficiencies in electrospray source. The integrated peak area of
the various phosphorylated peptide indicated the extent of exposure to each OP. The
relative ratio of the integrated peak intensities was AA1147 : AA1155 : AA1168 : AA1184
= 2.5 : 4.3 : 2.7 : 1 (AA is the area of the peak). The AA1147 was then added with AA1155
to obtain a total value, which demonstrated the total exposure to methyl paraoxon. As such,
the relative ratio was methyl paraoxon : ethyl paraoxon : EPN oxon = 6.8 : 2.7 : 1. This
indicated that eBChE was exposed to methyl paraoxon 6.8 times more than EPN oxon, and
2.7 times more than ethyl paraoxon. The result of this method was consistent with the
actual incubation concentration ratios, which was methyl paraoxon : ethyl paraoxon : EPN
oxon = 1.2:05:0.2 = 6.0 : 2.5 : 1. The relative standard error was 8% between the detected
value and the actual value. Such difference was caused by the different inhibition
efficiency of OPs. Based on the results from our previous work (Chapter 2), the inhibitory
ability of methyl paraoxon was lower than that of ethyl paraoxon and EPN oxon. The lower
inhibition efficiency produced less inhibited peptides, which corresponded to the extent of
pesticide exposure by methyl paraoxon. It has to be emphasized that the quantification was
not absolute, because no internal standard was used. However, a relative quantification was
obtained, and was consistent with the actual pesticide concentrations.
CONCLUSION

A new methodology was developed here to provide identification and baseline
separation of a mixture of phosphorylated active site peptides using LC/MS/MS. The
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LC/MS/MS methodology was more sensitive due to its online separation, which reduced
the complexity of the peptide mixture. Using the methodology, no offline separation was
needed before the analysis, which avoided the sample loss during the preparation
procedure. The methodology was successfully used in the analysis of single pesticide
exposure. In this study, a common dominant fragment ion at m/z 10912+ was observed in
tandem mass spectra of all phosphorylated peptides, and was used to monitor the precursor
ions. The phosphorylated peptides were differentiated by the neutral loss from the
precursor ions. The common fragment ion at m/z 10912+ was further fragmented to acquire
the sequence information and modification site of the phosphorylated peptides.
LC/MS/MS was a powerful technique for obtaining sequence information and for
localizing the phosphorylation site of the modified peptides. The methodology was also
successfully applied for the analysis of d peptide modifie by carbaryl. Finally, the time
segment of LC/MS/MS analysis of the selected ions was a great tool for baseline separation,
detection, identification, and quantification of the phosphorylated active site peptides in a
single analysis run.
The application of the LC/MS/MS methodology for the analysis of multiple
pesticide exposure to human will be the subjects of future experiments. A purification
method for the isolation of BChE from human serum is a challenge. Chapter 4 describes
how to solve this problem.
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CHAPTER FOUR
DEVELOPMENT OF A PURIFICATION SCHEME FOR THE ANALYSIS OF
HUMAN SERUM BUTYRYLCHOLINESTERASE
INTRODUCTION

BChE has been notoriously difficult to purify. Although it was discovered in 1932
as an enzyme that hydrolyzes esters (76), hBChE was not sequenced until 1986(40) due to
the lack of adequate amounts of pure enzyme. The relatively low concentration of plasma
BChE (3-5 mg/l), and the complex protein compositions in serum make BChE purification
difficult. Affinity gels are widely used in the purification procedure due to their relatively
specific characters. In this work, affinity gels were synthesized in laboratory to enable
hBChE isolation from serum.
The invention of affinity gels was a milestone in the BChE purification history,
which has been applied for more than 35 years. Before the application of affinity gels, a
conventional purification method was employed for the BChE isolation. This method was
based on the use of an ammonium sulfate fraction at neutral and acid pH (45, 76). A
drawback of this method is poor purification and yield. Furthermore, the method is not
suitable hBChE purification, because the enzyme is not stable at low pH. A big
improvement in the esterase purification occurred in 1970. Affinity gels were used for the
BChE purification, which were originally developed for the purification of AChE by
Kalderon (77). Until 1978, affinity gels with procainamide ligands, which totally changed
the BChE purification history, were first introduced in a small-scale purification of hBChE
by Lockridge & La Du (51). The use of the procainamide affinity gels enabled the
production of high purity and high yield BChE from serum.
Ralston et al. (52) applied two large-scale methods for the purification of horse and
human serum BChE using procainamide gels. In brief, the procainamide-Sepharose 4B
gels were used to treat large volumes of serum followed by the elution of BChE. The eluted
fractions containing BChE were then subjected to ion-exchange chromatography on
DEAE-Sephadex, and the bound BChE was eluted with choline chloride gradient. The
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eluted fractions containing BChE were further purified with preparative polyacrimide-gel
electrophoresis. This assay needs a large amount of sample, which was not available in this
dissertation.
This chapter describes a procedure for synthesizing procainamide-affinity gels. The
ability of the synthesized affinity gels to isolate hBChE was also evaluated and compared
with that of the normal Sepharose 4B column. Laboratory-synthesized affinity gels were
also applied for the analysis of the serum hBChE. In order to analyze hBChE present in
serum, a new strategy was developed in this chapter. An on-bead digestion protocol was
developed in the study. The new assay was based on the combination of affinity
chromatography with LC/MS. In brief, affinity beads synthesized in our laboratory were
used to isolate BChE from serum. The enriched BChE bound on the affinity beads was
further subjected to trypsin digestion. The tryptic digest was subsequently analyzed using
LC/MS/MS. Collision induced dissociation (CID) was applied to analyze peptide of
interest generated from a tryptic digest of hBChE. Our results clearly demonstrated that
procainamide-Sepharose 4B was a powerful tool for the isolation of both intact and
inhibited BChE from human serum.
EXPERIMENTAL
Materials

Frozen human serum was obtained from cognitively normal control subjects
through the neuropathology core of the University of Kentucky Alzheimer’s Disease
Center (ADC), Lexington, KY, using UK Institutional Review Board (IRB) approved
protocols. The serum was diluted to 10 times the original volume with 0.10 M NaCl / 50
mM-sodium phosphate buffer, pH 8.0. Butyrylthiocholine iodide (BTCh), 5,
5’-dithiobis-(2-nitrobenzoic

acid)

(DTNB),

procainamide

hydrochloride,

1-(3-dimethyl-aminopropyl)-3-ethylcarbodi-imide hydrochloride (EDC), CNBr and
6-aminohexanoic acid were purchased from Sigma Chemical Co. (ST. Louis, MO).
Sequencing grade modified porcine trypsin was purchased from Promega Corporation
(Madison, WI).
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Preparation of Affinity Gels

Procainamide-Sepharose 4B affinity gel was synthesized in three steps as described
by Cuatrecasas and Anfinsen (78). The washed and settled Sepharose-4B beads (10 ml)
were activated with 2.5 g CNBr for 30 min at pH 11 to produce CNBr-activated beads.
After reaction, 1 mg beads were washed with acetone and dried by Speed Vacuum
concentrator. IR spectra (KBr) of dried beads were determined. 6-Aminohexanoic acid,
0.1416 g dissolved in 8 ml 0.2 M Na2CO3 buffer pH 9.29, was added to the washed
CNBr-activated beads and gently stirred at 4 ºC overnight. As such, CH-Sepharose 4B was
produced, and IR spectra (KBr) of 1 mg such dried beads were obtained. CH-Sepharose 4B
beads (5 ml) were re-suspended in 5 ml 1M HCl pH 4.5. Procainamide (2.72 g) dissolved
in 5 ml 1M HCl pH 4.5 was added to the former suspension. EDC was added dropwise as
an aqueous solution to a final concentration of 0.1 M. The mixture was rotated overnight at
room temperature. The total amount of procainamide bound to beads was determined
through measuring the free procainamide in the washing solutions based on the extinction
coefficient of 16,900 M-1 cm-1 at 278 nm.
Affinity Isolation

Settled affinity gels (27 μl) were incubated in diluted serum, 100 μl serum diluted
to 1 ml with 0.10 M NaCl / 50 mM-sodium phosphate buffer, pH 8.0, for 4 h at 4 ºC. After
incubation with serum, beads were washed with 10 ml buffer A (20 mM phosphate, 1 mM
EDTA, pH 6.9), followed by 10 ml of 0.10 M NaCl in buffer A, further washed with 10 ml
0.15 M NaCl in buffer A, and finally equilibrated with 5 ml 25 mM NH4HCO3.
Evaluation of Affinity Gels

The same bead incubation procedure was used as described above. BChE activities
of the diluted serum before and after incubation with affinity beads (modified beads) or
original beads (unmodified beads) were detected and compared.
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hBChE Activity

The same procedure was used to measure hBChE activity in diluted serum as
described in Experimental Section of Part I, Chapter 2.
The procedure for direct measurement of the bound hBChE activity on beads is as
follows. Beads suspended in solution of 50% glycerol in water (v/v) were used for the
enzyme activity measurement. The absorbance of the suspended bead solution with a
mixture of BTCh (1mM) and DTNB (0.32 mM), was measured at 412 nm for the first 10
min of the reaction. Raw data were converted to the relative activity (percent) of the diluted
serum before the incubation with beads.
On-bead Digestion

Affinity beads with bound proteins were incubated in 10 μl trypsin (0.01 μg / μl in
25 mM NH4HCO3 buffer) overnight at 37 ºC. The supernatants with peptides from tryptic
digestion were separated from the beads, and were ready for mass spectrometric analysis.
LC-MS Analysis

HPLC separation program, C18 capillary column, and parameters of the mass
spectrometer were the same as described in the Experimental Section of Part I, Chapter 3.

MALDI-TOF-MS Analysis

The sample preparation, target spotting technique and parameters of the mass
spectrometer were the same as described in the Experimental Section of Part I, Chapter 2.
RESULTS AND DISCUSSION
Preparation of Affinity Beads

IR was used to confirm the first two reactions of the affinity gel synthesis (reaction
of Step 1 and 2 shown in Figure 1-4-1). Beads (1 mg) after each reaction were washed with
acetone and dried by Speed Vacuum concentrator. IR spectra (KBr) of dried beads were
recorded (Figure 1-4-2 to 1-4-4). The following peaks, shown in the IR of CNBr-activated
beads (Figure 1-4-3), but absent in the original beads (Figure 1-4-2), were: 2593.6 cm-1
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(C≡N), 1735 cm-1 (C=N). This observation was consistent with previous study (63), that
confirmed the formation of C≡N and C=N bond on the Sepharose 4B beads. The peak at
2593.6 cm-1 (C≡N) shown in the IR of CNBr-activated beads (Figure 1-4-2), was absent in
that of CH-Sepharose 4B beads (Figure 1-4-4). As shown in Figure 1-4-4, a peak at 3400
cm-1 in the IR of CH-Sepharose 4B beads suggested the –COOH groups bound on beads,
which indicated that the 6-aminohexanoic acid was attached to the CNBr-activated beads.
The total amount of procainamide bound to beads was determined through
measuring the unbound procainamide in the washing solutions based on the extinction
coefficient of 16,900 M-1 cm-1 at 278 nm. The yield of the affinity gels was of 12.7 μmol
procainamide / ml of the swollen beads.
Evaluation of Affinity Isolation

Equal volume of settled affinity beads (synthesized in laboratory) and original
beads were incubated in the same diluted serum. hBChE activity was measured (see
Experimental section) at 412 nm. Slopes of the line resulting from the plot of absorbance vs
time, were obtained. Table 1-4-1 summarized all of the slopes indicating hBChE activities
from the diluted serums before and after incubation with affinity beads and original beads.
Three parallel experiments were performed. After incubation with affinity beads, the
percentage of hBChE left in solution was 18.1 %. However, the percentage of the
remaining BChE in solution after incubation with non-modified beads was 87.8 %. Results
from

preliminary

experiments

indicated

that

the

binding

of

hBChE

to

procainamide-Sepharose 4B beads was 6.7 times more than that to the original beads.
The specific character of the affinity beads can also be confirmed by direct
measurement of the bound BChE activity on beads. Beads suspended in solution of 50%
glycerol in water (v/v) were used for the enzyme activity measurement. Table 1-4-2 lists
the slopes from three parallel experiments. The percentage of hBChE bound to
procainamide-Sepharose 4B gels was 55.7 ± 4.7 %. However, only 1.93 ± 2.5 % was
detected for the original beads. This result showed that hBChE bound to the affinity gels
was about 29 times more than that bound to the original beads.
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Figure 1-4-1. Activation of Sepharose by CNBr and subsequent coupling of ligand.
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COOH

2922.2

3425.5

Figure 1-4-2. IR spectrum (KBr) of dried original beads (unmodified beads).
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2593.6
C≡N

1735.9
C=N

Figure 1-4-3. IR spectrum (KBr) of dried CNBr-activated beads.
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-COOH

Figure 1-4-4. IR spectrum (KBr) of dried CH-Sepharose 4B beads.
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Table 1-4-1. hBChE activities of the diluted serum before and after incubation with beads.

Slope after

% left after

Slope after

% left after

incubation

incubation

incubation

incubation

Slope before

with affinity

with affinity

with original

with original

Exp.

incubation

beads

beads

beads

beads

1

0.2590

0.0406

15.7

0.19245

84.3

2

0.2059

0.036

17.5

0.19945

96.9

3

0.2224

0.04675

21.0

0.18305

82.3

Ave. ± SD

18.1 ± 2.7

Ave. ± SD

87.8 ± 7.9
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Table 1-4-2. hBChE activities from direct absorbance measurement on beads.

Slope before

Slope on

% hBChE on

affinity beads affinity beads

Slope on

% hBChE on

original

original

beads

beads

Exp.

incubation

1

0.2590

0.1307

50.4

0.013

4.9

2

0.2059

0.1219

59.2

0.001

0.5

3

0.2224

0.1276

57.4

0.001

0.4

Ave. ± SD

55.7 ± 4.7

Ave. ± SD

1.9 ± 1.5
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The big difference between the two measurements was because the light was
diffracted by the suspended beads during the absorbance measurements. We suggested that
the activity measurement in solution was more reliable than the measurement direct on
beads. Despite the difference, both measurements proved that affinity beads (synthesized
in laboratory) were able to enrich hBChE from the serum.
LC/MS/MS Analysis

The procainamide-Sepharose 4B gels facilitated the enrichment of hBChE in the
presence of the other serum proteins. However, the high concentration of albumin and
immunoglobulins in the serum increased the amount of nonspecific binding to the affinity
beads, and increased the number of proteins subjected to proteolytic digestion.
Consequently, a much more complex peptide mixture, generated from these non-specific
binding proteins, made it more difficult to detect the peptide of interest from hBChE. In
order to reduce non-specific binding of serum proteins, high concentrations of salt were
used to wash the affinity beads (see Experimental Section).
After the stringent washing steps, the entire isolated protein complex was digested
with trypsin while still bound on the affinity beads. The resulting digest was then subjected
to LC/MS/MS analysis. The presence of hBChE was confirmed by the collision-induced
dissociation (CID) of a selected ion MH+ at m/z 2282.5+, which represents a tryptic peptide
of hBChE. The sequence of the ion was AILQSGSFNAPWAVTSLYEAR (calculated
average mass 2281.2). So, doubly charged ions at m/z 11412+ were isolated and fragmented
in the ion trap with the presence of other abundant peptides. Figure 1-4-5 shows the IC of
11412+ from a trypsin digest of hBChE and the tandem mass spectrum of this selected
peptide using the LC/MS/MS method.
The presence of hBChE on beads was also confirmed by the detection of the tryptic
active-site

peptide

at

m/z

2928.5,

the

sequence

of

which

was

SVTLFGESAGAASVSLHLLSPGSHSLFTR (the catalytic serine is underlined). Figure
1-4-6 shows the RIC and tandem mass spectrum of 14642+ from on-bead tryptic digest of
hBChE using LC/MS/MS method. The poor MS/MS spectrum of the selected ion was
because it was out of mass detection limit of the ion trap, which was less than 2000 Da.
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Figure 1-4-6. (A) RIC of the selected peptide (MH2+ at m/z 1464+2) for collision-induced

dissociation of LC/MS/MS analysis from tryptic digest of hBChE. (B) Product ion
spectrum of the selected singly charged peptide, the sequence of which was
SVTLFGESAGAASVSLHLLSPGSHSLFTR (the catalytic serine is underlined).
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In order to prove that procainamide-Sepharose 4B beads are able to isolate
inhibited BChE, eBChE was used. Since an ion trap cannot detect ions higher than 2000 Da,
it is unsuitable to detect the inhibited active site peptide by ethyl paraoxon (calculated MH+
at m/z 3096+) from a tryptic digest of hBChE. The modified peptide by ethyl paraoxon
(calculated MH+ m/z 2368+) generated from a tryptic digest of eBChE is much smaller than
that from hBChE (calculated MH+ at m/z 3096+). Therefore, the inhibited eBChE by ethyl
paraoxon was used to evaluate the enrichment ability of the inhibited enzyme. Figure 1-4-7
shows the RIC and MS/MS of this selected ion at m/z 11852+ from a tryptic on-bead digest
of inhibited eBChE. The results clearly showed that procainamide-Sepharose 4B beads
were able to isolate inhibited eBChE.
From the above discussion, tandem mass spectrum of the active site peptide
generated from the tryptic digest of eBChE was better than that from hBChE. Two reasons
are responsible for this phenomenon. First, the tryptic active-site peptide (calculated MH+
at m/z 2200.5) from eBChE is smaller than that (calculated MH+ at m/z 2928.5) from
hBChE. Furthermore, the performance of procainamide-Sepharose 4B gels at retaining
BChE from native human serum is worse than that from eBChE (52).
MALDI-TOF-MS analysis

The enrichment of the active and inhibited hBChE for procainamide-Sepharose 4B
beads was also proved by MALDI-TOF-MS analysis. Figure 1-4-8 A shows the MALDI
spectrum of the tryptic on-bead digest of the enriched hBChE. After serum was incubated
with carbaryl, the inhibited hBChE was enriched on the affinity beads. Then, the isolated
hBChE bound on the beads was subjected to trypsin digestion. The resulting tryptic digest
was analyzed using MALDI-TOF-MS technique. The peak at m/z 2985.5 corresponded to
the modified active site peptide with carbamylate group CH3NHC(O) (Figure 1-4-8B).
Although there is no detection mass limit for MALDI-TOF, low responses of both the
active site peptide and the modified active site peptide of hBChE were observed. The
suppression of the peptide of interest, resulting from the presence of the other peptides, was
responsible for the low detection signal. Despite the low detection response, data shown
here demonstrate that procainamide-Sepharose 4B gels were able to isolate the intact
hBChE, as well as to isolate the inhibited hBChE.
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Figure 1-4-7. (A) IC of the selected peptide (MH2+ at m/z 11852+) for collision-induced

dissociation of LC/MS/MS analysis from tryptic digest of eBChE. (B) Product ion
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Figure 1-4-8. Representative MALDI-TOF-MS spectra of control (A) and tryptic digests

of hBChE treated with carbaryl (B). Labeled peaks with average mass correspond to the
presence of unmodified and modified active site peptides. The peak at m/z 2985.5
corresponds to the active site peptide modified with carbamylation group (CH3NHC(O)).
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CONCLUSION

Affinity beads were successfully synthesized in the laboratory. The specific
character of the affinity beads was proven by the hBChE activity measurement in the
diluted human serum before and after incubation with affinity beads. Results demonstrated
that the procainamide-Sepharose 4B beads enriched BChE at least 6.7 times more than the
original beads. The specific enrichment for both intact and inhibited BChE was proven by
both LC/MS/MS and MALDI-TOF-MS analysis. Our results confirmed that
procainamide-Sepharose 4B was a powerful technique for isolation of both intact and
inhibited BChE from human serum. The phosphorylated and carbamylated peptides were
successfully detected, which indicated that the developed method was not only useful for
the analysis of OP exposure, but also useful for the analysis of CB exposure. The
developed method was based on the combination of the affinity chromatography and mass
spectrometry. Furthermore, the detection of tryptic active site peptide of both hBChE and
eBChE indicated that the on-bead digestion protocol worked efficiently.
Although the developed method was successfully applied to the detection of a
small amount of BChE in human serum, the detection signal was much less than expected
for both LC/MS/MS and MALDI-TOF-MS techniques. A noteworthy limitation of
MALDI as described in Chapter 5, LC/MS/MS is a better choice for the hBChE analysis in
human serum. However, a low detection signal was observed for LC/MS/MS techniques in
this Chapter, because the tryptic active-site peptide was out of the detection mass range of
the ion trap. A new digestion method is required to produce a suitable size of peptide
containing the active-site serine of hBChE, which will be the next step in the analysis of
hBChE inhibition in real sample, as described in Chapter 5.
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CHAPTER FIVE
ANALYSIS OF HUMAN BUTYRYLCHOLINESTERASE EXPOSED TO
ORGANOPHOSPHATES AND CARBAMATES IN SERUM WITH A
COMBINATION OF AFFINITY CHROMATOGRAPHY AND MASS
SPECTROMETRY
INTRODUCTION

There is an increasing concern over the extensive use of pesticides, such as OPs and
CBs, in the agricultural and other industries. The concern is based on the fact that OPs and
CBs cause the inhibition of key synaptic enzymes, including AChE. Some OPs are in the
form of chemical warfare (CW) agents, two of which, sarin and VX, were involved in the
1995 Tokyo subway terrorist attack (79). With the increasing terrorism and the escalating
use of CW agents in the battlefield like the Iran-Iraq conflict, the healthcare systems for
both military and civilians require a sensitive and reliable monitoring program for
detection of pesticide exposure. While most OPs and CBs are not extremely neurotoxic,
investigation of their cholinesterase inhibition can provide insight into human exposure to
these classes of compounds. In this chapter, a method is described for the identification and
quantification of OP and CB exposure in serum, with a combination of affinity
chromatography and LC/MS/MS.
The interest in hBChE as a bioscavenger of OPs and CBs is increasing because of
the extensive use of these chemicals. The rising concern in hBChE study is also because
chemical warfare (CW) agents (80) are used by terrorists based on their properties of the
mass destruction and low costs. OPs (including CW agents) and CBs exert their inhibitory
action by forming a covalent bond with the active site serine of BChE in a highly reactive
mode. Therefore, the cholinesterase inhibitors scavenged by BChE are unavailable for
further reaction with AChE, which is present in the nervous system and is much more
important than BChE. Although its true physiological function remains undetermined,
BChE is of pharmacological and toxicological importance. A major clinical application of
inhibited plasma BChE analysis is to detect OP and CB exposure.
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Fidder et al .(60) published a method for the analysis of human serum samples from
the victims in the 1995 Tokyo subway terrorism. The Fidder method is based on the
detection of nonapeptides obtained from pepsin digests of hBChE. Pepsin is known as a
nonspecific protease, which cleaves proteins more or less randomly. The use of Fidder
method is limited due to the poor reproducible pepsin digestion. In addition, synthesized
phosphorylated peptide is used for the quantification of inhibited hBChE. The
radioactive-phosphorylated peptide is synthesized using F-moc chemistry, which is time
consuming, requires a lot of chemical techniques, and needs a specialist for handling the
radioactive reagents. Furthermore, isolation of hBChE from serum involves multiple steps:
elution of proteins from the procainamide affinity column followed by heating the
fractions containing hBChE; digest filtered proteins on the filter; wash of peptides from
filters, and concentration of digested solution before LC/MS/MS analysis. It is known that
this multi-step procedure results in a low recovery due to lose of analyte during processing.
In this chapter, a novel improved procedure was developed for the analysis of
hBChE inhibition that has overcome all of the limitations of the Fidder method. Although
our method was also based on the analysis of the modified active site peptide of the
inhibited hBChE using electrospray tandem mass spectrometry, the improved
methodology provided higher sensitivity and reproducibility than the Fidder method. We
developed a new digestion method called ‘double digestion’, which incorporated a trypsin
digestion followed by a protease V8 digestion. A compatible size of the active site peptide
with LC/MS/MS was produced from the double digestion, which gave a reproducible
digest. The sequence of the intact active site peptide generated from double digestion is
SAGAASVSLHLLSPGSHSLFTR (average mass 2195.2), where the active site serine is
underlined. Results clearly show that double digestion works as efficiently as trypsin
digestion. An on-bead digestion was also developed here to minimize the analyte loss
during the sample preparation. In addition, a calibration system was constructed based on
the detection of modified active site peptides in vitro using LC/MS/MS technique. The
developed calibration system was applied to analyze the hBChE inhibition in serum
sample. Furthermore, results demonstrated that the improved methodology was applicable
for the detection and quantification of multiple pesticide exposure.
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EXPERIMENTAL
Chemicals

Highly purified hBChE (EC 3.1.1.8) was a kind gift of Dr. Oksana Lockridge,
University of Nebraska Medical Center (Nebraska, USA). This hBChE was provided as
2790 units/ml buffer (10 mM potassium phosphate, 0.15 M NaCl, 0.02% sodium azide).
Slide-A-Lyzer Dialysis Cassettes purchased from Pierce (Rockford, IL) were used to
remove salts from the former solution. The desalted hBChE solution was collected and
dried by Speed Vacuum concentrator, and the residue was dissolved in ammonium
bicarbonate buffer (pH=7.8). The concentration of hBChE was determined by the enzyme
activity measurement. Frozen human serum was obtained from cognitively normal control
subjects through the neuropathology core of the University of Kentucky Alzheimer’s
Disease Center (ADC), Lexington, KY, using UK Institutional Review Board (IRB)
approved protocols. The serum was diluted to 10 times the original serum volume with
0.10 M NaCl/50 mM-sodium phosphate buffer, pH 8.0. Butyrylthiocholine iodide (BTCh),
5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) EPN, ethyl paraoxon and carbaryl were used
as described in Experimental Section of Part I, Chapter 2. Sequencing grade modified
porcine trypsin was purchased from Promega Corporation (Madison, WI). Sequencing
grade protease V8 from Staphylococcus aureus V8 was purchased from Roche
(Indianapolis, IN). The synthesized procainamide affinity beads (Chapter 4) were used for
the study in this chapter.
Instrumentation
Electrospray LC/MS/MS Analysis

All mass spectrometric experiments were conducted on a mass spectrometer
(Finnigan LCQ) equipped with a standard electrospray interface. Digested hBChE (5 µl,
about 2 µg) was injected into a capillary column. HPLC separation program, C18 capillary
column, and parameters of the mass spectrometer were the same as described in the
Experimental Section of Part I, Chapter 3.
MALDI-TOF-MS Analysis

The sample preparation, target spotting technique and parameters of the mass
spectrometer were the same as described in the Experimental Section of Part I, Chapter 2.
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hBChE Inhibition

hBChE (316 units) was dissolved in 1ml 50 mM ammonium bicarbonate buffer
(pH=7.8), and incubated with OPs or carbaryl (dissolved in methanol) at 37 ºC for 1 h or 30
min, respectively. The final concentration of methanol was less than 0.05% (v/v) and did
not significantly affect enzyme activity.
hBChE Activity

hBChE activity was measured using the Ellman assay (56). Briefly, the absorbance
of the solution, containing hBChE with a mixture of BTCh (1 mM) and DTNB (0.32 mM),
was measured at 412 nm for the first 10 min of the reaction.
Double Digestion

Tryptic digestion was performed in 40% ACN with a 20:1 excess of hBChE to
trypsin. hBChE (10 µl of 316 units/ ml solution) was subjected to trypsin digestion for each
experiment. The digest was performed in a 50 mM ammonium bicarbonate buffer (pH=7.8)
at 37 ºC overnight. Half of the tryptic digest was terminated by formic acid and analyzed
using MALDI-TOF-MS. The remaining 5 µl of hBChE solution continued to be incubated
with a 20:1 excess of hBChE to protease V8 for 24 h at 25 ºC. Formic acid was used to
terminate the double digestion. The resulting digest was analyzed using MALDI-TOF-MS
and LC/MS/MS techniques.
Procedure for Analysis of hBChE Inhibition in Serum

A schematic of the procedure for analysis of hBChE inhibition is shown in Figure
1-5-1. In brief, 100 µl of serum sample was incubated with carbaryl for 30 min as described
by Rao et al. (71)), or with OPs for 1 h as described by Doorn et al. (58, 59). After reaction,
the serum sample was diluted with 1000 µl of 0.1 M NaCl in 50 mM phosphate buffer (pH
8) to reduce the non-specific protein binding on the affinity beads. The settled affinity
beads (50 µl) were incubated with the diluted serum sample for 4 h at 4 ºC to ensure
complete reaction of hBChE with procainamide-Sepharose 4B beads as described by
Ralston et al. (52). After incubation, the diluted serum solution was removed, and affinity
beads were washed with 10 ml buffer A (20 mM phosphate, 1 mM EDTA, pH 6.9),
followed by 10 ml 0.10 M NaCl in buffer A, and further washed with 10 ml 0.15 M NaCl in
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buffer A, and finally equilibrated with 5 ml 25 mM NH4HCO3 (pH 7.8). After the washing
solution was removed, the remaining affinity beads with bound proteins were incubated
with 10 μl of 0.01 μg / μl trypsin in 25 mM NH4HCO3 for 24 h at 37 ºC. Sequentially, 0.13
μg protease V8 was added and incubated for 24 h at 25 ºC. Supernatants with peptides from
double digestion were separated from beads, and were ready for mass spectrometric
analysis.
RESULTS
Identification of the Modified Peptides from Double Digestion

MALDI mass spectra for both the control and the treated sample were obtained.
The modified peptides in the digests of inhibited hBChE, after double digestion, were
determined by comparing the mass spectra before and after treatment. Figure 1-5-2 and
Figure 1-5-3 show the mass spectra of a control sample and a sample treated by OPs and
carbaryl. The peak at m/z 2253.2 was identified as a carbamylated peptide, since it is
present in the mass spectrum of the treated sample (Figure 1-5-2 B), but absent in the
control sample (Figure 1-5-2 A). However, peaks at m/z 2196.2 corresponding to the intact
active site peptide appear in both control and treated sample.
Modified peptides by ethyl paraoxon (Figure 1-5-3 A) and EPN oxon (Figure 1-5-3
B) were also determined using the same approach. Peaks with average masses, which
correspond to the modified and intact active peptides, were observed in mass spectra
generated from the digest of the inhibited hBChE after double digestion. Table 1-5-1
summarizes the observed peaks with average masses of MH+, corresponding to the intact
and modified active site peptide of hBChE treated with 5 µM pesticides. Modified groups
were determined based on the mass differences (Table 1-5-1) between the modified
peptide and the intact active site peptide. For instance, the modified group for carbaryl was
determined as carbamate (O=C-NHCH3, 58 Da), which is based on the mass difference of
the modified peptide (average m/z at 2253.2) and intact active site peptide (average m/z at
2196.2). This mass difference takes into account the proton loss on the catalytic serine
during the carbamylation reaction. Using the same approach, the modified group from
ethyl paraoxon was determined as O,O-diethyl phosphate, which corresponded to the
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Figure 1-5-1. Schematic of the procedure for the analysis of hBChE inhibition in serum

matrix.

112

Intens. [a.u.]

500

A

2196.2
Active sitePeptide

300

200

100

0
2150

Intens. [a.u.]

300

2200

2250

2300

2350

2400

m/z

B

200

150

100

Active Site
peptide

2253.2

Modified peptide with O=C-NHCH3

2196.2

50

0
2150

2200

2250

2300

2350

2400

m/z
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Figure 1-5-3. MALDI-TOF-MS spectra of the hBChE digest after double digestion,

which was inhibited by ethyl paraoxon (A), by EPN oxon (B). Labeled peaks display the
average masses of peptides. Peaks at m/z 2332.3, and 2364.2 correspond to the modified
active site peptide with O,O-diethyl phosphate, and O-ethyl phenyl phosphate,
respectively.
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modified peptide at m/z 2332.5. Similarly, the modified group from EPN oxon was
identified as O-ethyl phenyl phosphate, which corresponded to the modified peptide at m/z
2364.2.
LC/MS/MS Analysis to Identify the Amino Acid Sequence of Modified Peptides

MS/MS was used to further confirm intact peptide and modified peptides generated
from the digests of inhibited hBChE after double digestion. The amino acid sequence of
carbamylated peptide was identified as (S-carbamate)AGAASVSLHLLSPGSHSLFTR
using MS/MS (MH3+ at m/z 751.73+ Figure 1-5-5). An identical set of y ions were observed
in the tandem mass spectrum of the carbamylated peptide (Figure 1-5-5) with that of the
intact peptide (Figure 1-5-4). However, b ions had 57 Da mass shifts, because they
contained the active site serine with an attached carbamylated group. All the information
confirmed that the triply charged precursor ion MH3+ at m/z 751.73+ was the carbamylated
peptide.
The tandem mass spectrum of phosphorylated peptides is shown in Figure 1-5-6.
Although precursor ions of phosphorylated peptides were different (MH3+ at m/z 777.73+
for ethyl paraoxon, and at m/z 788.73+ for EPN oxon), they had the same tandem mass
spectrum. Only one fragment ion at m/z 726.83+ dominated in the MS/MS spectra of the
phosphorylated peptides (Figure 1-5-6). The common fragment ion was produced by a
neutral loss at the active site serine resulting in a homoalanine residue. Therefore, the
phosphorylated precursor ions can be identified by the neutral loss.
In order to know the amino acid sequence of the phosphorylated peptides, the
tandem mass spectrum of the product ion at m/z 726.83+ was also obtained (Figure 1-5-7).
All the y-ions (Figure 1-5-7) were the same as those in the tandem mass spectrum of the
intact peptide (Figure 1-5-4). However, b-ions had 18 Da mass shift for singly charged ions
and 9 Da mass shift for doubly charged ions, because b-ions contained active site serine.
Results clearly showed that precursor ions MH3+ at m/z 777.73+ and 788.73+ were
phosphorylated peptides, which corresponded to O,O-diethyl phosphorylated peptide and
O-ethyl phenyl phosphorylated peptide, respectively.

115

Table 1-5-1. Masses of observed MH+ (average mass)a for the intact and modified active

site peptide of hBChE treated with 5 μM inhibitor.

Pesticide

intact

inhibited

∆mb Modified with group

Carbaryl

2196.2

2253.3

57

Ethyl
paraoxon
EPN
oxon

O C NHCH3

CH3CH2O

2196.2
2196.2

2332.5
2364.2

P O

136

CH3CH2O

168

CH3CH2O
C6 H5 P O

a

The average mass of the modified or the intact peptide containing the
catalytic serine after double digestion.

b

Difference in mass between the modified and the intact active site peak. All
these mass differences takes into account the proton loss from the catalytic
serine during the phosphorylation reaction.
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Figure 1-5-4. MS/MS of the triply charged intact active site peptide ion (MH3+ at m/z

732.73+).

The

amino

acid

sequence

of

the

intact

active

site

peptide

is

SAGAASVSLHLLSPGSHSLFTR (numbered from right to left), where the catalytic
serine is underlined.

117

O=C-NHCH3

y18(2+)
100

SAGAASVSLHLLSPGSHSLFTR
22
10
1 y ion

y20 (2+)

13 (2+)

y

50

y20 (3+)
9 (2+)

y

y10 (2+)

y17 (2+)

y15 (2+)
y10 (1+)

y14 (2+)

y11 (2+)

Δ

b13
y11 (1+)

(1+)
Δ

b14

(1+)

0
200

300

400

500

600

700

800

900

1000

1100

1200

1300

1400

m/z
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serine. Phosphorylated peptides are identified by the mass shifts of b-ions, which contain
active site serine.
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Evaluation Double Digestion using MALDI

The inhibited hBChE by carbaryl was digested with trypsin. Half of the tryptic
digest of hBChE was subjected to MALDI-TOF-MS analysis. The remaining
tryptic-digested hBChE was subsequently incubated with protease V8 for 24 h at 25 ºC.
The resulting digest was then analyzed using MALDI-TOF-MS. The intensities of both
intact and carbamylated peptides were obtained from the MALDI analysis (data not
shown). The total intensity of active site peptides was obtained by adding the intensity of
the intact peptide and that of the modified peptide. The relative intensity ratio was the
intensity of intact peptide or modified peptide divided by the total intensity. Based on these
reported data, graphs of relative intensity ratio vs carbaryl concentrations were plotted for
both of the hBChE digests from trypsin digestion and from double digestion (Figure 1-5-8).
IC50s (concentration required for 50% hBChE inhibition) and IC100s (concentration
required for complete hBChE inhibition) were determined from these plots (Figure 1-5-8).
From trypsin digestion, IC50 and IC100 were determined as 21.00 µM and 41.84 µM,
respectively (Figure 1-5-8 A). These values were very close to the IC50 and IC100 from
double digestion, which were 20.19 and 40.60 µM, respectively (Figure 1-5-8 B). In
addition, the slopes for the intact peptide and the modified peptide were the same for both
digestion methods. Therefore, it is evident that double digestion had high efficiency and
reproducibility as single trypsin digestion.
Calibration System Construction using LC/MS/MS

Every digest of hBChE treated by CB and OPs, generated from double digestion,
was analyzed using LC/MS/MS methodology. Peak areas of intact peptides and modified
peptides were obtained from LC/MS/MS analysis (data not shown). The total peak area
was calculated by adding the peak area of the intact peptide and that of the modified
peptide. The relative area ratios were the peak area of intact peptide or modified peptide
divided by the total peak area. Based on these reported data, the relative area ratios vs CB
or OP concentrations were plotted (Figure 1-5-9 and Figure 1-5-10). A linear relationship
between the relative area ratio and the pesticide concentration was observed. A calibration
system for carbaryl, ethyl paraoxon, and EPN oxon was developed.
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Analysis of Single Pesticide Exposure

Serum was incubated with 0.2 µM carbaryl for 30 min, and with 0.1 µM ethyl
paraoxon for 1h, separately. hBChE was then enriched on the affinity beads. The affinity
beads with bound proteins were subjected to double digestion (see Experimental section).
The resulting digests of the isolated hBChE were analyzed using LC/MS/MS technique.
Triplicate analysis was performed as described above. Three triply charged precursor ions
were selectively analyzed in the ion trap. Precursor ions MH3+ were at m/z 732.73+ for
intact active site peptide, 751.73+ for carbamylated peptide, and 777.73+ for phosphorylated
peptide by ethyl paraoxon. Five main fragment ions, at m/z 680.13+, 726.72+, 919.72+,
955.32+, 1019.32+, were used to monitor the precursor ions of intact active site peptide and
carbamylated peptide (Figure 1-5-4 and Figure 1-5-5). A dominant fragment ion at m/z
726.83+ was used to monitor the phosphorylated peptide (precursor ion) by ethyl paraoxon
(Figure 1-5-6). Figure 1-5-11 demonstrates the RIC of the intact and modified active site
peptides in one of the three analyses using LC/MS/MS technique. The concentrations of
carbaryl and ethyl paraoxon were determined from the constructed calibration system
based on the average relative area ratios of triplicate analysis. The detected concentration
was 12.3 ± 0.1 µM for carbaryl, and 6.26 ± 0.4 µM for ethyl paraoxon from the calibration
curves (Figure 1-5-11 A and B). Because hBChE concentration for calibration curves was
75 times higher than that in the serum sample, the detected concentrations needed to be
normalized. The normalized concentration was 0.16 ± 0.01 µM for carbaryl, and 0.08 ±
0.01 µM for ethyl paraoxon, which were very close to the actual incubation concentration.
The assay was successfully performed for the analysis of pesticide exposure at a
high level inhibition. We questioned the lowest limit of hBChE inhibition could be
detected using the assay. To determine this, serum was incubated with EPN oxon, resulting
in 5 % hBChE inhibition. The extent of hBChE inhibition was confirmed by the enzyme
activity measurement (data not shown). hBChE was isolated, digested, and analyzed using
affinity chromatography and LC/MS/MS techniques. Figure 1-5-12 shows the RIC of
precursor ions at m/z 732.73+ and 788.73+ for intact peptide and modified peptide,
respectively. The relative peak area ratio was 5 % for the modified peptide, which
indicated that 5 % of hBChE inhibited. This result was consistent with the hBChE activity
measurement.
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Figure 1-5-11. IC of intact and modified peptides. Representative of one set of results from

three parallel experiments after serum treated with 0.2 µM carbaryl (A), and 0.1 µM ethyl
paraoxon (B).Five main fragment ions at m/z 680.12+, 726.72+, 919.72+, 955.32+, 1019.32+
were used to monitor intact active site peptide and carbamylated peptide, and the dominant
fragment ion at m/z 726.83+ was used to monitor the phosphorylated peptide by ethyl
paraoxon.
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Figure 1-5-12. IC of intact peptide (MH+ at m/z 732.73+) and modified peptide (MH+ at m/z

788.73+) by EPN oxon. The intact peptide was monitored by 5 main fragment ions at m/z
680.12+, 726.72+, 919.72+, 955.32+, 1019.32+. Modified peptides were monitored by the
dominant fragment ion at m/z 726.83+ corresponding to the phosphorylated peptide ion
with neutral loss of O-ethyl phenyl phosphoric acid.
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Analysis of Multiple Pesticide Exposure

From the abovementioned results, the assay was useful for the analysis of single
pesticide exposure, even at low level exposure down to 5% hBChE inhibition. We were
curious to find out whether the same assay could be used for the detection of multiple
pesticide exposure. Serum was incubated with 0.27 µM carbaryl for 30 min, 0.07 µM ethyl
paraoxon for 1h, and 0.05 µM EPN oxon for 1h, respectively. These concentrations were
chosen, because each pesticide inhibited 50 % of serum BChE at their corresponding
concentrations (proven by the enzyme activity measurement, data not shown). Equal
volume of diluted serum after reaction was mixed. The mixture was incubated with affinity
beads for 4 h. After incubation, affinity beads with enriched hBChE were washed, and
subsequently digested with trypsin and protease V8. The digests were analyzed using the
LC/MS/MS (Figure 1-5-13) method. Peaks of the carbamylated peptide (MH3+ at m/z
7523+), and two phosphorylated peptides (MH3+ at m/z 7783+ for ethyl paraoxon, MH3+ m/z
7883+ for EPN oxon) were baseline separated in a single analysis run. Phosphorylated
peptides were determined by the mass differences (neutral loss) between the common
fragment ion and precursor ions. Peak areas of these modified peptides indicated their
relative abundance present in serum. The relative area ratios were AA752 : AA778 :
AA788 = 0.90 : 1.1 : 0.99, where AA is peak area.
DISCUSSION

The goal of this study was to develop an improved methodology to detect and
quantify hBChE inhibition after OP and CB exposure in serum matrix. The developed
methodology was based on the combination of affinity chromatography with LC/MS/MS
analysis, which greatly improved the reproducibility and sensitivity compared with the
Fidder method. It also provided a critical evidence for an asserted exposure to pesticides.
Several digestion methods with different proteolytic enzymes were investigated.
The active site peptide of hBChE from tryptic digests is at m/z 2928.5, which is out of the
detection mass range of the ion trap analyzer, which is less than 2000 Da. Therefore, a new
digestion method was required to produce a suitable size of active site peptides. Pepsin and
chymotrypsin were applied to digest hBChE alone or in combination with trypsin
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Figure 1-5-13. RIC of carbamylated peptide (MH3+ at m/z 7523+) from carbaryl (A),

phosphorylated peptide (MH3+ at m/z 7783+) from ethyl paraoxon (B), and phosphorylated
peptide (MH3+ at m/z 7883+) from EPN oxon (C). Five main fragment ions m/z 680.13+,
726.72+, 919.72+, 955.32+, and 1019.32+ were used to monitor precursor ion at MH3+ 7523+
(A), common dominant fragment ions at m/z 726.82+ were used to monitor precursor ion
MH3+ at 7783+ (B), and at 7883+ (C).
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digestion (data not shown). Unfortunately, no peptide containing the active site serine was
detected due to the non-specific properties of the two proteolytic enzymes.
A double digestion was successfully developed, which greatly improved the
digestion reproducibility. Two specific proteolytic enzymes, trypsin and protease V8, were
used sequentially. After double digestion, the intact active site peptide, carbamylated
peptide, and phosphorylated peptide were identified by MALDI analysis and further
confirmed by LC/MS/MS analysis. The amino acid sequence of the intact peptide
generated from double digestion is SAGAASVSLHLLSPGSHSLFTR, where the catalytic
serine is underlined. Only one peptide, containing the active site serine residue, was
observed from the untreated hBChE digests, which was much better than the pepsin
digestion developed by Fidder et al .(60). In the Fidder study, several peptides containing
the active site serine were observed.
Double digestion was evaluated by comparing calibration curves of the inhibited
hBChE by carbaryl from trypsin digestion with that from double digestion using
MALDI-TOF-MS (Figure 1-5-8). Slopes of the calibration curves from trypsin digestion
were the same as those from the double digestion. In addition, IC50s and IC100s from the
two calibration curves were very close to each other, the relative standard error was within
5%. The result indicated that double digestion worked as well as single digestion by trypsin.
After the evaluation of double digestion, a calibration system of the double digested
peptides was required for the analysis of pesticide exposure.
Calibration systems were constructed for both OPs and CB based on the analysis of
hBChE inhibition in vitro using LC/MS methodology. From the LC/MS analysis, relative
peak area ratios of the intact peptide and modified peptide were obtained and plotted
against OP and CB concentrations. A linear relationship between peak area ratios and
pesticide concentrations was observed. IC50s determined from the calibration curves for
ethyl paraoxon and EPN oxon were 5.35 ± 0.04 µM and 3.66 ± 0.06 µM, respectively.
After normalizing the detected concentration of hBChE to the same concentration in serum,
the normalized IC50s were 0.07 µM and 0.05 µM for ethyl paraoxon and EPN oxon,
respectively. These normalized IC50s were consistent with those from the study by Misser

et al. (81) and Johnson et al. (82). Misser group (81) reported that IC50 of ethyl paraoxon is
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71 ± 7 nM. The average IC50 of EPN oxon is 51 nM based on the reported data by Johnson
group (82) that IC50s for L-EPN oxon and D-EPN oxon are 66 and 36 nM.
An interesting phenomenon was observed for the calibration curve of carbaryl,
which demonstrated a linear relationship between the modified peak area ratios and
carbaryl concentrations in this study. In contrast, a linear relationship was detected
between NIRs of modified peptide vs logarithmic carbaryl concentration for the eBChE
study (Chapter 1). This observation may result from differences between hBChE and
eBChE. Although eBChE has a 90.1% identity with the hBChE sequence, the amino acid
composition at active site of eBChE is significantly different from hBChE. As we
described before, the tryptic active site peptide for eBChE is at m/z 2200 while for hBChE
is at m/z 2928. The different amino acid sequence at active site of BChE may cause a
different reaction mechanism with inhibitiors. As such, the observation of the linear
relationship between the modified peptide and carbaryl concentration for eBChE is
different from that of hBChE.
A purification procedure needs to be developed before application of the assay to
analyze hBChE inhibition in serum. Procainamide-Sepharose 4B affinity beads were
synthesized in laboratory. As described in Chapter 4, the yield of the affinity bead was of
12.7 μmol procainamide / ml of beads. The yield was high enough for isolation of hBChE
from serum due to the low concentration of enzyme (3-5 mg/l). Results from Chapter 4 also
clearly showed that the synthesized affinity beads could enrich hBChE from serum matrix.
Procainamide-Sepharose 4B affinity chromatography ideally facilitated the
enrichment and separation of hBChE from the rest of serum proteins. However, since the
concentrations of proteins like albumin and immunoglobulins surpass that of hBChE by
several orders of magnitude, the non-specific binding of these proteins on the affinity
beads can not be omitted. Although LC/MS/MS is useful in isolating ions of interest, it is
still unlikely to analyze one kind of ions in the presence of other high-abundant ions
(several orders more than the ions of interest). Therefore, a more stringent washing
procedure (with a buffer containing high concentration of salt) was applied to minimize
nonspecific binding proteins on the affinity beads. Care must be taken here, because the
high salt-concentration buffer can also wash off hBChE from affinity beads resulting in a
low yield of isolated analyte. In addition to the stringent washing steps, incubation of
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affinity beads in the diluted serum solution with 0.1 M NaCl buffer also helped to reduce
the non-specific proteins bound to beads.
In order to increase the recovery efficiency, the affinity-chromatography/on-bead
digestion approach, performed in a single microtube, was applied in the study of hBChE
inhibition in serum. The common conventional affinity chromatography requires elution of
proteins from the column to isolate hBChE from serum followed by concentrating the
fractions containing hBChE. More experimental steps are required to further purify the
former fractions, such as filtration, resulting in more proteins or peptides loss. Since
hBChE concentration in the serum is low and sample is limited, an on-bead digestion was
developed in this chapter. The on-bead digestion approach reduced analysis time and the
number of experimental steps, which resulted in minimizing the proteins loss and
decreasing the possibility of inducing sample contamination during the preparation
process.
From the abovementioned results, a calibration system was already constructed,
and a purification procedure was successfully developed. At this stage, results
demonstrated that the assay was ready for the analysis of hBChE inhibition in serum
samples. Serum was exposed to 0.2 µM carbaryl and 0.1 µM ethyl paraoxon, separately.
To reveal the application of the assay, the treated serum was analyzed. The average
normalized detected concentration from triplicate analysis was 0.16 ± 0.01 µM for carbaryl
and 0.08 ± 0.01 µM for ethyl paraoxon. The relative standard error was 20% for both
analyses, which was much better compared with at least 50 % detection error based on the
recovery value using the Fidder’s method. The lower detection value was caused from the
low recovery of the inhibited hBChE during the purification procedure. The binding ability
of the inhibited hBChE on affinity beads was less favorable than the intact hBChE, since
the modification group (including carbamylated and alkyl phosphorylated group) at the
active site blocks the interactions with ligands on the beads.
The detection limit of pesticide exposure was also investigated using the assay
developed in this chapter. Serum was incubated with EPN oxon, which caused 5 % hBChE
inhibition based on the enzyme activity measurement. From the three parallel experiments,
the average relative peak area ratio of the modified peptide was 5 % using LC/MS/MS
method. Although the peak of modified peptide was absolutely detected, the signal was
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very weak at such a low inhibition level. No further investigation of a lower inhibition level
was performed.
At this stage, the assay was successfully applied to detect hBChE inhibition after
single pesticide exposure, even at low inhibition level of 5%. Since the chances of multiple
pesticide exposure are much more than single pesticide exposure in the daily life, we were
curious to find out whether the same methodology is useful for the investigation of
multiple pesticide exposure. The assay was applied for the detection of hBChE inhibition
after exposed to multiple pesticides. The carbamylated peptide and phosphorylated
peptides were baseline separated in a single analysis run. The relative abundances of these
modified peptides, which were related to the extent of exposure to individual pesticide,
were estimated by the peak area ratios. In this study, the peak area ratio (AA752 : AA778 :
AA788 = 0.90 : 1.1 : 0.99) was consistent with the original ratio (1:1:1). The detected
relative amount of carbamylated peptide was lower than the expected value because the
reactivation of the carbamylated enzyme occurred during the incubation time with affinity
beads.
CONCLUSION

An improved novel methodology has been developed for the detection and
quantification hBChE inhibition in serum by combination of affinity chromatography and
LC/MS/MS analysis. A novel double digestion was initially developed in this chapter,
which made it possible to analyze hBChE inhibition using LC/MS methods. Results
clearly showed that the double digestion method worked as efficiently as single trypsin
digestion. In addition, a novel on-bead double digestion protocol was investigated, which
eliminated the number of experimental steps, reduced the protein loss during sample
preparation. The on-bead digestion greatly improved the sample recovery resulting in high
detection sensitivity and elevated accuracy. The developed methodology was successfully
used in the analysis of both single pesticide exposure and multiple pesticide exposure in
serum.
The improved assay was applied for the analysis of single pesticide exposure in
serum sample. The detected values were within 20% relative standard error, which was
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much better than the Fidder’s method. The detection limit of the assay for the pesticide
analysis was also determined at hBChE inhibition level as low as 5 %. For the analysis of
multiple pesticide exposure, all the modified peptides were baseline separated, and the
extent of exposure to each pesticide was estimated by the individual peak area. Results
from the assay were consistent with the predicted values. Furthermore, carbamylated
peptides were differentiated from phosphorylated peptides based on the different pattern of
tandem mass spectra. Phosphorylated peptides were determined based on the mass
differences (neutral loss) between the common fragment ion and precursor ions. Therefore,
the types of pesticides and the extent of pesticide exposure to serum can be determined
using the developed methodology. Because of its high sensitivity, good reproducibility and
reliability, it is promising to apply the assay in clinical diagnosis in the near future.
Following the onset of the Gulf War Syndrome (72), the issue of multiple chemical
exposures poses an ever increasing military and civilian threat. Although analysis of the
hBChE exposed to chemical warfare (CW) agents was not investigated, the types and
extent of CW agent exposure should be detected and quantified using the same assay.
However, an unpredicted exposure, like the 1995 Tokyo Subway Attack (79), requires a
quick investigation from forensic analysis. How to apply the method in field is a challenge
for all mass spectrometry specialists. This will be the subject for the future research.
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CHAPTER SIX
CONCLUSIONS

With the introduction of the organophosphate pesticides (OPs) and carbamates
(CBs) into American agriculture, there has been considerable interest in their chemistry,
mode of action, and toxicity. From the public health perspective, a reliable monitoring
program is required to detect and quantify pesticide exposure. The U.S. Environmental
Protection Agency (USEPA) scientists proposed a blood esterase monitoring program for
pesticide exposure in 1991, which is based on the measurement of red cell blood AChE and
plasma BChE activity. However, because of the intrinsic drawbacks of these existing
monitoring methods, such as non-specificity, a novel and reliable method is required to
detect the source of inhibition, and quantify the extent of pesticide exposure.
Because of their high sensitivity, tolerance of protein mixtures and high-throughput,
MALDI-TOF-MS and LC/MS/MS were used to detect and quantify OP and CB exposure
in this dissertation. OPs and CBs inhibit BChE by forming a covalent bond with the active
site serine by attaching a phospholate or carbamylate group. The developed methodology
is based on the analysis of inhibited BChE in vitro and in serum. As such, quantification of
inhibited BChE can serve as a measurement of pesticide exposure.
A MALDI-TOF-MS methodology was designed for the sensitive detection and
accurate quantification of pesticide exposure. eBChE was chosen as a model system to
develop the methodology, because it is commercially available. The degree of poisoning
was determined by the intensity ratios of the modified peptide and the intact active site
peptide. The types of pesticides can also be determined by the mass difference between the
modified peptide and the intact active site peptide. Although the MALDI methodology was
successfully applied for the analysis of single pesticide exposure, it is limited for analysis
of multiple pesticide exposure. So, a methodology involving LC/MS/MS istechniques was
further investigated, because LC/MS/MS has more benefits, such as high sensitivity, lower
limit of detection (LOD) and simultaneous analysis of multiple pesticide exposure. For In

vitro study, the LC/MS/MS methodology was successfully applied for the analysis of a
mixture of the phosphorylated peptides generated from tryptic digests of the inhibited
eBChE. LC/MS/MS was proven as a great tool for separation, detection, identification,
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quantification, and categorization of phosphorylated peptide mixture in a single analysis
run.
Application of the developed LC/MS/MS methodology for measuring pesticide
exposure in vitro and in human serum clearly demonstrated the power of MS-based
methods in pesticide analysis. Results provided critical evidence for the trace exposure to
OPs and CB as low as 5 % hBChE inhibition in serum, which the traditional Ellman
method can not. A novel double digestion was firstly developed in this study, which made
the assay feasible to analyze hBChE inhibition using LC/MS methodology. In addition, a
novel on-bead double digestion protocol with high recovery was developed, which reduced
the experimental steps and minimized the analyte loss during the sample preparation. The
developed methodology, by combination of affinity chromatography and mass
spectrometry, greatly improved the sensitivity, reproducibility and accuracy in the hBChE
inhibition analysis. The reliability of the developed methodology was proved by the
successful use in the analyses of both the single pesticide exposure and the multiple
pesticide exposure in serum. Results from the developed methodology were consistent
with the predicted values.
The methodology developed here was very well-suited for detecting and
quantifying the pesticide analysis. This study reveals a promising future of the proteomics
approach and mass spectrometry for the analysis of pesticide exposure due to their high
sensitivity and high reliability. However, LC/MS/MS methodology is not the only
technique for measuring pesticide exposure. The combined use of all methods is valuable,
both in diagnosis of poisoning and in determination of exposure. The other methods, such
as determination of urinary metabolites using GC/MS, can also provide an indication of
exposure. Unfortunately, it is not possible to relate the concentration of urinary metabolites
to the level of intoxication. LC/MS/MS techniques are some of the best analytical tools for
pesticide analysis providing high sensitivity and analysis of multiple pesticide exposure in
a single analysis run. As with any poisoning, the best mode of action is treatment, which
relies on the identity and quantification of toxin exposure. Detection, diagnosis and
treatment at early exposure and at low level are the key ingredients to save victim lives.
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PART II. A STUDY OF ORGANOPHOSPHATE PESTICIDE-INDUCED PROTEOME
ALTERATION IN SH-SY5Y CELLS
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CHAPTER ONE
INTRODUCTION
CHLORPYRIFOS BACKGROUND
Chlorpyrifos (CPF) is an organophosphate pesticide, widely used to control a
variety of pests including fire ants, turf and ornamental plant insects, mosquitoes,
cockroaches, and termites. It is also used as a soil insecticide, in seed treatment, and
applied to dormant and foliar plants. An estimated average of 21 million pounds active
ingredient of CPF was used on 20 million acres of U.S. crops per year from 1987
through 1989. The domestic use of CPF has been curtailed by U.S. regulatory
provisions (83) because of its adverse neurological consequences, particularly in
situations of fetal and childhood pesticide exposure. Nevertheless, CPF remains a
widely used pesticide, and will continue to be so for the foreseeable future. As such, the
mode of action and toxicity of CPF has generated considerable interest.
Mode of Action of Cholinesterase Inhibition
The mechanism of esterase inhibition by CPF is similar to that observed in other
OPs. OPs exert their acute effects in both insects and mammals by inhibiting AChE in
the nervous system. As described in Part I, Chapter 1, CHE combines with inhibitors
(OPs or CBs) to form a Michaelis complex, followed by phosphorylation at the active
site serine of CHE with the loss of the X (leaving group of OPs). Two possible
pathways can follow this reaction. Reactivation may occur spontaneously at a rate
dependent on the effect of the attached group at the active site serine. Alternately, an
“aging” reaction can occur, which involves the cleavage of an R-O-P-bond with the
subsequent loss of R (alkyl group on the phosphorus), resulting in the formation of a
charged mono-substituted phosphoric acid residue on the enzyme. Once the “aging”
reaction has occurred, the enzyme will never be reactivated.
AChE functions to terminate neurotransmission by hydrolyzing acetylcholine
(Ach), a neurotransmitter produced at cholinergic nerve endings in response to nervous
stimuli. Inhibited AChE causes an accumulation of acetylcholine (Ach) (84), thus
prolonging the action of Ach. If CPF is administered to developing organisms at high
concentration levels to cause systemic toxicity, a cholinergic hyperstimulation is
observed. As shall be shown in the following paragraphs, anticholinergic toxicity is just
part of CPF action.
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Developmental Neurotoxicity
The fact that CPF may cause neurobehavioral damage during brain
development is becoming a major biomedical and social concern (85). As described
below, CPF has additional effects on brain development that may be overshadowed by
its cholinergic component. A variety of studies have clearly indicated that CPF has
adverse effects on brain development more than cholinesterase inhibition. Recent
findings indicate that potential exposures to pregnant women and children above the
“No Observable Adverse Effect Level” show that children are at higher risks of later
behavior deficits (86). Animal studies also confirm that exposure of neonates to CPF
result higher risks than adults (71). The LD50 values of CPF for neonates are about an
order of magnitude lower than that for adults.
Roy at al (87) describe an alternate experiment to show CPF action on neural
development. Rat embryo cultures were treated with CPF for 48 h at a concentration an
order of magnitude below that found in human meconium (88) at the neural tube stage
of development. The authors found mitotic abnormalities and apoptosis in the
developing brain. However, it should be noted that choline acetyltransferase, the
enzyme responsible for Ach biosynthesis, is not detectable at the neural tube stage of
development. As such, Ach is not available at this stage. So, inhibition of
cholinesterase by CPF would not produce cholinergic stimulation. It is evident that the
consequence of CPF action is not linked to anticholinergic toxicity.
Other studies (89, 90) have further confirmed that alternate mechanisms might
play important roles in CPF action on the developing brain. It has been hypothesized
that prenatal CPF exposure, at concentrations below the threshold for detectable
cholinesterase inhibition without systemic toxicity, induces later-appearing deficits.
This hypothesis has been directly tested using in vivo and in vitro models of postnatal
CPF exposure. One-day-old rats were treated with CPF (91), and acute inhibition of
DNA synthesis was observed in areas with low cholinergic innervations (cerebellum),
as well as in regions with cholinergically enriched zones (brainstem and forebrain).
These results were different from that for nicotinic (AChE inhibitor) treatment - only
DNA synthesis had clearly been altered at expected regions with high cholinergic
enrichment. Another study was conducted to test the hypothesis in a much more direct
way. A certain amount of CPF was injected directly into brain, which skipped the
activation process to CPF oxon, and the same observation as CPF in vivo study was
obtained. All these results show that CPF affects DNA synthesis by an initial,
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noncholinergic mode of action. CPF exposure at a concentration insufficient to produce
systemic toxicity, not only causes DNA synthesis inhibition, but also affects other
biological processes, including deficits in the number of neural cells (92), suppression
of gene expression and reduction of macromolecular constituents (important in cell
differentiation) (79, 93), abnormalities of synaptic function, and resulting in
abnormally behavioral performance (79, 94).
In vitro experiments further showed that CPF causes developmental
neurotoxicity through alternate mechanisms than those involved in cholinesterase
inhibition. For example, when undifferentiated PC12 cells were treated with CPF at
low level concentrations without causing detectable CHE inhibition, DNA synthesis
suppression was observed (95). Other similar studies (96) also found potent inhibition
of neurite outgrowth. These studies were unrelated to cholinesterase inhibition.
Although many investigations have been undertaken to understand the
noncholinergic mechanisms in the developmental neurotoxicity of CPF, the actual
mechanisms remain elusive and complicated. To this day, no systematic studies at the
subcellular, molecular levels have been undertaken to evaluate proteome changes in
neuronal cell line cultures exposed to CPF at low concentrations. In order to study the
toxcity caused by CPF in neuroblastoma cells, and as a result of the low levels of
choline acetyltransferase, the SH-SY5Y was chosen as a model for this work.

SH-SY5Y CELL LINE
The neuroblastoma cell line SH-SY5Y (SK-N-SH-SY5Y), which was
subcloned from human neuroblastoma SK-N-SH, is a nearly diploid dopaminergic
neuronal cell line with high levels of dopamine β-hydroxylase (a key enzyme in
adrenergic neurotransmitter synthesis). SK-N-SH was established in 1970 from the
bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, and consists of
two cell types with the neuroblast phenotype being predominant. When SH-SY5Y cells
are grown in 15% fetal calf serum, they have neuroblast-like properties in their
undifferentiated state. Treatment with dibutyryl cyclic AMP or nerve growth factor
(NGF) results in morphological and physiological differentiation (84). SH-SY5Y cell
lines have low levels of choline acetyltransferase, which makes them a good candidate
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for neurotoxicity studies. The SH-SY5Y cell line is a convenient resource for research
on neuronal cell biology in vitro.
TWO-DIMENSIONAL ELECTROPHORESIS WITH IMMOBILIZED PH
GRADIENTS
Two-dimensional gel electrophoresis (2D gel) was developed by O’Farrell in
1975 (97). Proteins are separated based on their intrinsic charges (pI) by isoelectric
focusing (IEF) in the first dimension and followed by molecular weight (MW) based
separations with SDS-PAGE in the second dimension. 2D gels can resolve complex
mixtures of proteins and simultaneously analyze hundreds or even thousands of
proteins. After the introduction of immobilized pH gradients (IPG) for IEF, the
reproducibility of 2D gel data greatly improved (11). The pH gradients of IPGs are
prepared by a limited number (6-8) of well defined chemicals (the ‘immobilines’).
These chemicals are co-polymerized with the acrylamide matrix, which enhances the
reproducibility of 2D gels. Due to the high reproducibility and high loading capacity of
IPG strips, 2D gel electrophoresis has become the core technology of proteome
analysis in combination with either matrix-assisted laser desorption / ionization-time of
flight - mass spectrometry (MALDI-TOF-MS) or electrospray mass spectrometry
(ESI-MS).
Prior to IEF, IPG dry strips are rehydrated with sample solution containing 8 M
urea, 0.5–2% (non-ionic or zwitterionic) detergent, 0.2% dithiothreitol (DTT) and
0.2% carrier ampholytes. The rehydrated strips are then placed onto the cooling plate of
an electro-focusing chamber (Figure 2-1-1). A program, including desired rehydration
time, voltage gradient, and temperature, is set for IEF running condition. After IEF,
IPG strips are incubated with equilibration buffers containing dithiothreitol (DTT) for
10 min in the first step. They continue to be equilibrated in the buffer containing
iodoacetamide for 10 min in the second step. After equilibration, the IPG gel strip is
placed on the top of a pre-cast polyacrylamide gel (PAGE) and overlaid with agarose
solution. After termination of the second dimension run (SDS-PAGE), it is necessary
to immobilize the resolved proteins in the gel with fixing solution. Twenty percent
TCA, methanolic or ethanolic of acetic acid are extensively used as fixatives. Proteins
can be visualized by several staining methods – silver staining, fluorescent staining,
colloidal coommassie blue G-250, and Coommassie R-250 staining. Both fluorescent
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staining (laboratory synthesized ruthenium reagents) and Colloidal Coommassie blue
G-250 staining were used in this project, as both approaches afford high sensitivity and
MS compatibility. Gel images were then captured with the VersaDoc Imaging system
(Bio-Rad), and quantitatively analyzed by PDQuest software (Bio-Rad). All protein
spots with a relative quantitative difference equal to or greater than a 2-fold change
were excised and further analyzed by MALDI-TOF-MS, following tryptic in-gel
digestion. Finally, these proteins were identified by database searching with the
MASCOT algorithm.
DATABASE SEARCH USING MASCOT ALGORITHM
Several algorithms have been used to identify proteins by searching an
appropriate database using peptide mass-fingerprinting mass spectra or tandem mass
spectrometry (MS/MS) data. Currently, MASCOT (98) and SEQUEST (15) algorithms
for database searching are the most popular in proteomics. Only MASCOT was used in
this dissertation, so a brief overview of this algorithm will be discussed.
The scoring algorithm of MASCOT is based on probability with a number of
additional advantages: i) it is simple to judge whether a result is significant or not, ii)
different types of matching (peptide masses or MS/MS fragment ion masses) can easily
be combined into a single search, iii) it is feasible to compare scores from different
searches and different databases, iv) searching parameters can be readily optimized.
MOWSE Score
The MOWSE scoring algorithm was first described in 1993 by Pappin et al.
(99). Based on this algorithm, experimental data are first compared with the calculated
peptide masses for each protein in the sequence database. Each calculated value within
a user-defined mass tolerance of an experimental value is taken as a match. Molecular
weight, pI values, and sources for the intact protein can be used as pre-filters.
A statistical weighting factor is empirically assigned to each individual peptide
match instead of counting the number of matching peptides. All matching fragments
contribute to the final score for every database entry scanned.
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Figure 2-1-1. Photograph of a Bio-Rad isoelectric focusing chamber and focusing tray.

143

A frequency factor matrix, F, is created. Each row in F represents an interval of 100
Da in peptide molecular weight, and each column is an interval of 10 kDa in intact protein
molecular weight. The cells therefore contain the number of times that a particular
fragment molecular weight occurred in a protein. It is similar for each protein in the
database. Each cell value is divided by the total number of peptides in each 10 kDa protein
interval to obtain cell frequency values. These frequency values are further divided by the
largest cell value for each 10 kDa column to get the MORSE factor matrix M.
The matrix of weighting factors is described as follows:
mi , j =

f i, j
f i, j

(2.1.1)

max incolumnj

The MOWSE search program is based on these distribution frequency values for
each cleavage reagent. For each matching peptide, a score is assigned by looking up the
appropriate normalized distribution frequency value. When there are several matching
peptides in any one target protein, the total frequency value equals the product of the
distribution frequency for each peptide. Consideration of the average protein molecular
weight as 50 kDa, the final score for each entry is calculated as follows:
S core =

50,000
M prot × ∏ mi , j

(2.1.2)

where Mprot is the molecular weight of the entry and ∏ mi , j is the product of distribution
factors for all the matching peptides between the experimental data and peptides calculated
from the database.
STATEMENT OF RESEARCH

This part of the dissertation describes the first time systematic investigation of the
CPF-induced toxicity at subcellular levels using SH-SY5Y as a model system. The
hypothesis of this study is that changes in protein expression underlie neuronal anomalies
associated with CPF exposure. After SH-SY5Y cell lines were treated with CPF, proteins
from this cell line were collected and analyzed by 2DE-PAGE and MALDI-TOF-MS.
Results clearly demonstrated that CPF has significant effects on cell process.
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CHAPTER TWO

CHLORPYRIFOS-INDUCED PROTEIN ALTERATIONS IN THE SH-SY5Y
CELL LINE

INTRODUCTION

Most children in the US have been exposed to chlorpyrifos (CPF), an
organophosphate pesticide. In recent years, there has been heightened concern about
exposure of pregnant women, infants and children to CPF in view of its developmental
neurotoxic effects. Despite recent curtailment of its domestic use in US (U.S.
Environmental Protection Agency 2000), CPF remains one of the most widely used
pesticides in the world. Unfortunately, to date, no systematic studies at the subcellular level
have been undertaken to evaluate CPF-induced proteome changes in neurons. In this
chapter, investigation of whole proteome alterations induced by CPF is described. CPF
concentrations at levels below the threshold for symptoms of systemic toxicity were
studied using the SH-SY5Y cell line as a model system. The combination of
two-dimensional

gel

electrophoresis

(2DE)

with

matrix-assisted

laser

desorption/ionization-time of flight- mass spectrometry (MALDI-TOF-MS) was applied to
take a closer look at protein alterations induced by exposure to this pesticide.
CPF is primarily recognized for its ability to induce physiological toxicity in
humans and animals via acetylcholinesterase (AChE) inhibition. However, a variety of
studies showed that CPF has additional effects besides cholinesterase inhibition. Levin et
al. studied rats subjected to prenatal (90) and postnatal (94) exposure to CPF and evaluated
their behavioral performance in adolescence and adulthood. The results showed that both
prenatal and postnatal exposure to CPF induced long-term changes in cognitive
performance. Other animal studies also confirmed that exposure of neonates to CPF
subjected to higher risks than adults (71). The LD50 values of CPF for neonates are about
an order of magnitude lower than that for adults. At the cellular level, S.J. Garcia et al.
suggested that CPF had shifting targets, initially impairing neuronal development
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(gestational days (GD) 17-20), and then influencing glia (postnatal days (PN 11-14). These
findings were the result of examinations of neuroprotein markers (89) using biochemical
techniques, such as western blot.
Studies both in vivo and in vitro confirm that CPF at sublethal levels can
compromise cellular processes involved in brain development (100). However, the actual
mechanism for CPF perturbation in neuronal development at the molecular level is
complicated and remains unclear. All these studies show that CPF can influence neuronal
development by targeting a diverse range of events including cell proliferation, migration,
differentiation, neuritogenesis, synaptogenesis and synaptic function. Long-term
irreversible consequences can happen by perturbing these processes (46). The perturbing
processes are through adverse effects on the structure and function of the nervous system.
Until now, no systematic studies at the molecular level have been undertaken to investigate
these influences on neuronal development as initiated by CPF.
In this chapter, a description of the first systematic study of CPF-induced adverse
effect on cell process at the molecular level is provided. We hypothesized that changes in
protein expression underlie neuronal anomalies associated with CPF exposure. The
SH-SY5Y neuroblastoma cell line was used as a model system due to the low level of
choline acetyltransferase (the enzyme responsible for acetylcholine biosynthesis). Through
a combination of 2DE and MALDI-TOF-MS, the whole proteome in SH-SY5Y cells was
examined to identify altered proteins resulting from CPF exposure. The reproducibility of
2DE was also evaluated in this chapter. The differential proteins (which showed 2-fold
change between the control and treated sample, based on the optical density measurement)
were detected. Altered proteins were identified by comparing the experimental mass
spectra with theoretical mass spectra from the insilico digestion of the protein database.
The results clearly demonstrated that altered protein expressions induced by CPF exposure
were linked to developmental damage observed in neuroblastoma cells.
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EXPERIMENTAL

Materials

Isoelectric pH gradient (IPG) strips (5 mm wide, 7 cm or 18 cm long, pH 3-10
linear gradient), urea, Tris (electrophoresis grade), TEMED (electrophoresis purity
reagent), acrylamide, heavy mineral oil, and a 2-D Starter kit were obtained from Bio-Rad
(Hercules,

CA).

Dithiothreitol

(DTT,

electrophoresis

grade),

iodoacetamide

(electrophoresis grade), ammonium bicarbonate, and SDS were all obtained from Sigma
(St. Louis, MO). For protein staining of gels, fluorescent ruthenium reagents (lab
synthesized); colloidal Coomassie Blue (J.T. Baker Chemical Co., Philipsburg, N.J.) were
employed. Glacial acidic acid (ACS grade, EM Science, Gibbstown, N.J.), and methanol
(HPLC grade, Fisher Scientific, Fair Lawn, NJ) were employed. For MALDI analysis of
peptides, α-cyano-4-hydroxycinnamic acid (HCCA) matrix was purchased from Sigma (St.
Louis, MO) and used without further purification. Trifluoroacetic acid employed in the
extraction of peptides from de-stained gel spots was obtained from Fisher Scientific (Fair
lawn, NJ). High-purity water (18.2 MΩ cm-1) was prepared using a water purification
system (Nanopure II, Barnstead, Van Nuys, CA) and was employed for all protocols in this
study.

Cell Culture

SY5Y neuroblastoma cells were grown to 75% confluence in 75 cm2 flasks in
Dulbecco modified essential medium (Omon) supplemented with 55 mM glucose, 26 mM
NaHCO3, 16 mM KCl, 1.36 mM pyruvic acid, 10 mg/mL gentamicin sulfate, and 10%
clarified bovine serum (pH 7.2). Cells were incubated at 37ºC in 94% air/6% CO2. Cultures
were split 1:3 every 2-3 days using 0.25% trypsin/0.03% EDTA. When cells reached
confluence, they were switched to Locke’s medium containing 154 mM NaCl, 56 mM KCl,
2.3 mM CaCl2, 1.0 mM MgCl2, 3.6 mM NaHCO3, 10 mM glucose, 5 mM HEPEs (pH 7.2)
with 10 mg/l gentamicin sulfate. Control cells were treated with dimethylsulfoxide
(DMSO) only and treated with CPF at 50 µM in 1% DMSO.
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Cell Viability Assay

Cell were plated in 96 well culture plates and treated with CPF. After treatment,
cell

viability

was

assayed

by

the

addition

of

10

μl

of

1

mg/ml

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)/well (100 µl Locke
medium) and incubated for the last hour of treatment. After removal of the media, the
formazan crystals produced from MTT by mitochondrial enzymes in active cells were
dissolved in 100 μl DMSO. Formazan absorbance was measured at 620 nm using a
multi-well plate reader. The mean value of 8 parallel experiments for cell viability was
used. Raw data were converted to the relative percentage of control absorbance, and
expressed as the mean ± SEM % control absorbance.

Preparation of Cell Lysate for 2DE-PAGE

After the culture was switched to Locke’s medium, treatment was initiated with 50
µM CPF in 1% DMSO for 16 h or 24 h. After treatment, cultures were washed with
phosphate buffered saline (PBS) pH 7.4, and cells were scraped into 3 ml PBS and pelleted
by centrifugation at 800 x g for 10 min. The pellet was re-suspended in 200 μL
distilled/deionized water and homogenized using a micro-Dounce homogenizer. Protein
content of this cell lysate was determined using a Pierce BCA kit.

Protein Sample Preparation

Following sonication for 20 minutes, 350 µg aliquots of protein lysate were
evaporated to dryness and subjected to 2D gel electrophoresis. The protein was then
solubilized in rehydration buffer (8 M urea, 2 % CHAPS, 50 mM dithiothreitol (DTT),
0.2% (w/v) Bio-lyte 3/10 ampholytes and a trace of Bromophenol Blue). The protein
solution was ready for Isoelectric focusing experiments.
2D Gel Electrophoresis Validation

In order to evaluate 2DE reproducibility, four proteins were used in this study. The
used proteins were bovine serum albumin (BSA), ovalbumin (Ova), carbonic anhydrase
(CA), and soybean trypsin inhibitor (STI). Each protein (0.1 μg) was mixed, and then
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solubilized in sample preparation buffer containing 0.5 M Tris-HCl pH 6.8, glycerol, SDS
and 0.1% bromophenol blue. The resulting solution was loaded onto strips (5 mm wide, 7
cm long, pH 3-10 linear gradient). A second experimental set was designed for the
evaluation of 2DE reproducibility, in which 0.1 μg of Ova, CA and STI, and 0.2 μg BSA
were mixed. As described above, three parallel experiments were performed for statistical
analysis. The optical density (OD) of each spot was normalized based on the percentage of
the total valid spots on the 2D gel using PDQuest software.
2D Gel Electrophoresis

An aliquot of 350 μg of protein lysate from SY5Y cells was dissolved in 350 μl
rehydration buffer. The solution was then added to an IPG strip (5 mm wide, 18 cm long,
pH 3-10 linear gradient) (Bio-Rad). Following rehydration for 24 h, strips were subjected
to isoelectric focusing (IEF) at 20ºC. Table 2-2-1 lists the gradient program used for the
experiment. Total focusing time was 23 h. After IEF was complete, strips were removed
from the Protean IEF (Bio-Rad) cell. They were then equilibrated with 6 ml buffer A (6 M
Urea, 2% SDS, 0.375 M Tris-HCl pH 8.8, 20% glycerol) containing an additional 0.12 mg
DTT for 15 minutes in the first step. Subsequently, strips were incubated with buffer A
containing 0.15 mg iodoacetamide for 15 minutes in the second step. Strips were removed
from equilibration solution and placed on the top of pre-cast SDS gel (1 mm thick, 20 cm x
20 cm and 8%-16% linaer acrylamide gradient). The strips were sealed into position with
0.5% low melting point agarose in 25 mM Tris, 192 mM glycine, 0.1% SDS, and a trace of
bromophenol blue. Gels were run at a constant current 16 mA/ gel for 30 min, then 24 mA/
gel until the blue dye front line reached the bottom of the gel.
SDS gels were fixed in 30% EtOH/10% acetic acid overnight, then washed with
20% EtOH four times over 2 h. Gels were finally stained with lab-synthesized fluorescent
ruthenium reagent (50 µl in 250 ml 20% EtOH) overnight. Gels were scanned using
VersaDoc Imaging system (Bio-Rad) and 2D gel images were analyzed with PDQuest
software (Bio-Rad).
In-Gel Digestion

Protein spots of interest were excised manually from the gel, and then placed into
micro well plates. A Proteineer dP robot (Bruker) was used for the in-gel digestion. The
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Table 2-2-1. Gradient program of IEF.

Voltage (V)

Time (h)

Step 1

300

5

Step 2

1000

1

Step 3

2500

1

Step 4

5000

16
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digestion program was set up as follows: i) gel pieces were washed with 50 mM NH4HCO3
followed by washes with 25 mM NH4HCO3 in 50% acetonitrile for three cycles (10 min/
cycle), then gel pieces were dried with acetonitrile for 5 min; ii) trypsin solution (10 µl, 6.7
μg/ ml) was added to each well and incubated with the gel pieces for 30 min at 20 ºC and
for 4 h at 50 ºC; iv) the supernatant containing peptides was recoved for MS analysis.

Mass spectrometry

A drying thin layer strategy was used to spot an affinity Anchorchip with a matrix
solution of 10 mg/ml α-cyano-4-hydroxycinnamic acid in 0.2% TFA/acetone (1:9 by
volume). Tryptic digests (4 µl) were loaded onto each matrix spot and allowed to desorb on
the target for 10 min. The residue of sample solution was removed from the target followed
by washing the spot with 0.1% TFA. An Autoflex MALDI-TOF mass spectrometer
(Bruker) was used to obtain mass spectra. Analysis in the reflectron mode was
accomplished with 19 kV accelerating potential and a lens voltage of 20 kV. Each
spectrum was obtained from an average 300 laser shots. A standard peptide mixture
consisting of angiotensin II and vasopressin was used to provide an external mass
calibration. A trypsin autoproteolysis product m/z 842.5 was used for an internal mass
calibration.

Database search

Proteins were identified by searching the National Center for Biotechnology
Information (NCBI) database or Sprot using the MASCOT algorithm. The search
parameters allowed for the oxidation of methionine. Mass accuracy at 150 ppm was used
for the database search. Peptides were excluded if their masses corresponded to those for
porcine trypsin, human keratins or other irrelevant proteins.
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RESULTS
Cell Viability

Cell viability was investigated for CPF at a series of concentrations: 10, 25, 50, 100,
250, 500 and 1000 µM (Figure 2-2-1). These concentrations were investigated to find a
suitable exposure level for the study of CPF-induced toxicity in SH-SY5Y cells. Results
were calculated for each treated sample as the percentages of control sample based on the
measurement of formzan absorbance (related to cell viability). Cell viability (as a
percentage of control cells) was expressed as the mean ± SEM % from eight parallel
experiments. Statistical analysis was carried out using ANOVA with Dunnett’s post hoc
test for the cell viability of individual samples using commercially available ABSTAT
software. The outcome from these statistical analysis showed that concentrations of CPF
greater than 250 µM caused a significant (p < 0.05) decrease in cell viability. No
significant change was observed in cell viability when the CPF incubation concentration
was between 10 to 100 µM. CPF at 50 µM was chosen, because no systematic toxicity
would happen at this concentration.

Evaluation of 2D Gel Reproducibility

BSA, Ova, CA and STI were used to evaluate 2D gel reproducibility. In the first set
of experiments, 0.1 µg of each protein was used to do small format 2D gel experiments. All
the OD values of the spots were normalized based on the percentage of the total valid spots
on the 2D gel analyzed with PDQuest software. Table 2-2-2 lists the experimental values of
proteins along with expected percentages. The relative standard errors for BSA, Ova, CA,
and STI were 3.5 %, 3.0 %, 0.9 %, and 4.2 %, respectively. For the second set of
experiments, 0.1 µg of Ova, CA and STI, along with 0.2 µg of BSA were used in small
format 2 D gel analyses. Table 2-2-3 lists the experimental ratios of proteins along with
expected values for the second experimental set. The relative errors for BSA, Ova, CA, and
STI were 3.09, 1.17, 3.97, and 6.65%, respectively.
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All the relative errors were within 10%. The results clearly showed that 2D gel is a
reliable method for protein quantification and therefore well suited for the investigations
present here.

Proteome Analysis of SH-SY5Y Cells

In this study, approximately 350 μg of total protein was loaded for each gel.
Proteins were separated on an isoelectric focusing strip (18 cm long, pH 3-10 from left to
right) in the first dimension, and resolved by linear gradient (8-16%) SDS-PAGE in the
second dimension. The gels with separated proteins were stained with a lab-synthesized
fluorescent ruthenium reagent. A typical set of 2D SDS gels for the treated (50 μM CPF for
24 h) and control sample is shown in Figure 2-2-2. Three independent assays are
represented. Figure 2-2-2 illustrates a typical example of a gel image region containing
up-regulated proteins in treated sample. The normalized optical densities of spots 1, 2 and
3 were plotted in Figure 2-2-2 C.
Table 2-2-4, and Table 2-2-5 present an overview of the CPF-induced down-, and
up-regulated proteins that could be identified in one or more of the three experiments
(Figure 2-2-3 refers to experiment set 2) using MS. Both tables list the National Center for
Biotechnology Information (NCBI) accession numbers, the positions on the gels of Figure
2-2-3, and the calculated molecular masses of the identified proteins. Figure 2-2-3
identifies the spots corresponding to the identified proteins in experiment set 2 on the 2D
gels of the sample from control and treated SY5Y cells. A total of 37 unique proteins from
56 spots were identified, out of which 16 proteins from 26 ± 4 spots were down-regulated,
and 21 proteins from 30 ± 3 spots were up-regulated (mean ± SD for three experiments).
Spot count differences between experiments likely arise due to inter-individual differences
in the protein spot patterns. Altered proteins were categorized as chaperone proteins,
cytoskeletal proteins, enzymes, redox enzymes etc.
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Table 2-2-2. Experimental and theoretical ratios of proteins with relative standard errors

for the first experimental set.
Avg.

Relative

Protein

Exp. #1

Exp. #2

Exp. #3

( x ± s)

Expected

error (%)

BSA

0.91

0.95

1.04

0.97±0.06

1.00

3.00

Ova

1.07

1.01

0.84

0.97±0.12

1.00

3.00

CA

0.93

0.99

1.05

0.99±0.06

1.00

1.00

STI

0.97

0.92

1.24

1.04±0.17

1.00

4.00
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Table 2-2-3. Experimental and theoretical ratios and their relative standard error for the

second experimental set.
Avg.

Expected

Relative

Protein

Exp. #1

Exp. #2

Exp. #3

( x ± s)

Value.

error (%)

BSA

1.78

1.72

1.80

1.77±0.04

1.71

3.09

Ova

0.87

0.85

0.82

0.85±0.03

0.86

1.17

CA

0.85

0.84

0.78

0.82±0.04

0.86

3.97

STI

0.81

0.79

0.80

0.80±0.01

0.86

6.65
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1: Control
2: 10 µM CPF
3: 25 µM CPF
4: 50 µM CPF
5: 100 µM CPF
6: 250 µM CPF
7: 500 µM CPF
8: 1000 µM CPF

*P < 0.05
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Figure 2-2-1. Viability of SH-SY5Y cells exposed to vehicle alone (control), 10, 25, 50,

100, 250, 500, and 1000 µM chlorpyrifos (CPF) for 24 h. Concentrations greater than 250
µM caused a statistically significant (p < 0.05) decrease in cell viability.
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B

A

Figure 2-2-2. A typical example of gel image regions contain up-regulated proteins in the

sample from the SY5Y cells treated with 50 μM CPF for 24 h. Gel images for the control
sample (A), and for the sample treated with 50 μM CPF for 24 h (B). The experiment
shown is representative of three trials.
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Figure 2-2-2. The normalized optical densities of spots 1, 2, and 3.
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Table 2-2-4. Summary of down-regulated proteins in SH-SY5Y cells treated with 50 µM

CPF for 24 h compared with control samples.
NCBI
Protein

Accession no.

Spot no.

Molecular

Morwse

Coverage

mass (KDa)

Score

(%)

Chaperone Proteins
HSP90-alpha

172222

1, 2

80

118

22

HSP70

5729877

4,17

70

279

38

HSP27

662841

26

22

121

14

Enzymes
+

ATP synthase, H transporting

32189394

6

56

96

30

Enolase1, alpha

4503571

15

47

117

32

Thioredoxin peroxidase B, chain A

9955007

9

21

61

14

31645

3

36

54

12

433413

12

31

97

19

Glyceraldehyde-3-phosphate
dehydrogenase
Mitochondrial short-chain
enoyl-coenzyme A hydratase 1

Cytoskeletal Proteins
Actin, beta

15277503

23, 7,14

40

104

22

Ubiquilin

24659706

5

62

96

30

Tubulin

14389309

8,16,21

49

103

29

Vimentin

2119204

13,24

54

147

28

Other Proteins
Histone family

4504259

18,19,20,22

14

75

30

ribonucleoprotein C isoform b

4758544

10

32

62

14

CGI-150 protein

16198390

11

33

73

14

R33729-1

3513302

25

16

57

24

Heterogeneous nuclear
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Table 2-2-5. Summary of the up-regulated proteins in SH-SY5Y cells treated with 50 µM

CPF for 24 h compared with control samples.

Protein

NCBI

Molecular

Accession no.

mass (KDa)

Morwse

Coverage

Spot no.

Score

(%)

Chaperone Proteins
HSP90

72222

83

2,3,4

190

40

HSP gp96 precursor

15010550

90

12,15

168

29

HSP70

16507237

72

16

100

19

BIP protein

6470150

71

17

170

30

HSP70 protein isoform 1

5729877

71

18,22

85

10

T complex protein 1

135538

60

9

91

18

Chaperonin containing TCP 1

5453603

57

10

77

18

4506753

50

27

112

13

TATA binding protein interacting protein
49Kda

Enzymes
Propyl 4-hydroxylase

20070125

57

23

56

6

Glucose-6-phosphate dehydrogenase

26224790

55

20

88

10

Protein disulfide isomerase- related

1710248

46

11

62

14

Enolase 1

4503571

47

21

218

36

Regulatory domain of human PP2a

4558258

65

24

84

15

Cytoskeletal Proteins
Tubulin, beta

2119276

49

19

96

24

Vimentin

2119204

53

13,14

248

44

Profilin 1

4826898

15

7, 5

83

15

Coffilin 1

5031635

18

25

70

22

12804891

38

26

103

17

Similar to tubulin ,
beta 5

Other Proteins
Neuro-endocrine specific protein VGF

17136078

67

1

65

11

GDP dissociation inhibitor 1

4503971

51

6

104

32

DNA binding protein

148790

15

8

59

11

H2B histone family

4504259

14

28

92

41

(fragment)

23503064

36

29

130

33

Annexin V

999926

36

30

101

17

Human mitochondrial single-stranded

Eukaryotic translation initiation factor 3

160

A

5

1
30

2

4
21 23

17

26

14
13

27
15

6
24

7
32
10
8
16

3

11

31

12
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9

29
19
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18
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Figure 2-2-3. (A) 2D sodium dodecyl sulfate polyacrylamide gel electrophoresis

(SDS-PAGE) of 350 μg total protein from the control SH-SY5Y cells. Proteins were
separated on an isoelectric focusing strip (pH 3-10 from left to right) in the first dimension
and by linear gradient (8-16%) SDS-PAGE in the second dimension. A lab-synthesized
fluorescent ruthenium reagent was used to stain. The down-regulated proteins (Table 2-2-4
and Table 2-2-6) are labeled on the control (A) gels.
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Figure 2-2-3. (B) 2D sodium dodecyl sulfate polyacrylamide gel electrophoresis

(SDS-PAGE) of 350 μg total protein from the SH-SY5Y cells treated with 50 μM CPF.
Proteins were separated on an isoelectric focusing strip (pH 3-10 from left to right) in the
first dimension and by linear gradient (8-16%) SDS-PAGE in the second dimension. A
lab-synthesized fluorescent ruthenium reagent was used to stain. The up-regulated proteins
(Table 2-2-5 and Table 2-2-7) are labeled on the treated sample gel.
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Among the altered proteins, some correspond to different isoforms of the same
protein. Such isoforms aligned as a horizontal row of several spots on the 2D gel, with
different pI values and the same molecular weight, and likely resulted from
posttranslational modifications. In particular, HSP 90 was identified in 3 spots (Figure
2-2-1) as an up-regulated protein. A similar pattern was observed for enolase with the spots
numbered as 15 in Figure 2-2-3 A and 21 in Figure 2-2-3 B. From amino acid composition
of the enolase, the expected pI is 7.01, however the actual pIs for these two isoforms are
about 5.8 and 6.6. The isoform at spot 15 in Figure 2-2-3 A (pI 5.8) was detected as
down-regulated a protein, but the other isoform at spot 21 in Figure 2-2-3 B (pI 6.6) was
detected as an up-regulated protein. A similar situation was also observed for other proteins
like heat shock proteins, actin proteins, and tubulin proteins.
Proteome analysis of SH-SY5Y cells treated with 50 µM CPF for 16h

The previous discussion explored proteome alterations of SH-SY5Y cells after
treatment with 50 μM CPF for 24 h. At this stage, we were curious to find out what
proteome changes would occur after exposure to CPF for a shorter period of time. In order
to study time-dependent proteome changes of SH-SY5Y cells caused by CPF, a separate
proteome analysis was undertaken following exposure to 50 μM CPF for 16 h. The
resolved protein spots on gels, which showed a 2-fold change in concentration between
control and treated sample based on OD density measurement, were digested by trypsin.
The tryptic digests were further analyzed by MALDI-TOF-MS. The proteins were then
identified by searching the Sprot database using the MASCOT algorithm.
Table 2-2-6 and Table 2-2-7 present an overview of the additional down- and
up-regulated proteins and proteins with changing trends induced by 50 μM CPF for 16 h
compared with an incubation time of 24 h. A total of 48 unique proteins from 68 spots,
which includes the same 37 identified unique proteins as those from the samples treated for
24 h, were identified. Out of the altered proteins, 23 were down-regulated and 25 were
up-regulated after incubation with 50 μM CPF for 16 h. These proteins were identified by
three trials using mass spectrometry. Figure 2-2-3 displays all of the spots (including the
additional proteins identified from the samples treated with 16 h,) corresponding to the
identified proteins on the 2D gels of the sample from the control (Figure 2-2-3 A) and the
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treated SH-SY5Y samples (Figure 2-2-3 B). These identified proteins can be classified as
chaperone proteins, cytoskeletal proteins, enzymes and other proteins.
DISCUSSION
Cell Viability

MTT assay based on the measurement of the reduced product from MTT was
applied to examine cell viability for the cytotoxicity assessment caused by CPF. During
investigation, cell viability was observed as high as 140% for the cells treated with 25 µM
CPF compared with control cells (Figure 2-2-1). A possible explanation for the high MTT
assay value is that CPF promoted enhanced mitochondrial activity producing more
formazan from MTT. Since enhanced mitochondrial activity induced by CPF can cause an
increase in the abundance of reactive oxygen species in cells, cellular oxidative stress may
be a consequence of CPF exposure. The increase of the measured cell viability indicated
the increase of oxygen radicals, which is consistent with the result of Crumpton et al. (111)
who showed that increased reactive oxygen species are associated with CPF in PC12 cells.
Evaluation of 2D Gel Electrophoresis Reproducibility

2D gel electrophoresis is an extremely powerful tool for the analysis of complex
protein mixtures. The utility of this technique lies in its enormous resolving power, which
allows for the separation of approximately 2,000 proteins in a single electrophoretic run.
This technique is powerful for detecting small changes in the levels or properties of
proteins in response to changes in cellular conditions. However, several factors can
influence the quantification feature of 2D gel electrophoresis, such as solubilization of
proteins, rehydration condition of IPG strips, staining, and how PDQuest is used to analyze
gel images. The reproducibility of 2D gels can be improved by keeping the practical
parameters constant or running all samples at the same time. Even so, there is still another
question about the quantification property of this technique. Does the OD value really
reflect the real amount of protein in mixtures? The hypothesis of the quantification by 2D
gel electrophoresis is that the same percentage of protein in the sample should have the
same normalized optical density (OD) on the 2D gel using PDQuest software.
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Table 2-2-6. Summary of the additional down-regulated proteins following treatment of

SH-SY5Y cells with 50 µM CPF for 16 h compared with control samples
Protein
Stress-induced-phosphoprotein 1

Accession
#(Sprot)

Molecular
mass (KDa)

Chapterone proteins
P31948
63

Spot
#
26, 27

Score

146

Cov(%)

26

Enzymes
Ubiquitin carboxyl-terminal hydrolase
isozyme L1

Stathmin
Lamin B2

25

28

59

30

P16949

17

29

120

53

Q03252

63

30

68

7

25
34
23

31
32
33

58
90
104

13
16
50

P09936
Cytoskeletal Protein

Other Proteins
Elongation factor 1-beta
GTP-binding protein GEM
Rho GDP-dissociation inhibitor 1

P24534
P55040
P52565
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Table 2-2-7. Summary of the additional up-regulated proteins following treatment of

SH-SY5Y cells with 50 µM CPF for 16 h compared with control samples.

Protein

Accession
#(Sprot)

Molecular
mass (KDa)

Spot
#

Score

Cov(%)

Enzymes
ATP synthase chain, mitochondrial
precursor
Carbonic anhydrase-related protein 10
Stathmin 3 (SCG10-like protein)
RAS-related protein Rab-25

P06576
Q9NS85

57

31

77

18

38
Cytoskeletal Proteins

32

53

10

Q9NZ72
Other Proteins

21

34

68

17

P57735

23

33

58

14
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The reproducibility of 2D gel electrophoresis was investigated using four proteins
as standards in this chapter. Two sets of experiments were performed. Results showed that
the experimental data were consistent with the expected data (Table 2-2-2 and 2-2-3),
which indicated that 2D-PAGE was a reliable technique for protein quantification.
Evaluation of Protein Identification with Combination of 2DE and MALDI

Protein identifications were also investigated using proteins, BSA, Ova, CA and
STI, as standards in this chapter. In the validation experiments, 0.1 µg of each protein was
used to do small format 2D gel experiments and three replicate experiments were
performed. Proteins were identified by comparing the experimental MALDI mass spectra
of the tryptic digests with those from ‘in silico digestion’. Results clearly demonstrated the
identies of proteins with significant match. The highest MOWSE scores (n=3) for BSA
Ova, CA and STI were 1280, 1050, 980 and 550, respectively.
Proteome Analysis of SH-SY5Y Cells Exposed to 50 µM CPF for 24h

Previous studies of the effects of CPF on neuron development have focused on
specific protein alterations, especially Ca2+/cAMP response element binding protein
(CREB) and adenylyl cyclase (95, 96) using Western-blot and activity assays. There have
been no simultaneous, quantitative proteomic studies of changes in protein expression
from SH-SY5Y cell cultures treated with CPF at low exposure levels.
This is the first study to investigate proteome analysis of SH-SY5Y cells treated
with 50 μM CPF for 24 h. A total of 37 unique, altered proteins were identified in three
parallel experiments. These proteins can be classified as chaperone proteins, cytoskeletal
proteins, enzymes and other proteins based on their functions. Characterization of proteins
identified in these experiments showed that they were from diverse pathways, including
ATP energy production, neuritogenesis, protein synthesis, DNA transcription, cell
signaling cascades, and antioxidant defense systems.
ATP Energy Production

ATP synthase was detected as a down-regulated protein in CPF-treated samples.
This protein plays important roles in the synthesis of ATP from ADP and Pi in the presence
of a proton gradient across the membrane. The detected ATP synthase is responsible for
proton transportation into the matrix to form ATP. We also observed that one isoform of
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enolase 1 (spot 15 in Figure 2-3-3 A) and glyceraldehyde-3-phosphate dehydrogenase
were down-regulated. Meanwhile, another isoform of enolase 1 (spot 21 in Figure 2-2-3 B)
was up-regulated in CPF-treated neurons. Enolase is important for the ninth step in
glycolysis, and glyceraldehydes-3-phosphate dehydrogenase is responsible for the sixth
step. Because our study quantified different isoforms of the protein on 2D gels, it was a
challenge to determine the total change of enolase represented by different isoforms.
Down-regulation of proteins associated with ATP production suggests that ATP levels
decreased following exposure to CPF at subcytotoxic doses. These results were consistent
with those of Song et al.(95), who showed that adenylyl cyclase, which catalyzes the
formation of cyclic AMP from ATP, decreased after exposed to CPF at low levels.
Neuritogenesis

Actin is the most abundant cytoskeletal protein in the neuronal proteome. The state
of actin polymerization determines the status of cytoskeleton, neurite (baby axon) and
growth cone mobility (101), as well as neurite maintenance and extension. Actin
polymerization can make axons extend within the growth cone, a highly dynamic structure
at the tip of the axon. In this study, several isoforms of actin (spots marked as 7, 14, 23 in
Figure 2-2-3 A and Table 2-2-4) were detected as down-regulated proteins induced by CPF.
Changes in actin reported here indicate changes in actin polymerization, which is very
important in neuritogenesis and the spiny outgrowths on dendrites. Dendritic spines are
known to change shape, to the extension of appearing and disappearing entirely. It has
long been hypothesized that such changes may be the basis of memory itself (102) (103).
Actin is thought to mediate these changes in dendritic spine shape (104). Therefore, actin
changes can eventually lead to long term irreversible learning damage.
Several detected altered proteins play important roles in the regulation of actin
polymerization. Rho GDI, which is a small G protein and regulates the reorganization of
the actin cytoskeleton, was detected as up-regulated in CPF-treated samples. The role of
Rho GDI in pathways is displayed in Figure 2-2-4. The up-regulation of Rho GDI suggests
decrease in actin levels and indeed three isoforms of which were detected as
down-regulated. Cofilin, which is critical in the control of polymerization/
depolymerzation of actin, increased in the CPF-treated cultures. Levels of annexin V,
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which was reported as a γ-actin binding protein and influences actin polymerization in
neuritogenesis (75), were also increased. The elevation of annexin V observed here may be
a compensatory response of cells to increase levels of functional protein necessary for the
maintenance of actin levels. Profilin another actin-binding protein, which regulates actin
polymerization, was detected as an up-regulated protein in CPF-treated neurons. The
addition of profilin usually inhibits the assembly of actin filaments, thereby resulting in the
decrease of actin. Results suggest that the neuritogenesis may be damaged due to decreased
actin.
Actin is not the only important protein in neuritogenesis; vimentin and tubulin also
play important roles. Three main cytoskeletal systems (including microtubules,
intermediate filaments, and microfilaments composed of tubulin, vimentin and actin)
regulate the growth of neurites (axons and dentrites) and their subsequent maintenance,
stability and functionality. These cytoskeletal proteins are important in generating and
maintaining the morphology of differentiating neurons, motility and leading the pathway
of growth cones as well as helping to transport cytoplasmic constituentes (105). Although
these skeletal proteins share some common functions, they also have some unique
functions as described in the next several paragraphs.
The expressions of three isoforms of vimentin (Vm) were altered after exposure to
CPF. Vm at spots 13 and 24 in Figure 2-2-3 A were detected as down-regulated; however,
Vm at spots 13 and 14 in Figure 2-2-3 B were up-regulated. Vm from the native source has
several isoforms due to differential phosphorylations (106). These identified Vm isoforms
suggested that the cross-linked infrastructure of an axon may be altered by CPF, resulting
in neuritogenesis alteration. The reason is that vimentin is an intermediate filament species
which is gradually replaced by neurofilaments during the development of axonal stability
(23). In addition, vimentin plays an important role in neurite initiation in the neuroblastoma
and hippocampal neurons in culture (22).
Tubulins were identified as altered proteins in this study with many different
isoforms resulting from posttranslational modifications. Three posttranslational
modifications of α-tubulin are described in the literature (106), and β-tubulin has
significantly more complicated and undetermined modifications (106). Here, tubulin at
spots 8, 16, and 21 in Figure 2-2-3 A was detected as down-regulated proteins, but tubulin
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at spots 19 and 26 in Figure 2-2-3 B was up-regulated. Since all the isoforms of tubulin are
structural units for microtubules, the different developing trends of tubulin isoforms must
result in different adverse consequence based on their specific functions in neurons. Thus,
the changes in tubulin expressions induced by CPF exposure indicated that the
developmental neuritogenesis would be damaged.
All the above information suggested that neuritogenesis in neuron cells was
impaired after treated with 50 µM CPF for 24 h. During brain development, neurite grows
toward other regions of the nerve system or other organisms such as muscle to form
connections. Since the proper functioning like memory/learning of the nervous system
depends on the proper formation of proper connections, any disturbance on the
neurogenesis could cause dysfunction of neurons.
Protein Synthesis

Studies (107) (108) in a variety of species have shown that the consolidation of
newly acquired memories into stable long-term memories depends on the synthesis of new
proteins and gene transcription in neurons. One can say that the influence of protein
synthesis parthway in neurons could cause memory/learning damage. Eukaryotic
translation initiation factor 3 (eIf) was been detected as an up-regulated protein in
CPF-treated samples. Translation initiation factors associated with ribosomes are required
for the initiation phase of protein synthesis. The observation of the increased levels of eIF,
which is involved in the synthetic pathway of other proteins, suggests a compensatory
increase by cells exposed to CPF to maintain protein levels. These results are consistent
with previous studies, which showed that CPF significantly reduced protein synthesis (95).
Heterogeneous nuclear ribonucleoprotein C, which modulates translation of c-myc mRNA
(61), was detected as a down-regulated protein in CPF-treated cultures. The decrease of
this protein suggests the responding decrease of the translation of mRNA, thus the decrease
of protein synthesis.
DNA Transcription

Because histones bind DNA to form nucleosomes, histone proteins regulate the
chromatin structure and function related to transcriptional activity and other nuclear
functions (109). The posttranslational modifications of the histones are very important for
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the regulation of transcription and chromatin condensation. The detected histone proteins
showed a similar pattern as a row of spots, some of which (spots at 18, 19, 20, 22 in Figure
2-2-3 A) were identified as down-regulated, some of which (spot at 28 in Figure 2-2-3 B)
were up-regulated in cells treated with 50 µM CPF for 24 h. This phenomenon implies that
the changed modifications of the histones may result in transcriptional changes, which may
induce memory damage. As known, long-term memory requires new gene expression or
gene transcription, which involves the formation of new synaptic connections.
Proteome Analysis of SH-SY5Y Cells Exposed to 50 µM CPF for 16 h

In the proteome analysis of SH-SY5Y cells from experiments treated with vehicle
alone (control) or 50 μM CPF for 16 h, 48 unique altered proteins were identified.
Comparing these identified proteins with those from the samples incubated with CPF for
24 h, 37 unique proteins were observed to be identical. However, 11 additional unique
proteins were identified from the samples with incubation time of 16 h. Most of the
identified common proteins demonstrated the same trend including glyceraldehyde
3-phosphate dehydrogenase (G-3-PD), which was detected as down-regulated in both 16 h
and 24 h samples. However, some protein isoforms were detected as down-regulated in this
work, but up-regulated in a former work, such as Rho GDP-dissociation inhibitor (Rho
GDI). Proteins identified in these experiments, which play an important role in diverse
pathways including ATP energy production, DNA synthesis, cell signaling cascades,
axonogenesis and oxidative stress, showed different response trends with time-dependent
incubation with CPF. Here, only altered proteins with different trends and the newly
identified proteins will be discussed.
One isoform of ATP synthase was detected as an up-regulated protein after
incubation with CPF for 16 h. However, a down-regulation of the enzyme was observed in
the sample treated with CPF for 24 h. As described before, ATP synthase regulates the
synthesis of ATP in mitochondria. Elevation of this protein suggests a compensatory
response of CPF-treated cells for a short time period (16 h) to try to maintain ATP levels.
However, after incubation for longer time (24 h), cells responded to this stimulation by
showing the depletion of ATP synthase, which agrees with that of Braber et al. (112) who
showed that CPF inhibited Ca-stimulated ATP synthase activity.
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One isoform of Rho GDI was detected as a down-regulated protein in cells treated
with CPF for 16 h and another isoform was up-regulated in samples treated for 24 h. This
protein functions as an inhibitor of the dissociation of GDP from Rho proteins and then
inhibits their GDP/GTP exchange reaction, which regulates the formation of cAMP from
ATP. Down-regulated Rho GDI suggests increased cAMP production from ATP, resulting
in low levels of ATP. This is consistent with the other proteins associated with ATP
production, such as ATP synthase. The elevation of Rho GDI at 24 h suggests that longer
incubation provides enough time for SY5Ys to adjust to the low levels of ATP in the
system. Furthermore, Rho GDI is important in the mediation of cytoskeletal organization.
GTP-binding protein GEM, another G-protein, was detected as down-regulated protein in
the cells after incubation for 16 h with CPF. The GEM protein interfaces with the Rho
pathway and eventually leads to alterations in cellular neurite growth (113). The decrease
in GEM suggests a compensatory response of cells to increase the levels of actin, which
was detected as down-regulated in this study.
Eukaryotic elongation factor 1-beta (elf), which plays a critical role in the
elongation phase of protein synthesis, was detected as a down-regulated protein in cells
after incubation with CPF for 16 h. The decrease of this protein suggests a decrease of
protein synthesis, which is consistent with previous studies that CPF significantly reduces
protein synthesis (95).
Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1), a neuronal
de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial
Parkinson's disease (PD), was detected as a down-regulated protein. This result is
consistent with the findings of Choi et al (114), who reported that UCH-L1 was
down-regulated in idiopathic PD as well as in Alzheimer's disease (AD) brains. The
down-regulated UCH-L1 suggests a direct link between damage to neurons and
neurodegenerative diseases.
Actions of these altered proteins caused by CPF are summarized in Figure 2-2-4.
These detected proteins play important roles in energy production, protein synthesis, DNA
transcription, antioxidant defense system, and cell signaling cascades, all of which interact
with each other through energy transfer or signal transductions. In brief, cells must be
ready to respond to essential signals in their environment. Signaling molecules are often
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Figure 2-2-4. Summary for the modes of action of CPF-induced altered proteins in the

energy production cycle, antioxidant defense systems and cell signaling cascades.
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Figure 2-2-5. Distribution of the identified proteins including the down- and up-regulated

proteins according to their functions.
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chemicals such as hormones, cytokines, or CPF in this study. Some signal proteins, such as
Rho GDI (a G-protein), can receive the signals and further transmit it by regulating
GDP/GTP exchange and eventually modulating axonogenesis development. The inhibition
of GDP/GTP exchange reactions catalyzes the formation of cAMP from ATP, which
further causes changes in all metabolism (e.g. glycogenolysis). The changes in metabolism
lead to changes in protein synthesis and changes in the antioxidant defense system.
Furthermore, these signal molecules can trigger changes in DNA transcription and electric
potential across the plasma membrane. It is evident that all cellular responses are related to
one other.
The detected proteins were categorized by their functions, as shown in Figure 2-2-5.
The largest percentage of detected proteins was neural structural proteins and chaperone
proteins. This is understandable, as a range of physiological stresses can induce the
expression of heat shock proteins (115). Furthermore, neuron structural proteins are the
most abundant proteins and play important roles during neuron development.
CONCLUSIONS

We have successfully investigated the proteome of SY5Y cells treated with 50 μM
CPF for 24 h and 16 h with the combination of 2D gel electrophoresis with
MALDI-TOF-MS. Using this approach, we simultaneously, quantitatively identified the
CPF- induced altered proteins (both up- and down- regulated). A total of 37 common
unique proteins from 56 spots were identified, out of which 16 proteins from 26 ± 4 spots
were down-regulated, and 21 proteins from 30 ± 3 spots were up-regulated (mean ± SD of
three experiments). These identified proteins play important roles in ATP production,
neuritogenesis, protein synthesis, DNA transcription, signaling cascades and antioxidant
defense systems. These detected proteins support the hypothesis that alterations in protein
expressions underlie the impairment of energy production, protein synthesis, and
neuritogenesis. All these studies show that cells need time to respond to the ‘stimulations’
caused by CPF. In order to respond to these stimulations from CPF, the cells have evolved
a response system that induces cell cycle to allow sufficient time to repair or follow the
cascades of the damage.
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It is still unclear how these protein changes were initiated by CPF. We suggest that
some signal proteins, such as Rho GDI, first receive the signal or insult from the cell
environment, and further transmit the signal to the whole cell through energy production,
or protein synthesis pathways. Based on the protein functions, several altered proteins,
such as ATP synthase, vimentin, and Rho GDI, will be further investigated in the next step
of experiments using bio-techniques. Mutation studies and metabolic experiments on
animals, such as mice, will be the future experiments. It is very promising to understand the
mechanism in biochemical pathways leading to neurodegeration associated with cognitive
damage after exposure to CPF at subtoxic levels.
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CHAPTER THREE
CONCLUSIONS

There is an increasing concern about exposure of pregnant women, infants and
children to chlorpyrifos (CPF), an organophosphate insecticide. This concern is based on
the in vitro and in vivo studies, which indicate that CPF is a developmental neurotoxin.
Previous studies suggest that CPF, at concentrations below the threshold for symptoms of
systemic toxicity, disrupts brain development and damages cognitive function. Studies
both in vivo and in vitro confirmed that CPF at levels that do not cause cytotoxicity can
compromise cellular processes in brain development. However, the actual mechanism for
CPF perturbation in neuron development at the subcellular level remains unclear and
complicated. This was the first study to systematically investigate CPF neurotoxicity at the
subcellular level using SH-SY5Y as a model system. We tested the hypothesis that changes
in protein expression underlie neuronal anomalies associated with CPF exposure.
We successfully investigated differential protein expression in SY5Y cells treated
with 50 µM CPF using 2D-PAGE with MALDI-TOF-MS. The time-dependent proteome
changes of SH-SY5Y cells resulting from CPF exposure were also successfully examined.
This was based on the comparison of the proteome changes of the neuroblastoma cells
treated with CPF for 24 h and 16 h. A total of 37 common unique proteins from 56 spots
were identified as altered proteins. However, 11 additional unique proteins were detected
as altered proteins in samples treated with CPF for 16h. These identified proteins play
important roles in ATP production, neuritogenesis, protein synthesis, DNA transcription,
signaling cascades and antioxidant defense systems. The changes in protein expression
suggested that the alterations were due to cellular responses to CPF stimulation. It is
evident that cells need time to respond to the ‘stimulation’ caused from CPF by evolving a
response system, which induces cell cycle to allow for sufficient time to repair or follow
the cascades of the damage.
2D gel electrophoresis has been a core technology of proteome analysis since the
1980s. The technique offers high-throughput and relatively high reproducibility in
combination with either MALDI-TOF-MS or LC/MS. 2D gel electrophoresis is an
extremely powerful tool for the analysis of complex protein mixtures. The utility of this

177

technique lies in its enormous resolving power, which allows for the separation of
approximately 2,000 proteins in a single electrophoretic run. The technique is powerful for
detecting small changes in the levels or properties of proteins in response to changes in
cellular conditions. However, 2D-PAGE is not the only method for proteome analysis.
Many research groups are beginning to realize that “MudPIT” (Multidimensional Protein
Identification Technology) is an alternate powerful tool. The rapid development of the
technique relies on reduced sample preparation and manual labor compared to 2D gel
electrophoresis.
Thirty seven common unique proteins were detected as altered proteins in this
study. Based on their functions, ATP synthase, vimentin, Rho GDI, and eukaryotic
translation initiation factor (eif) will be chosen for further experiments using
bio-techniques. The proteins of interest play important roles in ATP production,
neuritogenesis, signal cascade protein, and protein synthesis, respectively. Once we
systematically understand the altered proteins of the entire SH-SY5Y cells treated by CPF,
mutation studies and metabolic experiments on animals, such as mouse, will be followed.
These investigations can allow us to clearly understand the actual mechanism for CPF
perturbations in neuron development at the subcellular level.
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GENERAL CONCLUSION

Some bizarre and puzzling problems, such as altered behaviors of animals in
mating, parenting, and nesting, have been discovered all over the world since the 1950s.
Many of the disturbing wildlife reports involved behavioral abnormalities and
malfunctioning sexual organs, leading to damaged fertility. The loss of young, or the
sudden disappearance of entire animal populations indicated that wildlives are disturbed.
Most of these incidents seemed associated somehow to chemical pollution, especially
man-made pesticides. Through the creation and release of billions of pounds of these
man-made chemicals over the past half century, we have been instigating large-scale
changes to the Earth’s atmosphere and even in chemistry of our own bodies. The
magnitude of the damage is frightening. Most disturbing of all, many of us already carry
contamination levels that may put us and our children at considerable risk.
In the most extreme circumstances, chemicals were intentionally used as weapons
for mass destruction. Associated with military operations, chemical warfare (CW) agents
are designed with a high ability to kill, injure or incapacitate the enemy (including military
and civilians). Chemical warfare was revolutionized, during World War II, by the
discovery by Nazi Germany of nerve agents such as tabun, sarin and soman. Fortunately,
the CW agents were not extensively applied during that time. The threat of CW became
foremost during the Cold War. Both the Soviet and Western governments poured
enormous resources into developing chemical and biological weapons. After the Cold War,
mass destructions involving CW reagents occurred on several occasions. Implementation
and use of these CW weapons have often led to tragic memories and terrible costs to human
lives. About 100,000 Iranian soldiers were victims of Iraqi chemical attacks in 1980.
Approximately 5000 Iraqi Kurdish civilians were slaughtered in a few hours by chemical
bombs with multiple chemical agents. Things became worse, when CW agents were used
as tools by many terrorist organizations. Several events involving the notorious use of CW
agents in non-combat settings happened for several occasions lately. The most recent one
was the Tokyo subway attack with sarin in 1995.
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Defending ourselves from the hazard requires actions on several fronts involving
scientific researches. As bioanalytical scientists, we have been conducting research driven
by the need to answer several crucial questions:

•

What are the chemicals exposed to people?

•

Whar are the exposure levels?

•

How is the human body really responding to these chemicals?

The ultimate goal of pesticide exposure research should be recovery of victims. However,
efforts are still required for the early detection of pesticide exposure and knowledge of
pesticide effects on human before recovery comes to be true. As such, reliable, sensitive
and accurate clinical diagnostics are critical in saving human lives and increasing public
health.
The concern of public health is increasing because of the extensive use of pesticides
and occasional applications of CW agents in local conflicts or terrorism. Public health
demands more sensitive and reliable programs for monitoring pesticide exposure. In the
first part of this dissertation, a methodology was designed to solve the first two crucial
questions mentioned before. This was achieved based on a full understanding of the
chemistry, mode of action and toxicity of OPs and CBs, along with careful experimental
design in mass spectrometry. The new methodology was based on the analysis of inhibited
BChE by pesticides, particularly based on the detection of modified active site peptides
generated from trypsin digests of the enzyme. The methodology employed proteomic
approaches and much more sensitive, selective, accurate mass spectrometry techniques.
Although the MALDI method was proven as a powerful tool for the analysis of single
pesticide exposure, the lower ionization efficiency of phosphorylated peptides in MALDI
and the suppression of the modified peptides in a complex peptide mixture make this
method limited for the analysis of multiple pesticide exposure. However, LC/MS/MS can
particularly analyze the precursor ions of interest in the ion trap with the presence of other
abundant peptides. LC/MS/MS techniques were successfully applied to analyze a mixture
of the phosphorylated peptides in vitro, and the precursor ions were monitored by a
common fragment ion.
Application of the developed LC/MS/MS methodology for measuring pesticide
exposure in vitro and in serum samples clearly demonstrated the power of MS-based
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method development in pesticide analysis. Results clearly displayed critical evidence of
the exposure to OPs and CBs as low as 5 % human BChE inhibition in serum, which the
traditional Ellman method can not detect. To design a reliable monitoring methodology
and effect a treatment for victims, it is imperative that research focuses on the identification
and quantification of exposure to OPs and CBs at early exposure times and at low levels.
LC/MS/MS techniques can be broadly applied for the other possible pesticide analysis,
such as CW agents, due to the large varieties of LC/MS parameters. For instance, many
fragmentation techniques in MS and many types of LC columns can be adjusted to the
analyte of interest. The technique of packing columns in laboratory makes it more
attractive by customizing columns with the analyte of interest with numerous types of
stationary phase available. As such, it is very promising to apply LC/MS-based methods
for the analysis of other man-made chemicals. Metabolic studies in other body fluids, such
as urine, coupled LC/MS/MS with the other techniques can further provide an indication of
pesticide or CW agent exposure.
The two critical questions, ‘what are the chemicals’ and ‘Whar are the exposure
levels’, were successfully answered in the first part of this dissertation. To answer the third
crucial question, a comprehensive research program is needed to determine the effects of
synthetic chemicals on human health. Probing such questions will require a sophisticated
integration of epidemiology on human populations, animal studies, and laboratory
investigations of how these chemicals act at the cellular and molecular level.
Epidemiological studies are never easy, and particularly difficult in the following instances.
First, researchers confront the lack of an uncontaminated population for comparison. All
young persons in our society are more or less exposed to synthetic chemicals. Second of all,
there is a long time between exposure to these chemicals and the emergence of ill effects.
Scientists find that the good opportunities for testing human health effects are cell culture,
tissue culture, and organ culture. The diversities of cultures make it more appealing to
achieve the different goals of various research subjects, as well as avoiding the long time
period needed.
The second part of this dissertation focused on the proteome analysis of SH-SY5Y
cells, a neuroblastoma cell line, in an effort to obtain a clear understanding of protein
expression in a CPF-treated sample. The protein expression indicated how the cells
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respond to essential stimulation resulting from 50 µM chlorpyrifos (CPF), an
organophosphate pesticide. The concerns of CPF exposure to pregnant women, infants and
children are increasing due to its developmental neurotoxic effects. The main hypothesis of
part two of this dissertation was that changes in protein expression underlie neuronal
anomalies associated with CPF exposure. In this dissertation, we investigated the whole
proteome alteration induced by CPF at the concentration levels below the threshold for
symptoms of systemic toxicity using SH-SY5Y cell line as a model system.
Two-dimensional gel electrophoresis (2DE) was applied with MALDI-TOF-MS to
analyze differential protein expression. A total of 37 common unique altered proteins were
identified, which play important roles in energy production, protein synthesis, DNA
transcription, antioxidant defense system, and cell signaling cascades. The changes in
protein expression suggest the changes resulting from cell response. Part II of this
dissertation provided a basic insight for understanding how undifferentiated
neuroblastoma cells respond to CPF at concentration levels without causing cytotoxicity.
Some altered proteins, such as ATP synthase, will be further investigated to clearly
understand how CPF influences neuron development. These closer examinations should
combine biochemical techniques. A quantitative proteomics method combining
multi-dimensional chromatographic separation method (MudPIT) and ICAT will probe the
proteome analysis in a more productive way.
In order to thoroughly investigate differential protein expression of neuroblastoma
cells, proteome analysis of different organelles, such as proteins extracted from
mitochondria, should be examined. A sophisticated integration of epidemiology on human
populations, animal studies, and laboratory investigations is required to determine the
effects of pesticide on human health at the cellular and molecular level. Once we
systematically understand the altered proteins of the entire SH-SY5Y cells treated by CPF,
mutation studies and metabolic experiments on animals, such as mouse, will follow. These
investigations can allow us to clearly understand the actual mechanism for CPF
perturbation in neuron development at the subcellular level. Results from these
investigations can definitely enable us to find a way to cure or alleviate symptoms of the
memory damage and learning disability caused from CPF.
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The world market in pesticides amounted to 5 billion pounds in 1989 and included
sixteen hundred chemicals. In this dissertation, we successfully analyzed the detection and
quantification of two types pesticide of exposure (Part I), and we also successfully
investigated how neuroblastoma cells respond to one kind of OP using a proteomics
approach and mass spectrometry (Part II). This dissertation reveals a promising future of
the proteomics approach and mass spectrometry for pesticide analysis, because of high
sensitivity and high-throughput of this technique. However, this technique does have its
shortcomings and will not be able to single-handedly tackle and analyze all pesticides. In
addition, some emergent situations like the 1995 Tokyo Subway Attack, required a quick
investigation from forensic analysis. How to apply the method in the field is a challenge for
mass spectrometry specialists. A portable mass spectrometer with high sensitivity should
be invented in the next few years. In addition, a culmination of several techniques,
including but not limiting to mass spectrometry, UV, and biosensors, will result in the most
productivity of pesticide analysis. The next several years should be very exciting as
researchers apply mass spectrometry techniques and combine this with the other
techniques for the purpose of answering the three crucial questions about pesticides and the
other man-made chemicals.
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